id	sid	tid	token	lemma	pos
ajlm-741	1	1	abstract	abstract	ADJ
ajlm-741	1	2	introduction	introduction	NOUN
ajlm-741	1	3	surveillance	surveillance	NOUN
ajlm-741	1	4	of	of	ADP
ajlm-741	1	5	antimicrobial	antimicrobial	ADJ
ajlm-741	1	6	resistance	resistance	NOUN
ajlm-741	1	7	in	in	ADP
ajlm-741	1	8	healthcare	healthcare	NOUN
ajlm-741	1	9	-	-	PUNCT
ajlm-741	1	10	associated	associate	VERB
ajlm-741	1	11	pathogens	pathogen	NOUN
ajlm-741	1	12	in	in	ADP
ajlm-741	1	13	africa	africa	PROPN
ajlm-741	1	14	surveillance	surveillance	NOUN
ajlm-741	1	15	of	of	ADP
ajlm-741	1	16	antimicrobial	antimicrobial	ADJ
ajlm-741	1	17	resistance	resistance	NOUN
ajlm-741	1	18	in	in	ADP
ajlm-741	1	19	healthcare	healthcare	NOUN
ajlm-741	1	20	-	-	PUNCT
ajlm-741	1	21	associated	associate	VERB
ajlm-741	1	22	pathogens	pathogen	NOUN
ajlm-741	1	23	in	in	ADP
ajlm-741	1	24	south	south	PROPN
ajlm-741	1	25	africa	africa	PROPN
ajlm-741	1	26	acknowledgements	acknowledgement	NOUN
ajlm-741	1	27	references	reference	NOUN
ajlm-741	1	28	about	about	ADP
ajlm-741	1	29	the	the	DET
ajlm-741	1	30	author(s	author(s	NOUN
ajlm-741	1	31	)	)	PUNCT
ajlm-741	1	32	ashika	ashika	NOUN
ajlm-741	1	33	singh	singh	ADJ
ajlm-741	1	34	-	-	PUNCT
ajlm-741	1	35	moodley	moodley	NOUN
ajlm-741	1	36	centre	centre	NOUN
ajlm-741	1	37	for	for	ADP
ajlm-741	1	38	healthcare	healthcare	NOUN
ajlm-741	1	39	-	-	PUNCT
ajlm-741	1	40	associated	associate	VERB
ajlm-741	1	41	infections	infection	NOUN
ajlm-741	1	42	,	,	PUNCT
ajlm-741	1	43	antimicrobial	antimicrobial	ADJ
ajlm-741	1	44	resistance	resistance	NOUN
ajlm-741	1	45	and	and	CCONJ
ajlm-741	1	46	mycoses	mycose	NOUN
ajlm-741	1	47	,	,	PUNCT
ajlm-741	1	48	national	national	PROPN
ajlm-741	1	49	institute	institute	NOUN
ajlm-741	1	50	for	for	ADP
ajlm-741	1	51	communicable	communicable	NOUN
ajlm-741	1	52	diseases	disease	NOUN
ajlm-741	1	53	,	,	PUNCT
ajlm-741	1	54	johannesburg	johannesburg	PROPN
ajlm-741	1	55	,	,	PUNCT
ajlm-741	1	56	south	south	PROPN
ajlm-741	1	57	africa	africa	PROPN
ajlm-741	1	58	husna	husna	PROPN
ajlm-741	1	59	ismail	ismail	PROPN
ajlm-741	1	60	centre	centre	PROPN
ajlm-741	1	61	for	for	ADP
ajlm-741	1	62	healthcare	healthcare	NOUN
ajlm-741	1	63	-	-	PUNCT
ajlm-741	1	64	associated	associate	VERB
ajlm-741	1	65	infections	infection	NOUN
ajlm-741	1	66	,	,	PUNCT
ajlm-741	1	67	antimicrobial	antimicrobial	ADJ
ajlm-741	1	68	resistance	resistance	NOUN
ajlm-741	1	69	and	and	CCONJ
ajlm-741	1	70	mycoses	mycose	NOUN
ajlm-741	1	71	,	,	PUNCT
ajlm-741	1	72	national	national	PROPN
ajlm-741	1	73	institute	institute	NOUN
ajlm-741	1	74	for	for	ADP
ajlm-741	1	75	communicable	communicable	NOUN
ajlm-741	1	76	diseases	disease	NOUN
ajlm-741	1	77	,	,	PUNCT
ajlm-741	1	78	johannesburg	johannesburg	PROPN
ajlm-741	1	79	,	,	PUNCT
ajlm-741	1	80	south	south	PROPN
ajlm-741	1	81	africa	africa	PROPN
ajlm-741	1	82	olga	olga	PROPN
ajlm-741	1	83	perovic	perovic	PROPN
ajlm-741	1	84	centre	centre	PROPN
ajlm-741	1	85	for	for	ADP
ajlm-741	1	86	healthcare	healthcare	NOUN
ajlm-741	1	87	-	-	PUNCT
ajlm-741	1	88	associated	associate	VERB
ajlm-741	1	89	infections	infection	NOUN
ajlm-741	1	90	,	,	PUNCT
ajlm-741	1	91	antimicrobial	antimicrobial	ADJ
ajlm-741	1	92	resistance	resistance	NOUN
ajlm-741	1	93	and	and	CCONJ
ajlm-741	1	94	mycoses	mycose	NOUN
ajlm-741	1	95	,	,	PUNCT
ajlm-741	1	96	national	national	PROPN
ajlm-741	1	97	institute	institute	NOUN
ajlm-741	1	98	for	for	ADP
ajlm-741	1	99	communicable	communicable	NOUN
ajlm-741	1	100	diseases	disease	NOUN
ajlm-741	1	101	,	,	PUNCT
ajlm-741	1	102	johannesburg	johannesburg	PROPN
ajlm-741	1	103	,	,	PUNCT
ajlm-741	1	104	south	south	PROPN
ajlm-741	1	105	africa	africa	PROPN
ajlm-741	1	106	citation	citation	PROPN
ajlm-741	1	107	singh	singh	PROPN
ajlm-741	1	108	-	-	PUNCT
ajlm-741	1	109	moodley	moodley	NOUN
ajlm-741	1	110	a	a	NOUN
ajlm-741	1	111	,	,	PUNCT
ajlm-741	1	112	ismail	ismail	PROPN
ajlm-741	1	113	h	h	PROPN
ajlm-741	1	114	,	,	PUNCT
ajlm-741	1	115	perovic	perovic	ADJ
ajlm-741	1	116	o.	o.	NOUN
ajlm-741	1	117	an	an	DET
ajlm-741	1	118	overview	overview	NOUN
ajlm-741	1	119	of	of	ADP
ajlm-741	1	120	antimicrobial	antimicrobial	ADJ
ajlm-741	1	121	resistance	resistance	NOUN
ajlm-741	1	122	surveillance	surveillance	NOUN
ajlm-741	1	123	among	among	ADP
ajlm-741	1	124	healthcare	healthcare	NOUN
ajlm-741	1	125	-	-	PUNCT
ajlm-741	1	126	associated	associate	VERB
ajlm-741	1	127	pathogens	pathogen	NOUN
ajlm-741	1	128	in	in	ADP
ajlm-741	1	129	south	south	PROPN
ajlm-741	1	130	africa	africa	PROPN
ajlm-741	1	131	.	.	PUNCT
ajlm-741	2	1	afr	afr	PROPN
ajlm-741	2	2	j	j	PROPN
ajlm-741	2	3	lab	lab	PROPN
ajlm-741	2	4	med	med	PROPN
ajlm-741	2	5	.	.	PUNCT
ajlm-741	2	6	2018;7(2	2018;7(2	NUM
ajlm-741	2	7	)	)	PUNCT
ajlm-741	2	8	,	,	PUNCT
ajlm-741	2	9	a741	a741	PROPN
ajlm-741	2	10	.	.	PUNCT
ajlm-741	2	11	https://doi.org/10.4102/ajlm.v7i2.741	https://doi.org/10.4102/ajlm.v7i2.741	PROPN
ajlm-741	2	12	review	review	NOUN
ajlm-741	2	13	article	article	NOUN
ajlm-741	2	14	an	an	DET
ajlm-741	2	15	overview	overview	NOUN
ajlm-741	2	16	of	of	ADP
ajlm-741	2	17	antimicrobial	antimicrobial	ADJ
ajlm-741	2	18	resistance	resistance	NOUN
ajlm-741	2	19	surveillance	surveillance	NOUN
ajlm-741	2	20	among	among	ADP
ajlm-741	2	21	healthcare	healthcare	NOUN
ajlm-741	2	22	-	-	PUNCT
ajlm-741	2	23	associated	associate	VERB
ajlm-741	2	24	pathogens	pathogen	NOUN
ajlm-741	2	25	in	in	ADP
ajlm-741	2	26	south	south	PROPN
ajlm-741	2	27	africa	africa	PROPN
ajlm-741	2	28	ashika	ashika	PROPN
ajlm-741	2	29	singh	singh	PROPN
ajlm-741	2	30	-	-	PUNCT
ajlm-741	2	31	moodley	moodley	NOUN
ajlm-741	2	32	,	,	PUNCT
ajlm-741	2	33	husna	husna	PROPN
ajlm-741	2	34	ismail	ismail	PROPN
ajlm-741	2	35	,	,	PUNCT
ajlm-741	2	36	olga	olga	PROPN
ajlm-741	2	37	perovic	perovic	PROPN
ajlm-741	2	38	received	receive	VERB
ajlm-741	2	39	:	:	PUNCT
ajlm-741	2	40	20	20	NUM
ajlm-741	2	41	dec	dec	PROPN
ajlm-741	2	42	.	.	PROPN
ajlm-741	2	43	2017	2017	NUM
ajlm-741	2	44	;	;	PUNCT
ajlm-741	2	45	accepted	accept	VERB
ajlm-741	2	46	:	:	PUNCT
ajlm-741	2	47	30	30	NUM
ajlm-741	2	48	may	may	PROPN
ajlm-741	2	49	2018	2018	NUM
ajlm-741	2	50	;	;	PUNCT
ajlm-741	2	51	published	publish	VERB
ajlm-741	2	52	:	:	PUNCT
ajlm-741	2	53	06	06	NUM
ajlm-741	2	54	dec	dec	PROPN
ajlm-741	2	55	.	.	PROPN
ajlm-741	3	1	2018	2018	NUM
ajlm-741	3	2	copyright	copyright	NOUN
ajlm-741	3	3	:	:	PUNCT
ajlm-741	3	4	©	©	PROPN
ajlm-741	3	5	2018	2018	NUM
ajlm-741	3	6	.	.	PUNCT
ajlm-741	4	1	the	the	DET
ajlm-741	4	2	author(s	author(s	PROPN
ajlm-741	4	3	)	)	PUNCT
ajlm-741	4	4	.	.	PUNCT
ajlm-741	5	1	licensee	licensee	NOUN
ajlm-741	5	2	:	:	PUNCT
ajlm-741	5	3	aosis	aosis	NOUN
ajlm-741	5	4	.	.	PUNCT
ajlm-741	6	1	this	this	PRON
ajlm-741	6	2	is	be	AUX
ajlm-741	6	3	an	an	DET
ajlm-741	6	4	open	open	ADJ
ajlm-741	6	5	access	access	NOUN
ajlm-741	6	6	article	article	NOUN
ajlm-741	6	7	distributed	distribute	VERB
ajlm-741	6	8	under	under	ADP
ajlm-741	6	9	the	the	DET
ajlm-741	6	10	terms	term	NOUN
ajlm-741	6	11	of	of	ADP
ajlm-741	6	12	the	the	DET
ajlm-741	6	13	creative	creative	ADJ
ajlm-741	6	14	commons	common	NOUN
ajlm-741	6	15	attribution	attribution	NOUN
ajlm-741	6	16	license	license	NOUN
ajlm-741	6	17	,	,	PUNCT
ajlm-741	6	18	which	which	PRON
ajlm-741	6	19	permits	permit	VERB
ajlm-741	6	20	unrestricted	unrestricted	ADJ
ajlm-741	6	21	use	use	NOUN
ajlm-741	6	22	,	,	PUNCT
ajlm-741	6	23	distribution	distribution	NOUN
ajlm-741	6	24	,	,	PUNCT
ajlm-741	6	25	and	and	CCONJ
ajlm-741	6	26	reproduction	reproduction	NOUN
ajlm-741	6	27	in	in	ADP
ajlm-741	6	28	any	any	DET
ajlm-741	6	29	medium	medium	NOUN
ajlm-741	6	30	,	,	PUNCT
ajlm-741	6	31	provided	provide	VERB
ajlm-741	6	32	the	the	DET
ajlm-741	6	33	original	original	ADJ
ajlm-741	6	34	work	work	NOUN
ajlm-741	6	35	is	be	AUX
ajlm-741	6	36	properly	properly	ADV
ajlm-741	6	37	cited	cite	VERB
ajlm-741	6	38	.	.	PUNCT
ajlm-741	7	1	abstract	abstract	ADJ
ajlm-741	7	2	healthcare	healthcare	PROPN
ajlm-741	7	3	-	-	PUNCT
ajlm-741	7	4	associated	associate	VERB
ajlm-741	7	5	infections	infection	NOUN
ajlm-741	7	6	are	be	AUX
ajlm-741	7	7	a	a	DET
ajlm-741	7	8	serious	serious	ADJ
ajlm-741	7	9	public	public	ADJ
ajlm-741	7	10	health	health	NOUN
ajlm-741	7	11	concern	concern	NOUN
ajlm-741	7	12	resulting	result	VERB
ajlm-741	7	13	in	in	ADP
ajlm-741	7	14	morbidity	morbidity	NOUN
ajlm-741	7	15	and	and	CCONJ
ajlm-741	7	16	mortality	mortality	NOUN
ajlm-741	7	17	particularly	particularly	ADV
ajlm-741	7	18	in	in	ADP
ajlm-741	7	19	developing	develop	VERB
ajlm-741	7	20	countries	country	NOUN
ajlm-741	7	21	.	.	PUNCT
ajlm-741	8	1	the	the	DET
ajlm-741	8	2	lack	lack	NOUN
ajlm-741	8	3	of	of	ADP
ajlm-741	8	4	information	information	NOUN
ajlm-741	8	5	from	from	ADP
ajlm-741	8	6	africa	africa	PROPN
ajlm-741	8	7	,	,	PUNCT
ajlm-741	8	8	the	the	DET
ajlm-741	8	9	increasing	increase	VERB
ajlm-741	8	10	rates	rate	NOUN
ajlm-741	8	11	of	of	ADP
ajlm-741	8	12	antimicrobial	antimicrobial	ADJ
ajlm-741	8	13	resistance	resistance	NOUN
ajlm-741	8	14	and	and	CCONJ
ajlm-741	8	15	the	the	DET
ajlm-741	8	16	emergence	emergence	NOUN
ajlm-741	8	17	of	of	ADP
ajlm-741	8	18	new	new	ADJ
ajlm-741	8	19	resistance	resistance	NOUN
ajlm-741	8	20	mechanisms	mechanism	NOUN
ajlm-741	8	21	intensifies	intensify	VERB
ajlm-741	8	22	this	this	DET
ajlm-741	8	23	concern	concern	NOUN
ajlm-741	8	24	warranting	warrant	VERB
ajlm-741	8	25	the	the	DET
ajlm-741	8	26	need	need	NOUN
ajlm-741	8	27	for	for	ADP
ajlm-741	8	28	vigorous	vigorous	ADJ
ajlm-741	8	29	standardised	standardised	ADJ
ajlm-741	8	30	surveillance	surveillance	NOUN
ajlm-741	8	31	platforms	platform	NOUN
ajlm-741	8	32	that	that	PRON
ajlm-741	8	33	produce	produce	VERB
ajlm-741	8	34	reliable	reliable	ADJ
ajlm-741	8	35	and	and	CCONJ
ajlm-741	8	36	accurate	accurate	ADJ
ajlm-741	8	37	data	datum	NOUN
ajlm-741	8	38	which	which	PRON
ajlm-741	8	39	can	can	AUX
ajlm-741	8	40	be	be	AUX
ajlm-741	8	41	used	use	VERB
ajlm-741	8	42	for	for	ADP
ajlm-741	8	43	addressing	address	VERB
ajlm-741	8	44	these	these	DET
ajlm-741	8	45	concerns	concern	NOUN
ajlm-741	8	46	.	.	PUNCT
ajlm-741	9	1	the	the	DET
ajlm-741	9	2	implementation	implementation	NOUN
ajlm-741	9	3	of	of	ADP
ajlm-741	9	4	national	national	ADJ
ajlm-741	9	5	treatment	treatment	NOUN
ajlm-741	9	6	guidelines	guideline	NOUN
ajlm-741	9	7	,	,	PUNCT
ajlm-741	9	8	policies	policy	NOUN
ajlm-741	9	9	,	,	PUNCT
ajlm-741	9	10	antimicrobial	antimicrobial	ADJ
ajlm-741	9	11	stewardship	stewardship	NOUN
ajlm-741	9	12	programmes	programme	NOUN
ajlm-741	9	13	and	and	CCONJ
ajlm-741	9	14	infection	infection	NOUN
ajlm-741	9	15	prevention	prevention	NOUN
ajlm-741	9	16	and	and	CCONJ
ajlm-741	9	17	control	control	NOUN
ajlm-741	9	18	practices	practice	NOUN
ajlm-741	9	19	within	within	ADP
ajlm-741	9	20	healthcare	healthcare	NOUN
ajlm-741	9	21	institutions	institution	NOUN
ajlm-741	9	22	require	require	VERB
ajlm-741	9	23	a	a	DET
ajlm-741	9	24	platform	platform	NOUN
ajlm-741	9	25	from	from	ADP
ajlm-741	9	26	which	which	PRON
ajlm-741	9	27	it	it	PRON
ajlm-741	9	28	can	can	AUX
ajlm-741	9	29	draw	draw	VERB
ajlm-741	9	30	information	information	NOUN
ajlm-741	9	31	and	and	CCONJ
ajlm-741	9	32	direct	direct	VERB
ajlm-741	9	33	its	its	PRON
ajlm-741	9	34	approach	approach	NOUN
ajlm-741	9	35	.	.	PUNCT
ajlm-741	10	1	in	in	ADP
ajlm-741	10	2	this	this	DET
ajlm-741	10	3	review	review	NOUN
ajlm-741	10	4	,	,	PUNCT
ajlm-741	10	5	the	the	DET
ajlm-741	10	6	importance	importance	NOUN
ajlm-741	10	7	of	of	ADP
ajlm-741	10	8	standardised	standardised	ADJ
ajlm-741	10	9	surveillance	surveillance	NOUN
ajlm-741	10	10	systems	system	NOUN
ajlm-741	10	11	,	,	PUNCT
ajlm-741	10	12	the	the	DET
ajlm-741	10	13	challenges	challenge	NOUN
ajlm-741	10	14	faced	face	VERB
ajlm-741	10	15	in	in	ADP
ajlm-741	10	16	the	the	DET
ajlm-741	10	17	application	application	NOUN
ajlm-741	10	18	of	of	ADP
ajlm-741	10	19	a	a	DET
ajlm-741	10	20	surveillance	surveillance	NOUN
ajlm-741	10	21	system	system	NOUN
ajlm-741	10	22	and	and	CCONJ
ajlm-741	10	23	the	the	DET
ajlm-741	10	24	condition	condition	NOUN
ajlm-741	10	25	(	(	PUNCT
ajlm-741	10	26	existence	existence	NOUN
ajlm-741	10	27	and	and	CCONJ
ajlm-741	10	28	nonexistence	nonexistence	NOUN
ajlm-741	10	29	)	)	PUNCT
ajlm-741	10	30	of	of	ADP
ajlm-741	10	31	such	such	ADJ
ajlm-741	10	32	systems	system	NOUN
ajlm-741	10	33	in	in	ADP
ajlm-741	10	34	african	african	ADJ
ajlm-741	10	35	countries	country	NOUN
ajlm-741	10	36	is	be	AUX
ajlm-741	10	37	discussed	discuss	VERB
ajlm-741	10	38	.	.	PUNCT
ajlm-741	11	1	this	this	DET
ajlm-741	11	2	review	review	NOUN
ajlm-741	11	3	also	also	ADV
ajlm-741	11	4	reports	report	VERB
ajlm-741	11	5	on	on	ADP
ajlm-741	11	6	some	some	DET
ajlm-741	11	7	south	south	ADJ
ajlm-741	11	8	african	african	ADJ
ajlm-741	11	9	data	datum	NOUN
ajlm-741	11	10	.	.	PUNCT
ajlm-741	12	1	introduction	introduction	NOUN
ajlm-741	12	2	infections	infection	NOUN
ajlm-741	12	3	caused	cause	VERB
ajlm-741	12	4	by	by	ADP
ajlm-741	12	5	healthcare	healthcare	PROPN
ajlm-741	12	6	-	-	PUNCT
ajlm-741	12	7	associated	associate	VERB
ajlm-741	12	8	pathogens	pathogen	NOUN
ajlm-741	12	9	are	be	AUX
ajlm-741	12	10	a	a	DET
ajlm-741	12	11	public	public	ADJ
ajlm-741	12	12	health	health	NOUN
ajlm-741	12	13	concern	concern	NOUN
ajlm-741	12	14	that	that	PRON
ajlm-741	12	15	results	result	VERB
ajlm-741	12	16	in	in	ADP
ajlm-741	12	17	morbidity	morbidity	NOUN
ajlm-741	12	18	and	and	CCONJ
ajlm-741	12	19	mortality	mortality	NOUN
ajlm-741	12	20	particularly	particularly	ADV
ajlm-741	12	21	in	in	ADP
ajlm-741	12	22	developing	develop	VERB
ajlm-741	12	23	countries.1	countries.1	NOUN
ajlm-741	12	24	patients	patient	NOUN
ajlm-741	12	25	reporting	report	VERB
ajlm-741	12	26	to	to	ADP
ajlm-741	12	27	south	south	ADJ
ajlm-741	12	28	african	african	ADJ
ajlm-741	12	29	hospitals	hospital	NOUN
ajlm-741	12	30	(	(	PUNCT
ajlm-741	12	31	both	both	CCONJ
ajlm-741	12	32	the	the	DET
ajlm-741	12	33	public	public	ADJ
ajlm-741	12	34	and	and	CCONJ
ajlm-741	12	35	private	private	ADJ
ajlm-741	12	36	healthcare	healthcare	NOUN
ajlm-741	12	37	sectors	sector	NOUN
ajlm-741	12	38	)	)	PUNCT
ajlm-741	12	39	are	be	AUX
ajlm-741	12	40	at	at	ADP
ajlm-741	12	41	high	high	ADJ
ajlm-741	12	42	risk	risk	NOUN
ajlm-741	12	43	of	of	ADP
ajlm-741	12	44	acquiring	acquire	VERB
ajlm-741	12	45	healthcare	healthcare	NOUN
ajlm-741	12	46	-	-	PUNCT
ajlm-741	12	47	associated	associate	VERB
ajlm-741	12	48	infections	infection	NOUN
ajlm-741	12	49	and	and	CCONJ
ajlm-741	12	50	the	the	DET
ajlm-741	12	51	costs	cost	NOUN
ajlm-741	12	52	of	of	ADP
ajlm-741	12	53	managing	manage	VERB
ajlm-741	12	54	these	these	DET
ajlm-741	12	55	infections	infection	NOUN
ajlm-741	12	56	cause	cause	VERB
ajlm-741	12	57	an	an	DET
ajlm-741	12	58	additional	additional	ADJ
ajlm-741	12	59	burden.2	burden.2	NOUN
ajlm-741	12	60	the	the	DET
ajlm-741	12	61	inappropriate	inappropriate	ADJ
ajlm-741	12	62	use	use	NOUN
ajlm-741	12	63	and	and	CCONJ
ajlm-741	12	64	overuse	overuse	NOUN
ajlm-741	12	65	of	of	ADP
ajlm-741	12	66	antimicrobial	antimicrobial	ADJ
ajlm-741	12	67	agents	agent	NOUN
ajlm-741	12	68	leads	lead	VERB
ajlm-741	12	69	to	to	ADP
ajlm-741	12	70	the	the	DET
ajlm-741	12	71	selection	selection	NOUN
ajlm-741	12	72	of	of	ADP
ajlm-741	12	73	antimicrobial	antimicrobial	ADJ
ajlm-741	12	74	-	-	PUNCT
ajlm-741	12	75	resistant	resistant	ADJ
ajlm-741	12	76	organisms	organism	NOUN
ajlm-741	12	77	and	and	CCONJ
ajlm-741	12	78	since	since	SCONJ
ajlm-741	12	79	these	these	DET
ajlm-741	12	80	agents	agent	NOUN
ajlm-741	12	81	play	play	VERB
ajlm-741	12	82	a	a	DET
ajlm-741	12	83	critical	critical	ADJ
ajlm-741	12	84	role	role	NOUN
ajlm-741	12	85	in	in	ADP
ajlm-741	12	86	healthcare	healthcare	PROPN
ajlm-741	12	87	,	,	PUNCT
ajlm-741	12	88	increasing	increase	VERB
ajlm-741	12	89	rates	rate	NOUN
ajlm-741	12	90	of	of	ADP
ajlm-741	12	91	resistance	resistance	NOUN
ajlm-741	12	92	creates	create	VERB
ajlm-741	12	93	a	a	DET
ajlm-741	12	94	serious	serious	ADJ
ajlm-741	12	95	threat	threat	NOUN
ajlm-741	12	96	in	in	ADP
ajlm-741	12	97	healthcare	healthcare	NOUN
ajlm-741	12	98	settings.3	settings.3	VERB
ajlm-741	12	99	the	the	DET
ajlm-741	12	100	world	world	NOUN
ajlm-741	12	101	health	health	NOUN
ajlm-741	12	102	organization	organization	NOUN
ajlm-741	12	103	(	(	PUNCT
ajlm-741	12	104	who	who	PRON
ajlm-741	12	105	)	)	PUNCT
ajlm-741	12	106	released	release	VERB
ajlm-741	12	107	its	its	PRON
ajlm-741	12	108	first	first	ADJ
ajlm-741	12	109	global	global	ADJ
ajlm-741	12	110	antimicrobial	antimicrobial	ADJ
ajlm-741	12	111	resistance	resistance	NOUN
ajlm-741	12	112	surveillance	surveillance	NOUN
ajlm-741	12	113	report	report	NOUN
ajlm-741	12	114	in	in	ADP
ajlm-741	12	115	2014	2014	NUM
ajlm-741	12	116	which	which	PRON
ajlm-741	12	117	stated	state	VERB
ajlm-741	12	118	that	that	SCONJ
ajlm-741	12	119	resistance	resistance	NOUN
ajlm-741	12	120	to	to	ADP
ajlm-741	12	121	a	a	DET
ajlm-741	12	122	wide	wide	ADJ
ajlm-741	12	123	range	range	NOUN
ajlm-741	12	124	of	of	ADP
ajlm-741	12	125	antimicrobial	antimicrobial	ADJ
ajlm-741	12	126	agents	agent	NOUN
ajlm-741	12	127	is	be	AUX
ajlm-741	12	128	increasing	increase	VERB
ajlm-741	12	129	in	in	ADP
ajlm-741	12	130	all	all	DET
ajlm-741	12	131	six	six	NUM
ajlm-741	12	132	who	who	PRON
ajlm-741	12	133	regions	region	VERB
ajlm-741	12	134	.	.	PUNCT
ajlm-741	13	1	this	this	DET
ajlm-741	13	2	report	report	NOUN
ajlm-741	13	3	also	also	ADV
ajlm-741	13	4	highlighted	highlight	VERB
ajlm-741	13	5	that	that	SCONJ
ajlm-741	13	6	there	there	PRON
ajlm-741	13	7	was	be	VERB
ajlm-741	13	8	a	a	DET
ajlm-741	13	9	significant	significant	ADJ
ajlm-741	13	10	gap	gap	NOUN
ajlm-741	13	11	in	in	ADP
ajlm-741	13	12	surveillance	surveillance	NOUN
ajlm-741	13	13	data	datum	NOUN
ajlm-741	13	14	and	and	CCONJ
ajlm-741	13	15	a	a	DET
ajlm-741	13	16	lack	lack	NOUN
ajlm-741	13	17	of	of	ADP
ajlm-741	13	18	standards	standard	NOUN
ajlm-741	13	19	for	for	ADP
ajlm-741	13	20	methodology	methodology	NOUN
ajlm-741	13	21	,	,	PUNCT
ajlm-741	13	22	data	datum	NOUN
ajlm-741	13	23	sharing	sharing	NOUN
ajlm-741	13	24	and	and	CCONJ
ajlm-741	13	25	coordination	coordination	NOUN
ajlm-741	13	26	in	in	ADP
ajlm-741	13	27	numerous	numerous	ADJ
ajlm-741	13	28	countries	country	NOUN
ajlm-741	13	29	worldwide	worldwide	ADV
ajlm-741	13	30	,	,	PUNCT
ajlm-741	13	31	stressing	stress	VERB
ajlm-741	13	32	the	the	DET
ajlm-741	13	33	importance	importance	NOUN
ajlm-741	13	34	of	of	ADP
ajlm-741	13	35	and	and	CCONJ
ajlm-741	13	36	need	need	VERB
ajlm-741	13	37	for	for	ADP
ajlm-741	13	38	clearly	clearly	ADV
ajlm-741	13	39	defined	define	VERB
ajlm-741	13	40	,	,	PUNCT
ajlm-741	13	41	standardised	standardised	ADJ
ajlm-741	13	42	surveillance	surveillance	NOUN
ajlm-741	13	43	systems.4	systems.4	CCONJ
ajlm-741	13	44	the	the	DET
ajlm-741	13	45	centre	centre	NOUN
ajlm-741	13	46	for	for	ADP
ajlm-741	13	47	disease	disease	NOUN
ajlm-741	13	48	control	control	NOUN
ajlm-741	13	49	and	and	CCONJ
ajlm-741	13	50	prevention	prevention	NOUN
ajlm-741	13	51	(	(	PUNCT
ajlm-741	13	52	cdc	cdc	PROPN
ajlm-741	13	53	)	)	PUNCT
ajlm-741	13	54	defines	define	VERB
ajlm-741	13	55	surveillance	surveillance	NOUN
ajlm-741	13	56	as	as	ADP
ajlm-741	13	57	the	the	DET
ajlm-741	13	58	:	:	PUNCT
ajlm-741	13	59	ongoing	ongoing	ADJ
ajlm-741	13	60	systematic	systematic	ADJ
ajlm-741	13	61	collection	collection	NOUN
ajlm-741	13	62	,	,	PUNCT
ajlm-741	13	63	analysis	analysis	NOUN
ajlm-741	13	64	and	and	CCONJ
ajlm-741	13	65	interpretation	interpretation	NOUN
ajlm-741	13	66	of	of	ADP
ajlm-741	13	67	health	health	NOUN
ajlm-741	13	68	data	datum	NOUN
ajlm-741	13	69	essential	essential	ADJ
ajlm-741	13	70	to	to	ADP
ajlm-741	13	71	planning	planning	NOUN
ajlm-741	13	72	,	,	PUNCT
ajlm-741	13	73	implementation	implementation	NOUN
ajlm-741	13	74	and	and	CCONJ
ajlm-741	13	75	evaluation	evaluation	NOUN
ajlm-741	13	76	of	of	ADP
ajlm-741	13	77	public	public	ADJ
ajlm-741	13	78	health	health	NOUN
ajlm-741	13	79	practice	practice	NOUN
ajlm-741	13	80	,	,	PUNCT
ajlm-741	13	81	closely	closely	ADV
ajlm-741	13	82	integrated	integrate	VERB
ajlm-741	13	83	with	with	ADP
ajlm-741	13	84	the	the	DET
ajlm-741	13	85	timely	timely	ADJ
ajlm-741	13	86	dissemination	dissemination	NOUN
ajlm-741	13	87	of	of	ADP
ajlm-741	13	88	these	these	DET
ajlm-741	13	89	data	datum	NOUN
ajlm-741	13	90	to	to	ADP
ajlm-741	13	91	those	those	PRON
ajlm-741	13	92	who	who	PRON
ajlm-741	13	93	need	need	VERB
ajlm-741	13	94	to	to	PART
ajlm-741	13	95	know.5	know.5	VERB
ajlm-741	13	96	in	in	ADP
ajlm-741	13	97	a	a	DET
ajlm-741	13	98	hospital	hospital	NOUN
ajlm-741	13	99	environment	environment	NOUN
ajlm-741	13	100	,	,	PUNCT
ajlm-741	13	101	surveillance	surveillance	NOUN
ajlm-741	13	102	is	be	AUX
ajlm-741	13	103	an	an	DET
ajlm-741	13	104	important	important	ADJ
ajlm-741	13	105	tool	tool	NOUN
ajlm-741	13	106	that	that	PRON
ajlm-741	13	107	requires	require	VERB
ajlm-741	13	108	the	the	DET
ajlm-741	13	109	implementation	implementation	NOUN
ajlm-741	13	110	of	of	ADP
ajlm-741	13	111	an	an	DET
ajlm-741	13	112	effective	effective	ADJ
ajlm-741	13	113	and	and	CCONJ
ajlm-741	13	114	integrated	integrated	ADJ
ajlm-741	13	115	programme	programme	NOUN
ajlm-741	13	116	encompassing	encompass	VERB
ajlm-741	13	117	antimicrobial	antimicrobial	ADJ
ajlm-741	13	118	resistance	resistance	NOUN
ajlm-741	13	119	,	,	PUNCT
ajlm-741	13	120	an	an	DET
ajlm-741	13	121	antimicrobial	antimicrobial	ADJ
ajlm-741	13	122	stewardship	stewardship	NOUN
ajlm-741	13	123	programme	programme	NOUN
ajlm-741	13	124	and	and	CCONJ
ajlm-741	13	125	infection	infection	NOUN
ajlm-741	13	126	prevention	prevention	NOUN
ajlm-741	13	127	and	and	CCONJ
ajlm-741	13	128	control.2,6	control.2,6	PROPN
ajlm-741	13	129	the	the	DET
ajlm-741	13	130	extent	extent	NOUN
ajlm-741	13	131	of	of	ADP
ajlm-741	13	132	antimicrobial	antimicrobial	ADJ
ajlm-741	13	133	resistance	resistance	NOUN
ajlm-741	13	134	in	in	ADP
ajlm-741	13	135	healthcare	healthcare	PROPN
ajlm-741	13	136	-	-	PUNCT
ajlm-741	13	137	associated	associate	VERB
ajlm-741	13	138	pathogens	pathogen	NOUN
ajlm-741	13	139	needs	need	VERB
ajlm-741	13	140	to	to	PART
ajlm-741	13	141	be	be	AUX
ajlm-741	13	142	established	establish	VERB
ajlm-741	13	143	.	.	PUNCT
ajlm-741	14	1	however	however	ADV
ajlm-741	14	2	,	,	PUNCT
ajlm-741	14	3	it	it	PRON
ajlm-741	14	4	is	be	AUX
ajlm-741	14	5	challenging	challenge	VERB
ajlm-741	14	6	for	for	ADP
ajlm-741	14	7	healthcare	healthcare	NOUN
ajlm-741	14	8	facilities	facility	NOUN
ajlm-741	14	9	to	to	PART
ajlm-741	14	10	perform	perform	VERB
ajlm-741	14	11	surveillance	surveillance	NOUN
ajlm-741	14	12	due	due	ADP
ajlm-741	14	13	to	to	ADP
ajlm-741	14	14	the	the	DET
ajlm-741	14	15	lack	lack	NOUN
ajlm-741	14	16	of	of	ADP
ajlm-741	14	17	standardised	standardised	ADJ
ajlm-741	14	18	definitions	definition	NOUN
ajlm-741	14	19	for	for	ADP
ajlm-741	14	20	healthcare	healthcare	NOUN
ajlm-741	14	21	-	-	PUNCT
ajlm-741	14	22	associated	associate	VERB
ajlm-741	14	23	infections	infection	NOUN
ajlm-741	14	24	,	,	PUNCT
ajlm-741	14	25	data	datum	NOUN
ajlm-741	14	26	analysts	analyst	NOUN
ajlm-741	14	27	,	,	PUNCT
ajlm-741	14	28	information	information	NOUN
ajlm-741	14	29	technology	technology	NOUN
ajlm-741	14	30	(	(	PUNCT
ajlm-741	14	31	it	it	PRON
ajlm-741	14	32	)	)	PUNCT
ajlm-741	14	33	structure	structure	NOUN
ajlm-741	14	34	and	and	CCONJ
ajlm-741	14	35	staff	staff	NOUN
ajlm-741	14	36	trained	train	VERB
ajlm-741	14	37	on	on	ADP
ajlm-741	14	38	infection	infection	NOUN
ajlm-741	14	39	prevention	prevention	NOUN
ajlm-741	14	40	,	,	PUNCT
ajlm-741	14	41	particularly	particularly	ADV
ajlm-741	14	42	in	in	ADP
ajlm-741	14	43	resource	resource	NOUN
ajlm-741	14	44	-	-	PUNCT
ajlm-741	14	45	limited	limit	VERB
ajlm-741	14	46	settings	setting	NOUN
ajlm-741	14	47	like	like	ADP
ajlm-741	14	48	sub	sub	ADJ
ajlm-741	14	49	-	-	ADJ
ajlm-741	14	50	saharan	saharan	ADJ
ajlm-741	14	51	africa.7,8	africa.7,8	ADP
ajlm-741	14	52	a	a	DET
ajlm-741	14	53	systematic	systematic	ADJ
ajlm-741	14	54	review	review	NOUN
ajlm-741	14	55	of	of	ADP
ajlm-741	14	56	190	190	NUM
ajlm-741	14	57	antimicrobial	antimicrobial	ADJ
ajlm-741	14	58	resistance	resistance	NOUN
ajlm-741	14	59	surveillance	surveillance	NOUN
ajlm-741	14	60	studies	study	NOUN
ajlm-741	14	61	conducted	conduct	VERB
ajlm-741	14	62	in	in	ADP
ajlm-741	14	63	sub	sub	ADJ
ajlm-741	14	64	-	-	ADJ
ajlm-741	14	65	saharan	saharan	ADJ
ajlm-741	14	66	africa	africa	PROPN
ajlm-741	14	67	from	from	ADP
ajlm-741	14	68	january	january	PROPN
ajlm-741	14	69	1990	1990	NUM
ajlm-741	14	70	to	to	ADP
ajlm-741	14	71	january	january	PROPN
ajlm-741	14	72	2013	2013	NUM
ajlm-741	14	73	by	by	ADP
ajlm-741	14	74	leopold	leopold	PROPN
ajlm-741	14	75	and	and	CCONJ
ajlm-741	14	76	colleagues	colleague	NOUN
ajlm-741	14	77	in	in	ADP
ajlm-741	14	78	2014	2014	NUM
ajlm-741	14	79	,	,	PUNCT
ajlm-741	14	80	further	far	ADV
ajlm-741	14	81	highlighted	highlight	VERB
ajlm-741	14	82	the	the	DET
ajlm-741	14	83	flaws	flaw	NOUN
ajlm-741	14	84	in	in	ADP
ajlm-741	14	85	currently	currently	ADV
ajlm-741	14	86	available	available	ADJ
ajlm-741	14	87	data	datum	NOUN
ajlm-741	14	88	and	and	CCONJ
ajlm-741	14	89	the	the	DET
ajlm-741	14	90	challenges	challenge	NOUN
ajlm-741	14	91	experienced	experience	VERB
ajlm-741	14	92	when	when	SCONJ
ajlm-741	14	93	implementing	implement	VERB
ajlm-741	14	94	antimicrobial	antimicrobial	ADJ
ajlm-741	14	95	resistance	resistance	NOUN
ajlm-741	14	96	surveillance.9	surveillance.9	NOUN
ajlm-741	14	97	although	although	SCONJ
ajlm-741	14	98	south	south	PROPN
ajlm-741	14	99	africa	africa	PROPN
ajlm-741	14	100	has	have	VERB
ajlm-741	14	101	greater	great	ADJ
ajlm-741	14	102	resources	resource	NOUN
ajlm-741	14	103	as	as	ADP
ajlm-741	14	104	compared	compare	VERB
ajlm-741	14	105	to	to	ADP
ajlm-741	14	106	the	the	DET
ajlm-741	14	107	rest	rest	NOUN
ajlm-741	14	108	of	of	ADP
ajlm-741	14	109	africa	africa	PROPN
ajlm-741	14	110	,	,	PUNCT
ajlm-741	14	111	the	the	DET
ajlm-741	14	112	quality	quality	NOUN
ajlm-741	14	113	of	of	ADP
ajlm-741	14	114	these	these	DET
ajlm-741	14	115	programmes	programme	NOUN
ajlm-741	14	116	varies	vary	VERB
ajlm-741	14	117	across	across	ADP
ajlm-741	14	118	institutions	institution	NOUN
ajlm-741	14	119	and	and	CCONJ
ajlm-741	14	120	standardised	standardised	ADJ
ajlm-741	14	121	surveillance	surveillance	NOUN
ajlm-741	14	122	systems	system	NOUN
ajlm-741	14	123	are	be	AUX
ajlm-741	14	124	not	not	PART
ajlm-741	14	125	in	in	ADP
ajlm-741	14	126	place	place	NOUN
ajlm-741	14	127	in	in	ADP
ajlm-741	14	128	most	most	ADJ
ajlm-741	14	129	south	south	ADJ
ajlm-741	14	130	african	african	ADJ
ajlm-741	14	131	healthcare	healthcare	NOUN
ajlm-741	14	132	facilities.2	facilities.2	PROPN
ajlm-741	14	133	nevertheless	nevertheless	ADV
ajlm-741	14	134	,	,	PUNCT
ajlm-741	14	135	the	the	DET
ajlm-741	14	136	south	south	ADJ
ajlm-741	14	137	african	african	ADJ
ajlm-741	14	138	society	society	NOUN
ajlm-741	14	139	for	for	ADP
ajlm-741	14	140	clinical	clinical	ADJ
ajlm-741	14	141	microbiology	microbiology	NOUN
ajlm-741	14	142	(	(	PUNCT
ajlm-741	14	143	sascm	sascm	PROPN
ajlm-741	14	144	)	)	PUNCT
ajlm-741	14	145	has	have	AUX
ajlm-741	14	146	published	publish	VERB
ajlm-741	14	147	yearly	yearly	ADJ
ajlm-741	14	148	surveillance	surveillance	NOUN
ajlm-741	14	149	reports	report	NOUN
ajlm-741	14	150	from	from	ADP
ajlm-741	14	151	both	both	CCONJ
ajlm-741	14	152	the	the	DET
ajlm-741	14	153	public	public	ADJ
ajlm-741	14	154	and	and	CCONJ
ajlm-741	14	155	private	private	ADJ
ajlm-741	14	156	healthcare	healthcare	NOUN
ajlm-741	14	157	sectors.10	sectors.10	ADJ
ajlm-741	14	158	although	although	SCONJ
ajlm-741	14	159	reports	report	NOUN
ajlm-741	14	160	are	be	AUX
ajlm-741	14	161	not	not	PART
ajlm-741	14	162	accessible	accessible	ADJ
ajlm-741	14	163	in	in	ADP
ajlm-741	14	164	real	real	ADJ
ajlm-741	14	165	time	time	NOUN
ajlm-741	14	166	,	,	PUNCT
ajlm-741	14	167	the	the	DET
ajlm-741	14	168	data	datum	NOUN
ajlm-741	14	169	are	be	AUX
ajlm-741	14	170	made	make	VERB
ajlm-741	14	171	available	available	ADJ
ajlm-741	14	172	.	.	PUNCT
ajlm-741	15	1	the	the	DET
ajlm-741	15	2	latest	late	ADJ
ajlm-741	15	3	accessible	accessible	ADJ
ajlm-741	15	4	data	datum	NOUN
ajlm-741	15	5	from	from	ADP
ajlm-741	15	6	the	the	DET
ajlm-741	15	7	public	public	ADJ
ajlm-741	15	8	healthcare	healthcare	NOUN
ajlm-741	15	9	sector	sector	NOUN
ajlm-741	15	10	reported	report	VERB
ajlm-741	15	11	on	on	ADP
ajlm-741	15	12	bloodstream	bloodstream	NOUN
ajlm-741	15	13	infections	infection	NOUN
ajlm-741	15	14	over	over	ADP
ajlm-741	15	15	the	the	DET
ajlm-741	15	16	period	period	NOUN
ajlm-741	15	17	january	january	PROPN
ajlm-741	15	18	to	to	ADP
ajlm-741	15	19	december	december	PROPN
ajlm-741	15	20	2015	2015	NUM
ajlm-741	15	21	for	for	ADP
ajlm-741	15	22	gram	gram	NOUN
ajlm-741	15	23	-	-	PUNCT
ajlm-741	15	24	negative	negative	ADJ
ajlm-741	15	25	organisms	organism	NOUN
ajlm-741	15	26	(	(	PUNCT
ajlm-741	15	27	acinetobacter	acinetobacter	ADV
ajlm-741	15	28	baumannii	baumannii	ADJ
ajlm-741	15	29	complex	complex	ADJ
ajlm-741	15	30	,	,	PUNCT
ajlm-741	15	31	enterobacter	enterobacter	ADJ
ajlm-741	15	32	cloacae	cloacae	NOUN
ajlm-741	15	33	complex	complex	NOUN
ajlm-741	15	34	,	,	PUNCT
ajlm-741	15	35	escherichia	escherichia	NOUN
ajlm-741	15	36	coli	coli	NOUN
ajlm-741	15	37	,	,	PUNCT
ajlm-741	15	38	klebsiella	klebsiella	NOUN
ajlm-741	15	39	pneumoniae	pneumoniae	NOUN
ajlm-741	15	40	and	and	CCONJ
ajlm-741	15	41	pseudomonas	pseudomona	NOUN
ajlm-741	15	42	aeruginosa	aeruginosa	NOUN
ajlm-741	15	43	)	)	PUNCT
ajlm-741	15	44	and	and	CCONJ
ajlm-741	15	45	gram	gram	NOUN
ajlm-741	15	46	-	-	PUNCT
ajlm-741	15	47	positive	positive	ADJ
ajlm-741	15	48	organisms	organism	NOUN
ajlm-741	15	49	(	(	PUNCT
ajlm-741	15	50	staphylococcus	staphylococcus	NOUN
ajlm-741	15	51	aureus	aureus	NOUN
ajlm-741	15	52	,	,	PUNCT
ajlm-741	15	53	enterococcus	enterococcus	NOUN
ajlm-741	15	54	faecalis	faecali	NOUN
ajlm-741	15	55	and	and	CCONJ
ajlm-741	15	56	enterococcus	enterococcus	NOUN
ajlm-741	15	57	faecium	faecium	NOUN
ajlm-741	15	58	)	)	PUNCT
ajlm-741	15	59	from	from	ADP
ajlm-741	15	60	five	five	NUM
ajlm-741	15	61	provinces	province	NOUN
ajlm-741	15	62	(	(	PUNCT
ajlm-741	15	63	gauteng	gauteng	PROPN
ajlm-741	15	64	,	,	PUNCT
ajlm-741	15	65	kwazulu	kwazulu	PROPN
ajlm-741	15	66	-	-	PUNCT
ajlm-741	15	67	natal	natal	ADJ
ajlm-741	15	68	,	,	PUNCT
ajlm-741	15	69	free	free	ADJ
ajlm-741	15	70	state	state	NOUN
ajlm-741	15	71	,	,	PUNCT
ajlm-741	15	72	western	western	ADJ
ajlm-741	15	73	cape	cape	NOUN
ajlm-741	15	74	and	and	CCONJ
ajlm-741	15	75	eastern	eastern	ADJ
ajlm-741	15	76	cape	cape	NOUN
ajlm-741	15	77	)	)	PUNCT
ajlm-741	15	78	.	.	PUNCT
ajlm-741	16	1	sascm	sascm	PROPN
ajlm-741	16	2	extracted	extract	VERB
ajlm-741	16	3	routine	routine	ADJ
ajlm-741	16	4	data	datum	NOUN
ajlm-741	16	5	from	from	ADP
ajlm-741	16	6	sentinel	sentinel	ADJ
ajlm-741	16	7	sites	site	NOUN
ajlm-741	16	8	predominantly	predominantly	ADV
ajlm-741	16	9	from	from	ADP
ajlm-741	16	10	large	large	ADJ
ajlm-741	16	11	academic	academic	ADJ
ajlm-741	16	12	hospitals	hospital	NOUN
ajlm-741	16	13	from	from	ADP
ajlm-741	16	14	an	an	DET
ajlm-741	16	15	electronic	electronic	ADJ
ajlm-741	16	16	database.11	database.11	NOUN
ajlm-741	16	17	sascm	sascm	NOUN
ajlm-741	16	18	also	also	ADV
ajlm-741	16	19	reported	report	VERB
ajlm-741	16	20	information	information	NOUN
ajlm-741	16	21	from	from	ADP
ajlm-741	16	22	the	the	DET
ajlm-741	16	23	private	private	ADJ
ajlm-741	16	24	healthcare	healthcare	NOUN
ajlm-741	16	25	sector	sector	NOUN
ajlm-741	16	26	for	for	ADP
ajlm-741	16	27	the	the	DET
ajlm-741	16	28	period	period	NOUN
ajlm-741	16	29	january	january	PROPN
ajlm-741	16	30	to	to	ADP
ajlm-741	16	31	december	december	PROPN
ajlm-741	16	32	2013	2013	NUM
ajlm-741	16	33	from	from	ADP
ajlm-741	16	34	urine	urine	NOUN
ajlm-741	16	35	and	and	CCONJ
ajlm-741	16	36	bloodstream	bloodstream	NOUN
ajlm-741	16	37	infections	infection	NOUN
ajlm-741	16	38	from	from	ADP
ajlm-741	16	39	the	the	DET
ajlm-741	16	40	same	same	ADJ
ajlm-741	16	41	five	five	NUM
ajlm-741	16	42	provinces.12	provinces.12	NOUN
ajlm-741	16	43	antimicrobial	antimicrobial	ADJ
ajlm-741	16	44	susceptibility	susceptibility	NOUN
ajlm-741	16	45	for	for	ADP
ajlm-741	16	46	each	each	PRON
ajlm-741	16	47	of	of	ADP
ajlm-741	16	48	the	the	DET
ajlm-741	16	49	pathogens	pathogen	NOUN
ajlm-741	16	50	was	be	AUX
ajlm-741	16	51	reported	report	VERB
ajlm-741	16	52	from	from	ADP
ajlm-741	16	53	both	both	CCONJ
ajlm-741	16	54	the	the	DET
ajlm-741	16	55	public	public	ADJ
ajlm-741	16	56	and	and	CCONJ
ajlm-741	16	57	private	private	ADJ
ajlm-741	16	58	healthcare	healthcare	NOUN
ajlm-741	16	59	sectors	sector	NOUN
ajlm-741	16	60	in	in	ADP
ajlm-741	16	61	the	the	DET
ajlm-741	16	62	country	country	NOUN
ajlm-741	16	63	during	during	ADP
ajlm-741	16	64	these	these	DET
ajlm-741	16	65	periods	period	NOUN
ajlm-741	16	66	.	.	PUNCT
ajlm-741	17	1	the	the	DET
ajlm-741	17	2	south	south	ADJ
ajlm-741	17	3	african	african	PROPN
ajlm-741	17	4	national	national	PROPN
ajlm-741	17	5	department	department	PROPN
ajlm-741	17	6	of	of	ADP
ajlm-741	17	7	health	health	PROPN
ajlm-741	17	8	attributed	attribute	VERB
ajlm-741	17	9	the	the	DET
ajlm-741	17	10	weaknesses	weakness	NOUN
ajlm-741	17	11	of	of	ADP
ajlm-741	17	12	surveillance	surveillance	NOUN
ajlm-741	17	13	and	and	CCONJ
ajlm-741	17	14	reporting	report	VERB
ajlm-741	17	15	activities	activity	NOUN
ajlm-741	17	16	to	to	ADP
ajlm-741	17	17	a	a	DET
ajlm-741	17	18	number	number	NOUN
ajlm-741	17	19	of	of	ADP
ajlm-741	17	20	factors	factor	NOUN
ajlm-741	17	21	.	.	PUNCT
ajlm-741	18	1	these	these	PRON
ajlm-741	18	2	included	include	VERB
ajlm-741	18	3	the	the	DET
ajlm-741	18	4	low	low	ADJ
ajlm-741	18	5	number	number	NOUN
ajlm-741	18	6	of	of	ADP
ajlm-741	18	7	trained	train	VERB
ajlm-741	18	8	microbiologists	microbiologist	NOUN
ajlm-741	18	9	outside	outside	ADV
ajlm-741	18	10	of	of	ADP
ajlm-741	18	11	major	major	ADJ
ajlm-741	18	12	urban	urban	ADJ
ajlm-741	18	13	centres	centre	NOUN
ajlm-741	18	14	,	,	PUNCT
ajlm-741	18	15	limited	limited	ADJ
ajlm-741	18	16	funding	funding	NOUN
ajlm-741	18	17	,	,	PUNCT
ajlm-741	18	18	the	the	DET
ajlm-741	18	19	lack	lack	NOUN
ajlm-741	18	20	of	of	ADP
ajlm-741	18	21	a	a	DET
ajlm-741	18	22	national	national	ADJ
ajlm-741	18	23	electronic	electronic	ADJ
ajlm-741	18	24	prescribing	prescribing	NOUN
ajlm-741	18	25	system	system	NOUN
ajlm-741	18	26	and	and	CCONJ
ajlm-741	18	27	lack	lack	NOUN
ajlm-741	18	28	of	of	ADP
ajlm-741	18	29	linkage	linkage	NOUN
ajlm-741	18	30	to	to	ADP
ajlm-741	18	31	pharmacy	pharmacy	NOUN
ajlm-741	18	32	,	,	PUNCT
ajlm-741	18	33	clinical	clinical	ADJ
ajlm-741	18	34	and	and	CCONJ
ajlm-741	18	35	laboratory	laboratory	NOUN
ajlm-741	18	36	data	datum	NOUN
ajlm-741	18	37	systems	system	NOUN
ajlm-741	18	38	in	in	ADP
ajlm-741	18	39	institutions	institution	NOUN
ajlm-741	18	40	resulting	result	VERB
ajlm-741	18	41	in	in	ADP
ajlm-741	18	42	incomplete	incomplete	ADJ
ajlm-741	18	43	and	and	CCONJ
ajlm-741	18	44	variably	variably	ADV
ajlm-741	18	45	reported	report	VERB
ajlm-741	18	46	information	information	NOUN
ajlm-741	18	47	on	on	ADP
ajlm-741	18	48	antimicrobial	antimicrobial	ADJ
ajlm-741	18	49	resistance	resistance	NOUN
ajlm-741	18	50	and	and	CCONJ
ajlm-741	18	51	consumption.13	consumption.13	PRON
ajlm-741	18	52	in	in	ADP
ajlm-741	18	53	the	the	DET
ajlm-741	18	54	latest	late	ADJ
ajlm-741	18	55	activities	activity	NOUN
ajlm-741	18	56	from	from	ADP
ajlm-741	18	57	the	the	DET
ajlm-741	18	58	south	south	ADJ
ajlm-741	18	59	african	african	ADJ
ajlm-741	18	60	department	department	PROPN
ajlm-741	18	61	of	of	ADP
ajlm-741	18	62	health	health	PROPN
ajlm-741	18	63	,	,	PUNCT
ajlm-741	18	64	a	a	DET
ajlm-741	18	65	national	national	ADJ
ajlm-741	18	66	resistance	resistance	NOUN
ajlm-741	18	67	map	map	NOUN
ajlm-741	18	68	was	be	AUX
ajlm-741	18	69	released	release	VERB
ajlm-741	18	70	,	,	PUNCT
ajlm-741	18	71	and	and	CCONJ
ajlm-741	18	72	combined	combined	ADJ
ajlm-741	18	73	data	datum	NOUN
ajlm-741	18	74	for	for	ADP
ajlm-741	18	75	both	both	CCONJ
ajlm-741	18	76	public	public	ADJ
ajlm-741	18	77	and	and	CCONJ
ajlm-741	18	78	private	private	ADJ
ajlm-741	18	79	healthcare	healthcare	NOUN
ajlm-741	18	80	sectors	sector	NOUN
ajlm-741	18	81	on	on	ADP
ajlm-741	18	82	antimicrobial	antimicrobial	ADJ
ajlm-741	18	83	susceptibility	susceptibility	NOUN
ajlm-741	18	84	levels	level	NOUN
ajlm-741	18	85	are	be	AUX
ajlm-741	18	86	available	available	ADJ
ajlm-741	18	87	for	for	ADP
ajlm-741	18	88	the	the	DET
ajlm-741	18	89	first	first	ADJ
ajlm-741	18	90	time.14	time.14	PROPN
ajlm-741	18	91	an	an	DET
ajlm-741	18	92	example	example	NOUN
ajlm-741	18	93	of	of	ADP
ajlm-741	18	94	a	a	DET
ajlm-741	18	95	successful	successful	ADJ
ajlm-741	18	96	surveillance	surveillance	NOUN
ajlm-741	18	97	programme	programme	NOUN
ajlm-741	18	98	is	be	AUX
ajlm-741	18	99	the	the	DET
ajlm-741	18	100	european	european	ADJ
ajlm-741	18	101	antimicrobial	antimicrobial	ADJ
ajlm-741	18	102	resistance	resistance	NOUN
ajlm-741	18	103	surveillance	surveillance	NOUN
ajlm-741	18	104	scheme	scheme	NOUN
ajlm-741	18	105	(	(	PUNCT
ajlm-741	18	106	earss	earss	ADJ
ajlm-741	18	107	)	)	PUNCT
ajlm-741	18	108	,	,	PUNCT
ajlm-741	18	109	which	which	PRON
ajlm-741	18	110	was	be	AUX
ajlm-741	18	111	developed	develop	VERB
ajlm-741	18	112	in	in	ADP
ajlm-741	18	113	1999	1999	NUM
ajlm-741	18	114	and	and	CCONJ
ajlm-741	18	115	monitored	monitor	VERB
ajlm-741	18	116	two	two	NUM
ajlm-741	18	117	bacterial	bacterial	ADJ
ajlm-741	18	118	pathogen	pathogen	NOUN
ajlm-741	18	119	types	type	NOUN
ajlm-741	18	120	(	(	PUNCT
ajlm-741	18	121	staphylococcus	staphylococcus	NOUN
ajlm-741	18	122	aureus	aureus	NOUN
ajlm-741	18	123	and	and	CCONJ
ajlm-741	18	124	streptococcus	streptococcus	VERB
ajlm-741	18	125	pneumoniae	pneumoniae	NOUN
ajlm-741	18	126	)	)	PUNCT
ajlm-741	18	127	in	in	ADP
ajlm-741	18	128	12	12	NUM
ajlm-741	18	129	laboratories	laboratory	NOUN
ajlm-741	18	130	.	.	PUNCT
ajlm-741	19	1	by	by	ADP
ajlm-741	19	2	2015	2015	NUM
ajlm-741	19	3	,	,	PUNCT
ajlm-741	19	4	the	the	DET
ajlm-741	19	5	number	number	NOUN
ajlm-741	19	6	of	of	ADP
ajlm-741	19	7	bacterial	bacterial	ADJ
ajlm-741	19	8	pathogens	pathogen	NOUN
ajlm-741	19	9	monitored	monitor	VERB
ajlm-741	19	10	increased	increase	VERB
ajlm-741	19	11	to	to	ADP
ajlm-741	19	12	eight	eight	NUM
ajlm-741	19	13	and	and	CCONJ
ajlm-741	19	14	included	include	VERB
ajlm-741	19	15	over	over	ADP
ajlm-741	19	16	900	900	NUM
ajlm-741	19	17	laboratories.15,16	laboratories.15,16	NOUN
ajlm-741	19	18	from	from	ADP
ajlm-741	19	19	this	this	PRON
ajlm-741	19	20	,	,	PUNCT
ajlm-741	19	21	it	it	PRON
ajlm-741	19	22	is	be	AUX
ajlm-741	19	23	clear	clear	ADJ
ajlm-741	19	24	that	that	SCONJ
ajlm-741	19	25	it	it	PRON
ajlm-741	19	26	is	be	AUX
ajlm-741	19	27	important	important	ADJ
ajlm-741	19	28	to	to	PART
ajlm-741	19	29	start	start	VERB
ajlm-741	19	30	off	off	ADP
ajlm-741	19	31	with	with	ADP
ajlm-741	19	32	a	a	DET
ajlm-741	19	33	manageable	manageable	ADJ
ajlm-741	19	34	number	number	NOUN
ajlm-741	19	35	of	of	ADP
ajlm-741	19	36	sites	site	NOUN
ajlm-741	19	37	and	and	CCONJ
ajlm-741	19	38	provide	provide	VERB
ajlm-741	19	39	good	good	ADJ
ajlm-741	19	40	quality	quality	NOUN
ajlm-741	19	41	data	datum	NOUN
ajlm-741	19	42	that	that	PRON
ajlm-741	19	43	can	can	AUX
ajlm-741	19	44	then	then	ADV
ajlm-741	19	45	be	be	AUX
ajlm-741	19	46	expounded	expound	VERB
ajlm-741	19	47	.	.	PUNCT
ajlm-741	20	1	in	in	ADP
ajlm-741	20	2	an	an	DET
ajlm-741	20	3	effort	effort	NOUN
ajlm-741	20	4	to	to	PART
ajlm-741	20	5	improve	improve	VERB
ajlm-741	20	6	worldwide	worldwide	ADJ
ajlm-741	20	7	antimicrobial	antimicrobial	ADJ
ajlm-741	20	8	resistance	resistance	NOUN
ajlm-741	20	9	surveillance	surveillance	NOUN
ajlm-741	20	10	,	,	PUNCT
ajlm-741	20	11	the	the	DET
ajlm-741	20	12	global	global	ADJ
ajlm-741	20	13	antimicrobial	antimicrobial	ADJ
ajlm-741	20	14	resistance	resistance	NOUN
ajlm-741	20	15	surveillance	surveillance	NOUN
ajlm-741	20	16	system	system	NOUN
ajlm-741	20	17	(	(	PUNCT
ajlm-741	20	18	glass	glass	NOUN
ajlm-741	20	19	)	)	PUNCT
ajlm-741	20	20	was	be	AUX
ajlm-741	20	21	developed	develop	VERB
ajlm-741	20	22	to	to	PART
ajlm-741	20	23	support	support	VERB
ajlm-741	20	24	the	the	DET
ajlm-741	20	25	global	global	ADJ
ajlm-741	20	26	action	action	NOUN
ajlm-741	20	27	plan	plan	NOUN
ajlm-741	20	28	(	(	PUNCT
ajlm-741	20	29	gap	gap	NOUN
ajlm-741	20	30	)	)	PUNCT
ajlm-741	20	31	on	on	ADP
ajlm-741	20	32	antimicrobial	antimicrobial	ADJ
ajlm-741	20	33	resistance	resistance	NOUN
ajlm-741	20	34	.	.	PUNCT
ajlm-741	21	1	it	it	PRON
ajlm-741	21	2	is	be	AUX
ajlm-741	21	3	coordinated	coordinate	VERB
ajlm-741	21	4	with	with	ADP
ajlm-741	21	5	the	the	DET
ajlm-741	21	6	national	national	ADJ
ajlm-741	21	7	action	action	NOUN
ajlm-741	21	8	plans	plan	NOUN
ajlm-741	21	9	of	of	ADP
ajlm-741	21	10	countries	country	NOUN
ajlm-741	21	11	and	and	CCONJ
ajlm-741	21	12	aims	aim	VERB
ajlm-741	21	13	at	at	ADP
ajlm-741	21	14	enabling	enable	VERB
ajlm-741	21	15	countries	country	NOUN
ajlm-741	21	16	to	to	PART
ajlm-741	21	17	generate	generate	VERB
ajlm-741	21	18	antimicrobial	antimicrobial	ADJ
ajlm-741	21	19	resistance	resistance	NOUN
ajlm-741	21	20	data	datum	NOUN
ajlm-741	21	21	that	that	PRON
ajlm-741	21	22	is	be	AUX
ajlm-741	21	23	standardised	standardise	VERB
ajlm-741	21	24	,	,	PUNCT
ajlm-741	21	25	comparable	comparable	ADJ
ajlm-741	21	26	and	and	CCONJ
ajlm-741	21	27	validated	validated	ADJ
ajlm-741	21	28	.	.	PUNCT
ajlm-741	22	1	glass	glass	NOUN
ajlm-741	22	2	combines	combine	VERB
ajlm-741	22	3	patient	patient	NOUN
ajlm-741	22	4	,	,	PUNCT
ajlm-741	22	5	laboratory	laboratory	NOUN
ajlm-741	22	6	and	and	CCONJ
ajlm-741	22	7	epidemiological	epidemiological	ADJ
ajlm-741	22	8	surveillance	surveillance	NOUN
ajlm-741	22	9	information	information	NOUN
ajlm-741	22	10	which	which	PRON
ajlm-741	22	11	when	when	SCONJ
ajlm-741	22	12	together	together	ADV
ajlm-741	22	13	can	can	AUX
ajlm-741	22	14	aid	aid	VERB
ajlm-741	22	15	in	in	ADP
ajlm-741	22	16	understanding	understand	VERB
ajlm-741	22	17	the	the	DET
ajlm-741	22	18	extent	extent	NOUN
ajlm-741	22	19	of	of	ADP
ajlm-741	22	20	antimicrobial	antimicrobial	ADJ
ajlm-741	22	21	resistance	resistance	NOUN
ajlm-741	22	22	in	in	ADP
ajlm-741	22	23	individual	individual	ADJ
ajlm-741	22	24	and	and	CCONJ
ajlm-741	22	25	susceptible	susceptible	ADJ
ajlm-741	22	26	populations	population	NOUN
ajlm-741	22	27	worldwide.17	worldwide.17	NOUN
ajlm-741	22	28	currently	currently	ADV
ajlm-741	22	29	,	,	PUNCT
ajlm-741	22	30	the	the	DET
ajlm-741	22	31	glass	glass	NOUN
ajlm-741	22	32	early	early	ADJ
ajlm-741	22	33	implementation	implementation	NOUN
ajlm-741	22	34	manual	manual	NOUN
ajlm-741	22	35	focuses	focus	VERB
ajlm-741	22	36	on	on	ADP
ajlm-741	22	37	selected	select	VERB
ajlm-741	22	38	bacterial	bacterial	ADJ
ajlm-741	22	39	pathogens	pathogen	NOUN
ajlm-741	22	40	together	together	ADV
ajlm-741	22	41	with	with	ADP
ajlm-741	22	42	their	their	PRON
ajlm-741	22	43	selected	select	VERB
ajlm-741	22	44	antimicrobial	antimicrobial	ADJ
ajlm-741	22	45	combinations	combination	NOUN
ajlm-741	22	46	from	from	ADP
ajlm-741	22	47	four	four	NUM
ajlm-741	22	48	clinical	clinical	ADJ
ajlm-741	22	49	specimens.17	specimens.17	NOUN
ajlm-741	22	50	while	while	SCONJ
ajlm-741	22	51	surveillance	surveillance	NOUN
ajlm-741	22	52	systems	system	NOUN
ajlm-741	22	53	have	have	AUX
ajlm-741	22	54	been	be	AUX
ajlm-741	22	55	established	establish	VERB
ajlm-741	22	56	in	in	ADP
ajlm-741	22	57	europe	europe	PROPN
ajlm-741	22	58	,	,	PUNCT
ajlm-741	22	59	latin	latin	PROPN
ajlm-741	22	60	america	america	PROPN
ajlm-741	22	61	,	,	PUNCT
ajlm-741	22	62	central	central	ADJ
ajlm-741	22	63	asia	asia	PROPN
ajlm-741	22	64	and	and	CCONJ
ajlm-741	22	65	eastern	eastern	PROPN
ajlm-741	22	66	europe	europe	PROPN
ajlm-741	22	67	,	,	PUNCT
ajlm-741	22	68	they	they	PRON
ajlm-741	22	69	are	be	AUX
ajlm-741	22	70	lacking	lack	VERB
ajlm-741	22	71	in	in	ADP
ajlm-741	22	72	developing	develop	VERB
ajlm-741	22	73	countries	country	NOUN
ajlm-741	22	74	.	.	PUNCT
ajlm-741	23	1	the	the	DET
ajlm-741	23	2	united	united	PROPN
ajlm-741	23	3	kingdom	kingdom	PROPN
ajlm-741	23	4	department	department	PROPN
ajlm-741	23	5	of	of	ADP
ajlm-741	23	6	health	health	PROPN
ajlm-741	23	7	therefore	therefore	ADV
ajlm-741	23	8	launched	launch	VERB
ajlm-741	23	9	the	the	DET
ajlm-741	23	10	fleming	fleming	PROPN
ajlm-741	23	11	fund	fund	PROPN
ajlm-741	23	12	,	,	PUNCT
ajlm-741	23	13	aligned	align	VERB
ajlm-741	23	14	with	with	ADP
ajlm-741	23	15	who	who	PRON
ajlm-741	23	16	and	and	CCONJ
ajlm-741	23	17	glass	glass	NOUN
ajlm-741	23	18	,	,	PUNCT
ajlm-741	23	19	to	to	PART
ajlm-741	23	20	support	support	VERB
ajlm-741	23	21	these	these	DET
ajlm-741	23	22	countries	country	NOUN
ajlm-741	23	23	in	in	ADP
ajlm-741	23	24	developing	develop	VERB
ajlm-741	23	25	antimicrobial	antimicrobial	ADJ
ajlm-741	23	26	resistance	resistance	NOUN
ajlm-741	23	27	surveillance	surveillance	NOUN
ajlm-741	23	28	systems.18	systems.18	VERB
ajlm-741	23	29	the	the	DET
ajlm-741	23	30	african	african	ADJ
ajlm-741	23	31	continent	continent	NOUN
ajlm-741	23	32	and	and	CCONJ
ajlm-741	23	33	asia	asia	PROPN
ajlm-741	23	34	are	be	AUX
ajlm-741	23	35	included	include	VERB
ajlm-741	23	36	in	in	ADP
ajlm-741	23	37	this	this	DET
ajlm-741	23	38	initiative	initiative	NOUN
ajlm-741	23	39	.	.	PUNCT
ajlm-741	24	1	in	in	ADP
ajlm-741	24	2	addition	addition	NOUN
ajlm-741	24	3	,	,	PUNCT
ajlm-741	24	4	the	the	DET
ajlm-741	24	5	african	african	ADJ
ajlm-741	24	6	society	society	NOUN
ajlm-741	24	7	for	for	ADP
ajlm-741	24	8	laboratory	laboratory	NOUN
ajlm-741	24	9	medicine	medicine	NOUN
ajlm-741	24	10	(	(	PUNCT
ajlm-741	24	11	aslm	aslm	NOUN
ajlm-741	24	12	)	)	PUNCT
ajlm-741	24	13	,	,	PUNCT
ajlm-741	24	14	together	together	ADV
ajlm-741	24	15	with	with	ADP
ajlm-741	24	16	other	other	ADJ
ajlm-741	24	17	international	international	ADJ
ajlm-741	24	18	partners	partner	NOUN
ajlm-741	24	19	,	,	PUNCT
ajlm-741	24	20	is	be	AUX
ajlm-741	24	21	in	in	ADP
ajlm-741	24	22	the	the	DET
ajlm-741	24	23	process	process	NOUN
ajlm-741	24	24	of	of	ADP
ajlm-741	24	25	developing	develop	VERB
ajlm-741	24	26	a	a	DET
ajlm-741	24	27	holistic	holistic	ADJ
ajlm-741	24	28	stepwise	stepwise	NOUN
ajlm-741	24	29	framework	framework	NOUN
ajlm-741	24	30	to	to	PART
ajlm-741	24	31	coordinate	coordinate	VERB
ajlm-741	24	32	laboratory	laboratory	NOUN
ajlm-741	24	33	-	-	PUNCT
ajlm-741	24	34	based	base	VERB
ajlm-741	24	35	antimicrobial	antimicrobial	ADJ
ajlm-741	24	36	resistance	resistance	NOUN
ajlm-741	24	37	surveillance	surveillance	NOUN
ajlm-741	24	38	in	in	ADP
ajlm-741	24	39	africa	africa	PROPN
ajlm-741	24	40	,	,	PUNCT
ajlm-741	24	41	including	include	VERB
ajlm-741	24	42	south	south	ADJ
ajlm-741	24	43	africa.19,20	africa.19,20	NOUN
ajlm-741	24	44	surveillance	surveillance	NOUN
ajlm-741	24	45	of	of	ADP
ajlm-741	24	46	antimicrobial	antimicrobial	ADJ
ajlm-741	24	47	resistance	resistance	NOUN
ajlm-741	24	48	in	in	ADP
ajlm-741	24	49	healthcare	healthcare	NOUN
ajlm-741	24	50	-	-	PUNCT
ajlm-741	24	51	associated	associate	VERB
ajlm-741	24	52	pathogens	pathogen	NOUN
ajlm-741	24	53	in	in	ADP
ajlm-741	24	54	africa	africa	PROPN
ajlm-741	24	55	according	accord	VERB
ajlm-741	24	56	to	to	ADP
ajlm-741	24	57	the	the	PRON
ajlm-741	24	58	who	who	PRON
ajlm-741	24	59	global	global	ADJ
ajlm-741	24	60	report	report	NOUN
ajlm-741	24	61	on	on	ADP
ajlm-741	24	62	surveillance,4	surveillance,4	NOUN
ajlm-741	24	63	antimicrobial	antimicrobial	ADJ
ajlm-741	24	64	resistance	resistance	NOUN
ajlm-741	24	65	is	be	AUX
ajlm-741	24	66	increasing	increase	VERB
ajlm-741	24	67	in	in	ADP
ajlm-741	24	68	the	the	DET
ajlm-741	24	69	african	african	ADJ
ajlm-741	24	70	region	region	NOUN
ajlm-741	24	71	,	,	PUNCT
ajlm-741	24	72	and	and	CCONJ
ajlm-741	24	73	there	there	PRON
ajlm-741	24	74	have	have	AUX
ajlm-741	24	75	been	be	AUX
ajlm-741	24	76	reports	report	NOUN
ajlm-741	24	77	of	of	ADP
ajlm-741	24	78	a	a	DET
ajlm-741	24	79	significant	significant	ADJ
ajlm-741	24	80	number	number	NOUN
ajlm-741	24	81	of	of	ADP
ajlm-741	24	82	antimicrobial	antimicrobial	ADJ
ajlm-741	24	83	-	-	PUNCT
ajlm-741	24	84	resistant	resistant	ADJ
ajlm-741	24	85	bacteria	bacteria	NOUN
ajlm-741	24	86	that	that	PRON
ajlm-741	24	87	are	be	AUX
ajlm-741	24	88	transmissible	transmissible	ADJ
ajlm-741	24	89	in	in	ADP
ajlm-741	24	90	the	the	DET
ajlm-741	24	91	hospital	hospital	NOUN
ajlm-741	24	92	and	and	CCONJ
ajlm-741	24	93	in	in	ADP
ajlm-741	24	94	the	the	DET
ajlm-741	24	95	community	community	NOUN
ajlm-741	24	96	.	.	PUNCT
ajlm-741	25	1	since	since	SCONJ
ajlm-741	25	2	surveillance	surveillance	NOUN
ajlm-741	25	3	of	of	ADP
ajlm-741	25	4	antimicrobial	antimicrobial	ADJ
ajlm-741	25	5	-	-	PUNCT
ajlm-741	25	6	resistant	resistant	ADJ
ajlm-741	25	7	bacteria	bacteria	NOUN
ajlm-741	25	8	is	be	AUX
ajlm-741	25	9	performed	perform	VERB
ajlm-741	25	10	only	only	ADV
ajlm-741	25	11	in	in	ADP
ajlm-741	25	12	a	a	DET
ajlm-741	25	13	few	few	ADJ
ajlm-741	25	14	african	african	ADJ
ajlm-741	25	15	countries	country	NOUN
ajlm-741	25	16	,	,	PUNCT
ajlm-741	25	17	there	there	PRON
ajlm-741	25	18	is	be	VERB
ajlm-741	25	19	a	a	DET
ajlm-741	25	20	paucity	paucity	NOUN
ajlm-741	25	21	of	of	ADP
ajlm-741	25	22	accurate	accurate	ADJ
ajlm-741	25	23	and	and	CCONJ
ajlm-741	25	24	reliable	reliable	ADJ
ajlm-741	25	25	information	information	NOUN
ajlm-741	25	26	and	and	CCONJ
ajlm-741	25	27	consequently	consequently	ADV
ajlm-741	25	28	limited	limited	ADJ
ajlm-741	25	29	data	datum	NOUN
ajlm-741	25	30	concerning	concern	VERB
ajlm-741	25	31	the	the	DET
ajlm-741	25	32	true	true	ADJ
ajlm-741	25	33	extent	extent	NOUN
ajlm-741	25	34	of	of	ADP
ajlm-741	25	35	the	the	DET
ajlm-741	25	36	problem	problem	NOUN
ajlm-741	25	37	.	.	PUNCT
ajlm-741	26	1	an	an	DET
ajlm-741	26	2	additional	additional	ADJ
ajlm-741	26	3	challenge	challenge	NOUN
ajlm-741	26	4	noted	note	VERB
ajlm-741	26	5	during	during	ADP
ajlm-741	26	6	an	an	DET
ajlm-741	26	7	external	external	ADJ
ajlm-741	26	8	quality	quality	NOUN
ajlm-741	26	9	assessment	assessment	NOUN
ajlm-741	26	10	of	of	ADP
ajlm-741	26	11	public	public	ADJ
ajlm-741	26	12	health	health	NOUN
ajlm-741	26	13	laboratories	laboratory	NOUN
ajlm-741	26	14	in	in	ADP
ajlm-741	26	15	africa21	africa21	NOUN
ajlm-741	26	16	showed	show	VERB
ajlm-741	26	17	that	that	SCONJ
ajlm-741	26	18	many	many	ADJ
ajlm-741	26	19	countries	country	NOUN
ajlm-741	26	20	experience	experience	VERB
ajlm-741	26	21	problems	problem	NOUN
ajlm-741	26	22	with	with	ADP
ajlm-741	26	23	performing	perform	VERB
ajlm-741	26	24	antimicrobial	antimicrobial	ADJ
ajlm-741	26	25	susceptibility	susceptibility	NOUN
ajlm-741	26	26	testing	testing	NOUN
ajlm-741	26	27	.	.	PUNCT
ajlm-741	27	1	from	from	ADP
ajlm-741	27	2	this	this	DET
ajlm-741	27	3	external	external	ADJ
ajlm-741	27	4	quality	quality	NOUN
ajlm-741	27	5	assessment	assessment	NOUN
ajlm-741	27	6	,	,	PUNCT
ajlm-741	27	7	a	a	DET
ajlm-741	27	8	question	question	NOUN
ajlm-741	27	9	on	on	ADP
ajlm-741	27	10	the	the	DET
ajlm-741	27	11	consistency	consistency	NOUN
ajlm-741	27	12	and	and	CCONJ
ajlm-741	27	13	accuracy	accuracy	NOUN
ajlm-741	27	14	of	of	ADP
ajlm-741	27	15	antimicrobial	antimicrobial	ADJ
ajlm-741	27	16	susceptibility	susceptibility	NOUN
ajlm-741	27	17	testing	testing	NOUN
ajlm-741	27	18	data	datum	NOUN
ajlm-741	27	19	arises	arise	VERB
ajlm-741	27	20	.	.	PUNCT
ajlm-741	28	1	furthermore	furthermore	ADV
ajlm-741	28	2	,	,	PUNCT
ajlm-741	28	3	although	although	SCONJ
ajlm-741	28	4	some	some	DET
ajlm-741	28	5	countries	country	NOUN
ajlm-741	28	6	have	have	AUX
ajlm-741	28	7	established	establish	VERB
ajlm-741	28	8	surveillance	surveillance	NOUN
ajlm-741	28	9	programmes	programme	NOUN
ajlm-741	28	10	,	,	PUNCT
ajlm-741	28	11	there	there	PRON
ajlm-741	28	12	is	be	VERB
ajlm-741	28	13	a	a	DET
ajlm-741	28	14	lack	lack	NOUN
ajlm-741	28	15	of	of	ADP
ajlm-741	28	16	a	a	DET
ajlm-741	28	17	formal	formal	ADJ
ajlm-741	28	18	framework	framework	NOUN
ajlm-741	28	19	across	across	ADP
ajlm-741	28	20	the	the	DET
ajlm-741	28	21	region.4,21	region.4,21	PROPN
ajlm-741	28	22	as	as	ADP
ajlm-741	28	23	part	part	NOUN
ajlm-741	28	24	of	of	ADP
ajlm-741	28	25	the	the	PRON
ajlm-741	28	26	who	who	PRON
ajlm-741	28	27	’s	’	VERB
ajlm-741	28	28	gap	gap	NOUN
ajlm-741	28	29	on	on	ADP
ajlm-741	28	30	antimicrobial	antimicrobial	ADJ
ajlm-741	28	31	resistance	resistance	NOUN
ajlm-741	28	32	,	,	PUNCT
ajlm-741	28	33	the	the	PRON
ajlm-741	28	34	who	who	PRON
ajlm-741	28	35	has	have	AUX
ajlm-741	28	36	sent	send	VERB
ajlm-741	28	37	an	an	DET
ajlm-741	28	38	open	open	ADJ
ajlm-741	28	39	call	call	NOUN
ajlm-741	28	40	for	for	SCONJ
ajlm-741	28	41	countries	country	NOUN
ajlm-741	28	42	to	to	PART
ajlm-741	28	43	enrol	enrol	VERB
ajlm-741	28	44	in	in	ADP
ajlm-741	28	45	the	the	DET
ajlm-741	28	46	glass	glass	NOUN
ajlm-741	28	47	to	to	PART
ajlm-741	28	48	participate	participate	VERB
ajlm-741	28	49	in	in	ADP
ajlm-741	28	50	a	a	DET
ajlm-741	28	51	structured	structured	ADJ
ajlm-741	28	52	surveillance	surveillance	NOUN
ajlm-741	28	53	programme	programme	NOUN
ajlm-741	28	54	and	and	CCONJ
ajlm-741	28	55	provide	provide	VERB
ajlm-741	28	56	reliable	reliable	ADJ
ajlm-741	28	57	and	and	CCONJ
ajlm-741	28	58	complete	complete	ADJ
ajlm-741	28	59	demographic	demographic	ADJ
ajlm-741	28	60	data.22	data.22	NOUN
ajlm-741	28	61	for	for	ADP
ajlm-741	28	62	a	a	DET
ajlm-741	28	63	national	national	ADJ
ajlm-741	28	64	laboratory	laboratory	NOUN
ajlm-741	28	65	-	-	PUNCT
ajlm-741	28	66	based	base	VERB
ajlm-741	28	67	surveillance	surveillance	NOUN
ajlm-741	28	68	programme	programme	NOUN
ajlm-741	28	69	,	,	PUNCT
ajlm-741	28	70	government	government	NOUN
ajlm-741	28	71	commitment	commitment	NOUN
ajlm-741	28	72	and	and	CCONJ
ajlm-741	28	73	support	support	NOUN
ajlm-741	28	74	is	be	AUX
ajlm-741	28	75	non	non	ADJ
ajlm-741	28	76	-	-	ADJ
ajlm-741	28	77	negotiable	negotiable	ADJ
ajlm-741	28	78	.	.	PUNCT
ajlm-741	29	1	this	this	PRON
ajlm-741	29	2	requires	require	VERB
ajlm-741	29	3	the	the	DET
ajlm-741	29	4	drafting	drafting	NOUN
ajlm-741	29	5	of	of	ADP
ajlm-741	29	6	policies	policy	NOUN
ajlm-741	29	7	and	and	CCONJ
ajlm-741	29	8	strategies	strategy	NOUN
ajlm-741	29	9	and	and	CCONJ
ajlm-741	29	10	the	the	DET
ajlm-741	29	11	securing	securing	NOUN
ajlm-741	29	12	of	of	ADP
ajlm-741	29	13	resources	resource	NOUN
ajlm-741	29	14	both	both	ADV
ajlm-741	29	15	,	,	PUNCT
ajlm-741	29	16	financial	financial	ADJ
ajlm-741	29	17	and	and	CCONJ
ajlm-741	29	18	human	human	ADJ
ajlm-741	29	19	.	.	PUNCT
ajlm-741	30	1	glass	glass	NOUN
ajlm-741	30	2	participation	participation	NOUN
ajlm-741	30	3	also	also	ADV
ajlm-741	30	4	requires	require	VERB
ajlm-741	30	5	the	the	DET
ajlm-741	30	6	establishment	establishment	NOUN
ajlm-741	30	7	of	of	ADP
ajlm-741	30	8	a	a	DET
ajlm-741	30	9	coordinating	coordinating	NOUN
ajlm-741	30	10	centre	centre	NOUN
ajlm-741	30	11	which	which	PRON
ajlm-741	30	12	will	will	AUX
ajlm-741	30	13	systematically	systematically	ADV
ajlm-741	30	14	collect	collect	VERB
ajlm-741	30	15	,	,	PUNCT
ajlm-741	30	16	analyse	analyse	NOUN
ajlm-741	30	17	and	and	CCONJ
ajlm-741	30	18	share	share	NOUN
ajlm-741	30	19	data	datum	NOUN
ajlm-741	30	20	nationally	nationally	ADV
ajlm-741	30	21	and	and	CCONJ
ajlm-741	30	22	internationally	internationally	ADV
ajlm-741	30	23	.	.	PUNCT
ajlm-741	31	1	participation	participation	NOUN
ajlm-741	31	2	also	also	ADV
ajlm-741	31	3	requires	require	VERB
ajlm-741	31	4	a	a	DET
ajlm-741	31	5	regional	regional	ADJ
ajlm-741	31	6	reference	reference	NOUN
ajlm-741	31	7	laboratory	laboratory	NOUN
ajlm-741	31	8	which	which	PRON
ajlm-741	31	9	will	will	AUX
ajlm-741	31	10	provide	provide	VERB
ajlm-741	31	11	technical	technical	ADJ
ajlm-741	31	12	support	support	NOUN
ajlm-741	31	13	including	include	VERB
ajlm-741	31	14	training	training	NOUN
ajlm-741	31	15	,	,	PUNCT
ajlm-741	31	16	capacity	capacity	NOUN
ajlm-741	31	17	building	building	NOUN
ajlm-741	31	18	and	and	CCONJ
ajlm-741	31	19	strategy	strategy	NOUN
ajlm-741	31	20	advice.20	advice.20	PROPN
ajlm-741	31	21	a	a	DET
ajlm-741	31	22	review	review	NOUN
ajlm-741	31	23	of	of	ADP
ajlm-741	31	24	12	12	NUM
ajlm-741	31	25	published	publish	VERB
ajlm-741	31	26	articles	article	NOUN
ajlm-741	31	27	from	from	ADP
ajlm-741	31	28	2005	2005	NUM
ajlm-741	31	29	to	to	ADP
ajlm-741	31	30	may	may	PROPN
ajlm-741	31	31	2015	2015	NUM
ajlm-741	31	32	on	on	ADP
ajlm-741	31	33	antimicrobial	antimicrobial	ADJ
ajlm-741	31	34	resistance	resistance	NOUN
ajlm-741	31	35	in	in	ADP
ajlm-741	31	36	east	east	PROPN
ajlm-741	31	37	africa23	africa23	NOUN
ajlm-741	31	38	showed	show	VERB
ajlm-741	31	39	that	that	SCONJ
ajlm-741	31	40	resistance	resistance	NOUN
ajlm-741	31	41	to	to	ADP
ajlm-741	31	42	commonly	commonly	ADV
ajlm-741	31	43	used	use	VERB
ajlm-741	31	44	antimicrobial	antimicrobial	ADJ
ajlm-741	31	45	agents	agent	NOUN
ajlm-741	31	46	was	be	AUX
ajlm-741	31	47	prevalent	prevalent	ADJ
ajlm-741	31	48	and	and	CCONJ
ajlm-741	31	49	that	that	PRON
ajlm-741	31	50	multidrug	multidrug	VERB
ajlm-741	31	51	resistance	resistance	NOUN
ajlm-741	31	52	was	be	AUX
ajlm-741	31	53	increasing	increase	VERB
ajlm-741	31	54	in	in	ADP
ajlm-741	31	55	the	the	DET
ajlm-741	31	56	region	region	NOUN
ajlm-741	31	57	.	.	PUNCT
ajlm-741	32	1	there	there	PRON
ajlm-741	32	2	was	be	VERB
ajlm-741	32	3	scarcity	scarcity	NOUN
ajlm-741	32	4	of	of	ADP
ajlm-741	32	5	data	datum	NOUN
ajlm-741	32	6	on	on	ADP
ajlm-741	32	7	the	the	DET
ajlm-741	32	8	prevalence	prevalence	NOUN
ajlm-741	32	9	of	of	ADP
ajlm-741	32	10	antimicrobial	antimicrobial	ADJ
ajlm-741	32	11	resistance	resistance	NOUN
ajlm-741	32	12	and	and	CCONJ
ajlm-741	32	13	hospital	hospital	NOUN
ajlm-741	32	14	-	-	PUNCT
ajlm-741	32	15	acquired	acquire	VERB
ajlm-741	32	16	infections	infection	NOUN
ajlm-741	32	17	in	in	ADP
ajlm-741	32	18	developing	develop	VERB
ajlm-741	32	19	countries	country	NOUN
ajlm-741	32	20	in	in	ADP
ajlm-741	32	21	east	east	PROPN
ajlm-741	32	22	africa	africa	PROPN
ajlm-741	32	23	and	and	CCONJ
ajlm-741	32	24	the	the	DET
ajlm-741	32	25	authors	author	NOUN
ajlm-741	32	26	suggest	suggest	VERB
ajlm-741	32	27	that	that	SCONJ
ajlm-741	32	28	intensive	intensive	ADJ
ajlm-741	32	29	investigation	investigation	NOUN
ajlm-741	32	30	and	and	CCONJ
ajlm-741	32	31	surveillance	surveillance	NOUN
ajlm-741	32	32	is	be	AUX
ajlm-741	32	33	warranted.23	warranted.23	ADJ
ajlm-741	32	34	this	this	PRON
ajlm-741	32	35	was	be	AUX
ajlm-741	32	36	again	again	ADV
ajlm-741	32	37	indirectly	indirectly	ADV
ajlm-741	32	38	reiterated	reiterate	VERB
ajlm-741	32	39	in	in	ADP
ajlm-741	32	40	a	a	DET
ajlm-741	32	41	systematic	systematic	ADJ
ajlm-741	32	42	review	review	NOUN
ajlm-741	32	43	published	publish	VERB
ajlm-741	32	44	in	in	ADP
ajlm-741	32	45	2017	2017	NUM
ajlm-741	32	46	of	of	ADP
ajlm-741	32	47	antibiotic	antibiotic	ADJ
ajlm-741	32	48	-	-	PUNCT
ajlm-741	32	49	resistant	resistant	ADJ
ajlm-741	32	50	escherichia	escherichia	NOUN
ajlm-741	32	51	coli	coli	NOUN
ajlm-741	32	52	and	and	CCONJ
ajlm-741	32	53	salmonella	salmonella	NOUN
ajlm-741	32	54	data	datum	NOUN
ajlm-741	32	55	from	from	ADP
ajlm-741	32	56	2004	2004	NUM
ajlm-741	32	57	to	to	ADP
ajlm-741	32	58	early	early	ADJ
ajlm-741	32	59	2015	2015	NUM
ajlm-741	32	60	in	in	ADP
ajlm-741	32	61	tanzanian	tanzanian	ADJ
ajlm-741	32	62	healthcare	healthcare	NOUN
ajlm-741	32	63	settings.24from	settings.24from	ADP
ajlm-741	32	64	this	this	DET
ajlm-741	32	65	review	review	NOUN
ajlm-741	32	66	,	,	PUNCT
ajlm-741	32	67	a	a	DET
ajlm-741	32	68	significant	significant	ADJ
ajlm-741	32	69	increase	increase	NOUN
ajlm-741	32	70	in	in	ADP
ajlm-741	32	71	resistance	resistance	NOUN
ajlm-741	32	72	was	be	AUX
ajlm-741	32	73	observed	observe	VERB
ajlm-741	32	74	.	.	PUNCT
ajlm-741	33	1	the	the	DET
ajlm-741	33	2	authors	author	NOUN
ajlm-741	33	3	began	begin	VERB
ajlm-741	33	4	by	by	ADP
ajlm-741	33	5	stating	state	VERB
ajlm-741	33	6	in	in	ADP
ajlm-741	33	7	their	their	PRON
ajlm-741	33	8	abstract	abstract	NOUN
ajlm-741	33	9	that	that	SCONJ
ajlm-741	33	10	reliable	reliable	ADJ
ajlm-741	33	11	data	datum	NOUN
ajlm-741	33	12	are	be	AUX
ajlm-741	33	13	limited	limit	VERB
ajlm-741	33	14	and	and	CCONJ
ajlm-741	33	15	recommend	recommend	VERB
ajlm-741	33	16	that	that	DET
ajlm-741	33	17	proactive	proactive	ADJ
ajlm-741	33	18	strategies	strategy	NOUN
ajlm-741	33	19	in	in	ADP
ajlm-741	33	20	antimicrobial	antimicrobial	ADJ
ajlm-741	33	21	stewardship	stewardship	NOUN
ajlm-741	33	22	and	and	CCONJ
ajlm-741	33	23	infection	infection	NOUN
ajlm-741	33	24	control	control	NOUN
ajlm-741	33	25	measures	measure	NOUN
ajlm-741	33	26	are	be	AUX
ajlm-741	33	27	crucial	crucial	ADJ
ajlm-741	33	28	and	and	CCONJ
ajlm-741	33	29	must	must	AUX
ajlm-741	33	30	be	be	AUX
ajlm-741	33	31	implemented24	implemented24	NOUN
ajlm-741	33	32	,	,	PUNCT
ajlm-741	33	33	all	all	PRON
ajlm-741	33	34	of	of	ADP
ajlm-741	33	35	which	which	PRON
ajlm-741	33	36	can	can	AUX
ajlm-741	33	37	be	be	AUX
ajlm-741	33	38	solved	solve	VERB
ajlm-741	33	39	by	by	ADP
ajlm-741	33	40	establishing	establish	VERB
ajlm-741	33	41	a	a	DET
ajlm-741	33	42	structured	structured	ADJ
ajlm-741	33	43	surveillance	surveillance	NOUN
ajlm-741	33	44	system	system	NOUN
ajlm-741	33	45	.	.	PUNCT
ajlm-741	34	1	surveillance	surveillance	NOUN
ajlm-741	34	2	of	of	ADP
ajlm-741	34	3	antimicrobial	antimicrobial	ADJ
ajlm-741	34	4	resistance	resistance	NOUN
ajlm-741	34	5	in	in	ADP
ajlm-741	34	6	healthcare	healthcare	NOUN
ajlm-741	34	7	-	-	PUNCT
ajlm-741	34	8	associated	associate	VERB
ajlm-741	34	9	pathogens	pathogen	NOUN
ajlm-741	34	10	in	in	ADP
ajlm-741	34	11	south	south	PROPN
ajlm-741	34	12	africa	africa	PROPN
ajlm-741	34	13	in	in	ADP
ajlm-741	34	14	south	south	PROPN
ajlm-741	34	15	africa	africa	PROPN
ajlm-741	34	16	there	there	PRON
ajlm-741	34	17	is	be	VERB
ajlm-741	34	18	a	a	DET
ajlm-741	34	19	high	high	ADJ
ajlm-741	34	20	burden	burden	NOUN
ajlm-741	34	21	of	of	ADP
ajlm-741	34	22	infectious	infectious	ADJ
ajlm-741	34	23	diseases	disease	NOUN
ajlm-741	34	24	consisting	consist	VERB
ajlm-741	34	25	of	of	ADP
ajlm-741	34	26	a	a	DET
ajlm-741	34	27	significant	significant	ADJ
ajlm-741	34	28	population	population	NOUN
ajlm-741	34	29	that	that	PRON
ajlm-741	34	30	are	be	AUX
ajlm-741	34	31	of	of	ADP
ajlm-741	34	32	bacterial	bacterial	ADJ
ajlm-741	34	33	origin25	origin25	NOUN
ajlm-741	34	34	.	.	PUNCT
ajlm-741	35	1	a	a	DET
ajlm-741	35	2	prominent	prominent	ADJ
ajlm-741	35	3	increase	increase	NOUN
ajlm-741	35	4	in	in	ADP
ajlm-741	35	5	extended	extend	VERB
ajlm-741	35	6	-	-	PUNCT
ajlm-741	35	7	spectrum	spectrum	NOUN
ajlm-741	35	8	beta	beta	NOUN
ajlm-741	35	9	-	-	PUNCT
ajlm-741	35	10	lactamase	lactamase	NOUN
ajlm-741	35	11	(	(	PUNCT
ajlm-741	35	12	esbl	esbl	NOUN
ajlm-741	35	13	)	)	PUNCT
ajlm-741	35	14	production	production	NOUN
ajlm-741	35	15	and	and	CCONJ
ajlm-741	35	16	emergence	emergence	NOUN
ajlm-741	35	17	of	of	ADP
ajlm-741	35	18	carbapenemase	carbapenemase	NOUN
ajlm-741	35	19	production	production	NOUN
ajlm-741	35	20	in	in	ADP
ajlm-741	35	21	klebsiella	klebsiella	NOUN
ajlm-741	35	22	pneumoniae	pneumoniae	ADJ
ajlm-741	35	23	and	and	CCONJ
ajlm-741	35	24	enterobacter	enterobacter	ADJ
ajlm-741	35	25	spp	spp	NOUN
ajlm-741	35	26	.	.	PUNCT
ajlm-741	35	27	,	,	PUNCT
ajlm-741	35	28	multidrug	multidrug	VERB
ajlm-741	35	29	resistance	resistance	NOUN
ajlm-741	35	30	and	and	CCONJ
ajlm-741	35	31	an	an	DET
ajlm-741	35	32	increase	increase	NOUN
ajlm-741	35	33	of	of	ADP
ajlm-741	35	34	carbapenemase	carbapenemase	NOUN
ajlm-741	35	35	production	production	NOUN
ajlm-741	35	36	in	in	ADP
ajlm-741	35	37	acinetobacter	acinetobacter	ADJ
ajlm-741	35	38	baumannii	baumannii	ADJ
ajlm-741	35	39	and	and	CCONJ
ajlm-741	35	40	pseudomonas	pseudomona	NOUN
ajlm-741	35	41	aeruginosa	aeruginosa	NOUN
ajlm-741	35	42	,	,	PUNCT
ajlm-741	35	43	an	an	DET
ajlm-741	35	44	increase	increase	NOUN
ajlm-741	35	45	in	in	ADP
ajlm-741	35	46	multidrug	multidrug	NOUN
ajlm-741	35	47	-	-	PUNCT
ajlm-741	35	48	resistant	resistant	ADJ
ajlm-741	35	49	escherichia	escherichia	NOUN
ajlm-741	35	50	coli	coli	NOUN
ajlm-741	35	51	and	and	CCONJ
ajlm-741	35	52	resistance	resistance	NOUN
ajlm-741	35	53	in	in	ADP
ajlm-741	35	54	gram	gram	NOUN
ajlm-741	35	55	-	-	PUNCT
ajlm-741	35	56	positive	positive	ADJ
ajlm-741	35	57	isolates	isolate	NOUN
ajlm-741	35	58	with	with	ADP
ajlm-741	35	59	a	a	DET
ajlm-741	35	60	decline	decline	NOUN
ajlm-741	35	61	in	in	ADP
ajlm-741	35	62	methicillin	methicillin	NOUN
ajlm-741	35	63	-	-	PUNCT
ajlm-741	35	64	resistant	resistant	ADJ
ajlm-741	35	65	staphylococcus	staphylococcus	NOUN
ajlm-741	35	66	aureus	aureus	NOUN
ajlm-741	35	67	(	(	PUNCT
ajlm-741	35	68	mrsa	mrsa	NOUN
ajlm-741	35	69	)	)	PUNCT
ajlm-741	35	70	and	and	CCONJ
ajlm-741	35	71	a	a	DET
ajlm-741	35	72	steady	steady	ADJ
ajlm-741	35	73	increase	increase	NOUN
ajlm-741	35	74	in	in	ADP
ajlm-741	35	75	vancomycin	vancomycin	NOUN
ajlm-741	35	76	-	-	PUNCT
ajlm-741	35	77	resistant	resistant	ADJ
ajlm-741	35	78	enterococci	enterococci	NOUN
ajlm-741	35	79	(	(	PUNCT
ajlm-741	35	80	vre	vre	NOUN
ajlm-741	35	81	)	)	PUNCT
ajlm-741	35	82	have	have	AUX
ajlm-741	35	83	been	be	AUX
ajlm-741	35	84	noted	note	VERB
ajlm-741	35	85	in	in	ADP
ajlm-741	35	86	various	various	ADJ
ajlm-741	35	87	reports26,27,28,29,30,31,32	reports26,27,28,29,30,31,32	NOUN
ajlm-741	35	88	making	make	VERB
ajlm-741	35	89	use	use	NOUN
ajlm-741	35	90	of	of	ADP
ajlm-741	35	91	various	various	ADJ
ajlm-741	35	92	methodologies	methodology	NOUN
ajlm-741	35	93	.	.	PUNCT
ajlm-741	36	1	the	the	DET
ajlm-741	36	2	need	need	NOUN
ajlm-741	36	3	for	for	ADP
ajlm-741	36	4	a	a	DET
ajlm-741	36	5	systematic	systematic	ADJ
ajlm-741	36	6	and	and	CCONJ
ajlm-741	36	7	consistent	consistent	ADJ
ajlm-741	36	8	approach	approach	NOUN
ajlm-741	36	9	in	in	ADP
ajlm-741	36	10	selecting	select	VERB
ajlm-741	36	11	antimicrobials	antimicrobial	NOUN
ajlm-741	36	12	for	for	ADP
ajlm-741	36	13	the	the	DET
ajlm-741	36	14	treatment	treatment	NOUN
ajlm-741	36	15	of	of	ADP
ajlm-741	36	16	these	these	DET
ajlm-741	36	17	infections	infection	NOUN
ajlm-741	36	18	is	be	AUX
ajlm-741	36	19	essential	essential	ADJ
ajlm-741	36	20	.	.	PUNCT
ajlm-741	37	1	an	an	DET
ajlm-741	37	2	established	establish	VERB
ajlm-741	37	3	standardised	standardised	ADJ
ajlm-741	37	4	surveillance	surveillance	NOUN
ajlm-741	37	5	system	system	NOUN
ajlm-741	37	6	will	will	AUX
ajlm-741	37	7	provide	provide	VERB
ajlm-741	37	8	information	information	NOUN
ajlm-741	37	9	on	on	ADP
ajlm-741	37	10	causative	causative	ADJ
ajlm-741	37	11	pathogens	pathogen	NOUN
ajlm-741	37	12	and	and	CCONJ
ajlm-741	37	13	antimicrobial	antimicrobial	ADJ
ajlm-741	37	14	susceptibility	susceptibility	NOUN
ajlm-741	37	15	patterns	pattern	NOUN
ajlm-741	37	16	of	of	ADP
ajlm-741	37	17	these	these	DET
ajlm-741	37	18	pathogens	pathogen	NOUN
ajlm-741	37	19	.	.	PUNCT
ajlm-741	38	1	in	in	ADP
ajlm-741	38	2	addition	addition	NOUN
ajlm-741	38	3	,	,	PUNCT
ajlm-741	38	4	the	the	DET
ajlm-741	38	5	antimicrobial	antimicrobial	ADJ
ajlm-741	38	6	spectrum	spectrum	NOUN
ajlm-741	38	7	of	of	ADP
ajlm-741	38	8	a	a	DET
ajlm-741	38	9	selected	select	VERB
ajlm-741	38	10	agent	agent	NOUN
ajlm-741	38	11	,	,	PUNCT
ajlm-741	38	12	the	the	DET
ajlm-741	38	13	use	use	NOUN
ajlm-741	38	14	of	of	ADP
ajlm-741	38	15	appropriate	appropriate	ADJ
ajlm-741	38	16	dosing	dose	VERB
ajlm-741	38	17	schedules	schedule	NOUN
ajlm-741	38	18	based	base	VERB
ajlm-741	38	19	on	on	ADP
ajlm-741	38	20	the	the	DET
ajlm-741	38	21	selected	select	VERB
ajlm-741	38	22	agent	agent	NOUN
ajlm-741	38	23	’s	’s	PART
ajlm-741	38	24	pharmacokinetic	pharmacokinetic	ADJ
ajlm-741	38	25	and	and	CCONJ
ajlm-741	38	26	pharmacodynamic	pharmacodynamic	ADJ
ajlm-741	38	27	properties	property	NOUN
ajlm-741	38	28	and	and	CCONJ
ajlm-741	38	29	pharmacological	pharmacological	ADJ
ajlm-741	38	30	considerations	consideration	NOUN
ajlm-741	38	31	in	in	ADP
ajlm-741	38	32	the	the	DET
ajlm-741	38	33	patient	patient	NOUN
ajlm-741	38	34	should	should	AUX
ajlm-741	38	35	be	be	AUX
ajlm-741	38	36	included	include	VERB
ajlm-741	38	37	.	.	PUNCT
ajlm-741	39	1	an	an	DET
ajlm-741	39	2	intervention	intervention	NOUN
ajlm-741	39	3	strategy	strategy	NOUN
ajlm-741	39	4	such	such	ADJ
ajlm-741	39	5	as	as	ADP
ajlm-741	39	6	directing	direct	VERB
ajlm-741	39	7	therapy	therapy	NOUN
ajlm-741	39	8	to	to	ADP
ajlm-741	39	9	narrow	narrow	ADJ
ajlm-741	39	10	-	-	PUNCT
ajlm-741	39	11	spectrum	spectrum	NOUN
ajlm-741	39	12	agents	agent	NOUN
ajlm-741	39	13	once	once	SCONJ
ajlm-741	39	14	microbiology	microbiology	NOUN
ajlm-741	39	15	results	result	NOUN
ajlm-741	39	16	become	become	VERB
ajlm-741	39	17	available	available	ADJ
ajlm-741	39	18	should	should	AUX
ajlm-741	39	19	also	also	ADV
ajlm-741	39	20	be	be	AUX
ajlm-741	39	21	established	establish	VERB
ajlm-741	39	22	as	as	ADV
ajlm-741	39	23	well	well	ADV
ajlm-741	39	24	as	as	ADP
ajlm-741	39	25	the	the	DET
ajlm-741	39	26	routes	route	NOUN
ajlm-741	39	27	of	of	ADP
ajlm-741	39	28	transmission	transmission	NOUN
ajlm-741	39	29	when	when	SCONJ
ajlm-741	39	30	a	a	DET
ajlm-741	39	31	resistant	resistant	ADJ
ajlm-741	39	32	strain	strain	NOUN
ajlm-741	39	33	is	be	AUX
ajlm-741	39	34	recovered	recover	VERB
ajlm-741	39	35	from	from	ADP
ajlm-741	39	36	more	more	ADJ
ajlm-741	39	37	than	than	ADP
ajlm-741	39	38	one	one	NUM
ajlm-741	39	39	individual	individual	NOUN
ajlm-741	39	40	.	.	PUNCT
ajlm-741	40	1	once	once	ADV
ajlm-741	40	2	this	this	DET
ajlm-741	40	3	information	information	NOUN
ajlm-741	40	4	is	be	AUX
ajlm-741	40	5	known	know	VERB
ajlm-741	40	6	,	,	PUNCT
ajlm-741	40	7	an	an	DET
ajlm-741	40	8	intervention	intervention	NOUN
ajlm-741	40	9	can	can	AUX
ajlm-741	40	10	be	be	AUX
ajlm-741	40	11	introduced	introduce	VERB
ajlm-741	40	12	and	and	CCONJ
ajlm-741	40	13	subsequently	subsequently	ADV
ajlm-741	40	14	proved	prove	VERB
ajlm-741	40	15	effective.2,7	effective.2,7	DET
ajlm-741	40	16	a	a	DET
ajlm-741	40	17	report	report	NOUN
ajlm-741	40	18	by	by	ADP
ajlm-741	40	19	crowther	crowther	PROPN
ajlm-741	40	20	-	-	PUNCT
ajlm-741	40	21	gibson	gibson	PROPN
ajlm-741	40	22	and	and	CCONJ
ajlm-741	40	23	colleagues	colleague	NOUN
ajlm-741	40	24	in	in	ADP
ajlm-741	40	25	201125	201125	NUM
ajlm-741	40	26	aimed	aim	VERB
ajlm-741	40	27	at	at	ADP
ajlm-741	40	28	summarising	summarise	VERB
ajlm-741	40	29	surveillance	surveillance	NOUN
ajlm-741	40	30	efforts	effort	NOUN
ajlm-741	40	31	in	in	ADP
ajlm-741	40	32	south	south	PROPN
ajlm-741	40	33	africa	africa	PROPN
ajlm-741	40	34	.	.	PUNCT
ajlm-741	41	1	this	this	DET
ajlm-741	41	2	report	report	NOUN
ajlm-741	41	3	reviewed	review	VERB
ajlm-741	41	4	the	the	DET
ajlm-741	41	5	national	national	ADJ
ajlm-741	41	6	burden	burden	NOUN
ajlm-741	41	7	of	of	ADP
ajlm-741	41	8	disease	disease	NOUN
ajlm-741	41	9	and	and	CCONJ
ajlm-741	41	10	levels	level	NOUN
ajlm-741	41	11	of	of	ADP
ajlm-741	41	12	antimicrobial	antimicrobial	ADJ
ajlm-741	41	13	resistance	resistance	NOUN
ajlm-741	41	14	in	in	ADP
ajlm-741	41	15	common	common	ADJ
ajlm-741	41	16	bacterial	bacterial	ADJ
ajlm-741	41	17	infections	infection	NOUN
ajlm-741	41	18	and	and	CCONJ
ajlm-741	41	19	showed	show	VERB
ajlm-741	41	20	that	that	DET
ajlm-741	41	21	antimicrobial	antimicrobial	ADJ
ajlm-741	41	22	resistance	resistance	NOUN
ajlm-741	41	23	in	in	ADP
ajlm-741	41	24	healthcare	healthcare	PROPN
ajlm-741	41	25	-	-	PUNCT
ajlm-741	41	26	associated	associate	VERB
ajlm-741	41	27	infections	infection	NOUN
ajlm-741	41	28	varied	varied	ADJ
ajlm-741	41	29	among	among	ADP
ajlm-741	41	30	antimicrobial	antimicrobial	ADJ
ajlm-741	41	31	agents	agent	NOUN
ajlm-741	41	32	in	in	ADP
ajlm-741	41	33	the	the	DET
ajlm-741	41	34	public	public	ADJ
ajlm-741	41	35	and	and	CCONJ
ajlm-741	41	36	private	private	ADJ
ajlm-741	41	37	healthcare	healthcare	NOUN
ajlm-741	41	38	sectors	sector	NOUN
ajlm-741	41	39	.	.	PUNCT
ajlm-741	42	1	this	this	DET
ajlm-741	42	2	report	report	NOUN
ajlm-741	42	3	indicated	indicate	VERB
ajlm-741	42	4	the	the	DET
ajlm-741	42	5	need	need	NOUN
ajlm-741	42	6	for	for	ADP
ajlm-741	42	7	continuous	continuous	ADJ
ajlm-741	42	8	monitoring	monitoring	NOUN
ajlm-741	42	9	as	as	ADP
ajlm-741	42	10	an	an	DET
ajlm-741	42	11	effort	effort	NOUN
ajlm-741	42	12	to	to	PART
ajlm-741	42	13	observe	observe	VERB
ajlm-741	42	14	and	and	CCONJ
ajlm-741	42	15	control	control	VERB
ajlm-741	42	16	the	the	DET
ajlm-741	42	17	spread	spread	NOUN
ajlm-741	42	18	of	of	ADP
ajlm-741	42	19	resistance	resistance	NOUN
ajlm-741	42	20	.	.	PUNCT
ajlm-741	43	1	limitations	limitation	NOUN
ajlm-741	43	2	noted	note	VERB
ajlm-741	43	3	were	be	AUX
ajlm-741	43	4	that	that	SCONJ
ajlm-741	43	5	the	the	DET
ajlm-741	43	6	causes	cause	NOUN
ajlm-741	43	7	of	of	ADP
ajlm-741	43	8	illness	illness	NOUN
ajlm-741	43	9	and	and	CCONJ
ajlm-741	43	10	deaths	death	NOUN
ajlm-741	43	11	were	be	AUX
ajlm-741	43	12	not	not	PART
ajlm-741	43	13	well	well	ADV
ajlm-741	43	14	documented	document	VERB
ajlm-741	43	15	,	,	PUNCT
ajlm-741	43	16	a	a	DET
ajlm-741	43	17	common	common	ADJ
ajlm-741	43	18	occurrence	occurrence	NOUN
ajlm-741	43	19	in	in	ADP
ajlm-741	43	20	low	low	ADJ
ajlm-741	43	21	-	-	PUNCT
ajlm-741	43	22	resource	resource	NOUN
ajlm-741	43	23	countries	country	NOUN
ajlm-741	43	24	.	.	PUNCT
ajlm-741	44	1	distinguishing	distinguish	VERB
ajlm-741	44	2	viral	viral	ADJ
ajlm-741	44	3	from	from	ADP
ajlm-741	44	4	bacterial	bacterial	ADJ
ajlm-741	44	5	diseases	disease	NOUN
ajlm-741	44	6	requires	require	VERB
ajlm-741	44	7	a	a	DET
ajlm-741	44	8	level	level	NOUN
ajlm-741	44	9	of	of	ADP
ajlm-741	44	10	detail	detail	NOUN
ajlm-741	44	11	that	that	PRON
ajlm-741	44	12	did	do	AUX
ajlm-741	44	13	not	not	PART
ajlm-741	44	14	exist	exist	VERB
ajlm-741	44	15	in	in	ADP
ajlm-741	44	16	the	the	DET
ajlm-741	44	17	majority	majority	NOUN
ajlm-741	44	18	of	of	ADP
ajlm-741	44	19	the	the	DET
ajlm-741	44	20	cases.25	cases.25	NOUN
ajlm-741	44	21	other	other	ADJ
ajlm-741	44	22	efforts	effort	NOUN
ajlm-741	44	23	to	to	PART
ajlm-741	44	24	publish	publish	VERB
ajlm-741	44	25	south	south	ADJ
ajlm-741	44	26	african	african	ADJ
ajlm-741	44	27	data	datum	NOUN
ajlm-741	44	28	is	be	AUX
ajlm-741	44	29	the	the	DET
ajlm-741	44	30	sentry	sentry	NOUN
ajlm-741	44	31	antimicrobial	antimicrobial	ADJ
ajlm-741	44	32	surveillance	surveillance	NOUN
ajlm-741	44	33	programme	programme	NOUN
ajlm-741	44	34	which	which	PRON
ajlm-741	44	35	is	be	AUX
ajlm-741	44	36	an	an	DET
ajlm-741	44	37	international	international	ADJ
ajlm-741	44	38	programme	programme	NOUN
ajlm-741	44	39	documenting	document	VERB
ajlm-741	44	40	antimicrobial	antimicrobial	ADJ
ajlm-741	44	41	resistance	resistance	NOUN
ajlm-741	44	42	in	in	ADP
ajlm-741	44	43	predominantly	predominantly	ADV
ajlm-741	44	44	healthcare	healthcare	NOUN
ajlm-741	44	45	-	-	PUNCT
ajlm-741	44	46	associated	associate	VERB
ajlm-741	44	47	pathogens.33,34,35,36,37,38,39,40,41,42,43	pathogens.33,34,35,36,37,38,39,40,41,42,43	PROPN
ajlm-741	44	48	surveillance	surveillance	NOUN
ajlm-741	44	49	data	datum	NOUN
ajlm-741	44	50	,	,	PUNCT
ajlm-741	44	51	however	however	ADV
ajlm-741	44	52	,	,	PUNCT
ajlm-741	44	53	do	do	AUX
ajlm-741	44	54	not	not	PART
ajlm-741	44	55	report	report	VERB
ajlm-741	44	56	findings	finding	NOUN
ajlm-741	44	57	from	from	ADP
ajlm-741	44	58	south	south	PROPN
ajlm-741	44	59	africa	africa	PROPN
ajlm-741	44	60	exclusively	exclusively	ADV
ajlm-741	44	61	hence	hence	ADV
ajlm-741	44	62	findings	finding	VERB
ajlm-741	44	63	specific	specific	ADJ
ajlm-741	44	64	to	to	ADP
ajlm-741	44	65	the	the	DET
ajlm-741	44	66	country	country	NOUN
ajlm-741	44	67	can	can	AUX
ajlm-741	44	68	not	not	PART
ajlm-741	44	69	be	be	AUX
ajlm-741	44	70	extracted	extract	VERB
ajlm-741	44	71	.	.	PUNCT
ajlm-741	45	1	antimicrobial	antimicrobial	ADJ
ajlm-741	45	2	resistance	resistance	NOUN
ajlm-741	45	3	surveillance	surveillance	NOUN
ajlm-741	45	4	in	in	ADP
ajlm-741	45	5	healthcare	healthcare	NOUN
ajlm-741	45	6	-	-	PUNCT
ajlm-741	45	7	associated	associate	VERB
ajlm-741	45	8	infections	infection	NOUN
ajlm-741	45	9	is	be	AUX
ajlm-741	45	10	particularly	particularly	ADV
ajlm-741	45	11	important	important	ADJ
ajlm-741	45	12	because	because	SCONJ
ajlm-741	45	13	it	it	PRON
ajlm-741	45	14	is	be	AUX
ajlm-741	45	15	crucial	crucial	ADJ
ajlm-741	45	16	to	to	PART
ajlm-741	45	17	understand	understand	VERB
ajlm-741	45	18	the	the	DET
ajlm-741	45	19	dynamics	dynamic	NOUN
ajlm-741	45	20	in	in	ADP
ajlm-741	45	21	a	a	DET
ajlm-741	45	22	specific	specific	ADJ
ajlm-741	45	23	healthcare	healthcare	NOUN
ajlm-741	45	24	setting	setting	NOUN
ajlm-741	45	25	.	.	PUNCT
ajlm-741	46	1	however	however	ADV
ajlm-741	46	2	,	,	PUNCT
ajlm-741	46	3	as	as	SCONJ
ajlm-741	46	4	patients	patient	NOUN
ajlm-741	46	5	are	be	AUX
ajlm-741	46	6	often	often	ADV
ajlm-741	46	7	transferred	transfer	VERB
ajlm-741	46	8	between	between	ADP
ajlm-741	46	9	wards	ward	NOUN
ajlm-741	46	10	and	and	CCONJ
ajlm-741	46	11	hospitals	hospital	NOUN
ajlm-741	46	12	it	it	PRON
ajlm-741	46	13	becomes	become	VERB
ajlm-741	46	14	problematic	problematic	ADJ
ajlm-741	46	15	to	to	PART
ajlm-741	46	16	establish	establish	VERB
ajlm-741	46	17	a	a	DET
ajlm-741	46	18	system	system	NOUN
ajlm-741	46	19	that	that	PRON
ajlm-741	46	20	would	would	AUX
ajlm-741	46	21	work	work	VERB
ajlm-741	46	22	in	in	ADP
ajlm-741	46	23	all	all	DET
ajlm-741	46	24	healthcare	healthcare	NOUN
ajlm-741	46	25	settings	setting	NOUN
ajlm-741	46	26	due	due	ADP
ajlm-741	46	27	to	to	ADP
ajlm-741	46	28	differences	difference	NOUN
ajlm-741	46	29	in	in	ADP
ajlm-741	46	30	staff	staff	NOUN
ajlm-741	46	31	complement	complement	NOUN
ajlm-741	46	32	,	,	PUNCT
ajlm-741	46	33	antimicrobial	antimicrobial	ADJ
ajlm-741	46	34	stewardship	stewardship	NOUN
ajlm-741	46	35	programmes	programme	NOUN
ajlm-741	46	36	and	and	CCONJ
ajlm-741	46	37	infection	infection	NOUN
ajlm-741	46	38	prevention	prevention	NOUN
ajlm-741	46	39	and	and	CCONJ
ajlm-741	46	40	control	control	NOUN
ajlm-741	46	41	practices	practice	NOUN
ajlm-741	46	42	.	.	PUNCT
ajlm-741	47	1	these	these	DET
ajlm-741	47	2	differences	difference	NOUN
ajlm-741	47	3	highlight	highlight	VERB
ajlm-741	47	4	this	this	DET
ajlm-741	47	5	challenge	challenge	NOUN
ajlm-741	47	6	and	and	CCONJ
ajlm-741	47	7	is	be	AUX
ajlm-741	47	8	further	far	ADV
ajlm-741	47	9	reiterated	reiterate	VERB
ajlm-741	47	10	in	in	ADP
ajlm-741	47	11	a	a	DET
ajlm-741	47	12	6	6	NUM
ajlm-741	47	13	-	-	PUNCT
ajlm-741	47	14	month	month	NOUN
ajlm-741	47	15	surveillance	surveillance	NOUN
ajlm-741	47	16	study	study	NOUN
ajlm-741	47	17	conducted	conduct	VERB
ajlm-741	47	18	in	in	ADP
ajlm-741	47	19	tygerberg	tygerberg	PROPN
ajlm-741	47	20	children	child	NOUN
ajlm-741	47	21	’s	’s	PART
ajlm-741	47	22	hospital	hospital	NOUN
ajlm-741	47	23	,	,	PUNCT
ajlm-741	47	24	cape	cape	NOUN
ajlm-741	47	25	town	town	NOUN
ajlm-741	47	26	,	,	PUNCT
ajlm-741	47	27	in	in	ADP
ajlm-741	47	28	2015	2015	NUM
ajlm-741	47	29	whose	whose	DET
ajlm-741	47	30	aim	aim	NOUN
ajlm-741	47	31	was	be	AUX
ajlm-741	47	32	to	to	PART
ajlm-741	47	33	evaluate	evaluate	VERB
ajlm-741	47	34	three	three	NUM
ajlm-741	47	35	surveillance	surveillance	NOUN
ajlm-741	47	36	methods	method	NOUN
ajlm-741	47	37	.	.	PUNCT
ajlm-741	48	1	point	point	NOUN
ajlm-741	48	2	prevalence	prevalence	NOUN
ajlm-741	48	3	surveys	survey	NOUN
ajlm-741	48	4	,	,	PUNCT
ajlm-741	48	5	laboratory	laboratory	NOUN
ajlm-741	48	6	surveillance	surveillance	NOUN
ajlm-741	48	7	and	and	CCONJ
ajlm-741	48	8	tracking	tracking	NOUN
ajlm-741	48	9	of	of	ADP
ajlm-741	48	10	antimicrobial	antimicrobial	ADJ
ajlm-741	48	11	prescriptions	prescription	NOUN
ajlm-741	48	12	were	be	AUX
ajlm-741	48	13	evaluated	evaluate	VERB
ajlm-741	48	14	against	against	ADP
ajlm-741	48	15	the	the	DET
ajlm-741	48	16	reference	reference	NOUN
ajlm-741	48	17	method	method	NOUN
ajlm-741	48	18	which	which	PRON
ajlm-741	48	19	was	be	AUX
ajlm-741	48	20	prospective	prospective	ADJ
ajlm-741	48	21	clinical	clinical	ADJ
ajlm-741	48	22	healthcare	healthcare	NOUN
ajlm-741	48	23	-	-	PUNCT
ajlm-741	48	24	associated	associate	VERB
ajlm-741	48	25	infection	infection	NOUN
ajlm-741	48	26	surveillance	surveillance	NOUN
ajlm-741	48	27	.	.	PUNCT
ajlm-741	49	1	while	while	SCONJ
ajlm-741	49	2	a	a	DET
ajlm-741	49	3	combination	combination	NOUN
ajlm-741	49	4	of	of	ADP
ajlm-741	49	5	antimicrobial	antimicrobial	ADJ
ajlm-741	49	6	prescription	prescription	NOUN
ajlm-741	49	7	tracking	tracking	NOUN
ajlm-741	49	8	and	and	CCONJ
ajlm-741	49	9	laboratory	laboratory	NOUN
ajlm-741	49	10	surveillance	surveillance	NOUN
ajlm-741	49	11	produced	produce	VERB
ajlm-741	49	12	the	the	DET
ajlm-741	49	13	best	good	ADJ
ajlm-741	49	14	results	result	NOUN
ajlm-741	49	15	in	in	ADP
ajlm-741	49	16	their	their	PRON
ajlm-741	49	17	setting	setting	NOUN
ajlm-741	49	18	,	,	PUNCT
ajlm-741	49	19	the	the	DET
ajlm-741	49	20	authors	author	NOUN
ajlm-741	49	21	concluded	conclude	VERB
ajlm-741	49	22	that	that	SCONJ
ajlm-741	49	23	healthcare	healthcare	PROPN
ajlm-741	49	24	facilities	facility	NOUN
ajlm-741	49	25	should	should	AUX
ajlm-741	49	26	select	select	VERB
ajlm-741	49	27	a	a	DET
ajlm-741	49	28	suitable	suitable	ADJ
ajlm-741	49	29	method	method	NOUN
ajlm-741	49	30	subject	subject	ADJ
ajlm-741	49	31	to	to	ADP
ajlm-741	49	32	available	available	ADJ
ajlm-741	49	33	resources	resource	NOUN
ajlm-741	49	34	and	and	CCONJ
ajlm-741	49	35	practice	practice	NOUN
ajlm-741	49	36	context.44	context.44	NOUN
ajlm-741	49	37	however	however	ADV
ajlm-741	49	38	,	,	PUNCT
ajlm-741	49	39	as	as	SCONJ
ajlm-741	49	40	indicated	indicate	VERB
ajlm-741	49	41	repeatedly	repeatedly	ADV
ajlm-741	49	42	in	in	ADP
ajlm-741	49	43	the	the	DET
ajlm-741	49	44	current	current	ADJ
ajlm-741	49	45	review	review	NOUN
ajlm-741	49	46	,	,	PUNCT
ajlm-741	49	47	the	the	DET
ajlm-741	49	48	problem	problem	NOUN
ajlm-741	49	49	that	that	PRON
ajlm-741	49	50	exists	exist	VERB
ajlm-741	49	51	with	with	ADP
ajlm-741	49	52	such	such	DET
ajlm-741	49	53	a	a	DET
ajlm-741	49	54	recommendation	recommendation	NOUN
ajlm-741	49	55	is	be	AUX
ajlm-741	49	56	that	that	SCONJ
ajlm-741	49	57	methodologies	methodology	NOUN
ajlm-741	49	58	are	be	AUX
ajlm-741	49	59	not	not	PART
ajlm-741	49	60	standardised	standardise	VERB
ajlm-741	49	61	and	and	CCONJ
ajlm-741	49	62	in	in	ADP
ajlm-741	49	63	order	order	NOUN
ajlm-741	49	64	to	to	PART
ajlm-741	49	65	obtain	obtain	VERB
ajlm-741	49	66	a	a	DET
ajlm-741	49	67	holistic	holistic	ADJ
ajlm-741	49	68	picture	picture	NOUN
ajlm-741	49	69	of	of	ADP
ajlm-741	49	70	antimicrobial	antimicrobial	ADJ
ajlm-741	49	71	resistance	resistance	NOUN
ajlm-741	49	72	in	in	ADP
ajlm-741	49	73	healthcare	healthcare	PROPN
ajlm-741	49	74	-	-	PUNCT
ajlm-741	49	75	associated	associate	VERB
ajlm-741	49	76	infections	infection	NOUN
ajlm-741	49	77	in	in	ADP
ajlm-741	49	78	south	south	PROPN
ajlm-741	49	79	africa	africa	PROPN
ajlm-741	49	80	,	,	PUNCT
ajlm-741	49	81	standardised	standardised	ADJ
ajlm-741	49	82	methods	method	NOUN
ajlm-741	49	83	need	need	VERB
ajlm-741	49	84	to	to	PART
ajlm-741	49	85	be	be	AUX
ajlm-741	49	86	implemented	implement	VERB
ajlm-741	49	87	.	.	PUNCT
ajlm-741	50	1	our	our	PRON
ajlm-741	50	2	group	group	NOUN
ajlm-741	50	3	at	at	ADP
ajlm-741	50	4	the	the	DET
ajlm-741	50	5	antimicrobial	antimicrobial	ADJ
ajlm-741	50	6	resistance	resistance	NOUN
ajlm-741	50	7	laboratory	laboratory	NOUN
ajlm-741	50	8	,	,	PUNCT
ajlm-741	50	9	which	which	PRON
ajlm-741	50	10	is	be	AUX
ajlm-741	50	11	a	a	DET
ajlm-741	50	12	national	national	ADJ
ajlm-741	50	13	reference	reference	NOUN
ajlm-741	50	14	laboratory	laboratory	NOUN
ajlm-741	50	15	at	at	ADP
ajlm-741	50	16	the	the	DET
ajlm-741	50	17	national	national	PROPN
ajlm-741	50	18	institute	institute	PROPN
ajlm-741	50	19	for	for	ADP
ajlm-741	50	20	communicable	communicable	NOUN
ajlm-741	50	21	diseases	disease	NOUN
ajlm-741	50	22	(	(	PUNCT
ajlm-741	50	23	nicd	nicd	NOUN
ajlm-741	50	24	)	)	PUNCT
ajlm-741	50	25	,	,	PUNCT
ajlm-741	50	26	established	establish	VERB
ajlm-741	50	27	and	and	CCONJ
ajlm-741	50	28	commenced	commence	VERB
ajlm-741	50	29	(	(	PUNCT
ajlm-741	50	30	through	through	ADP
ajlm-741	50	31	the	the	DET
ajlm-741	50	32	germs	germ	NOUN
ajlm-741	50	33	-	-	PUNCT
ajlm-741	50	34	sa	sa	NOUN
ajlm-741	50	35	platform	platform	NOUN
ajlm-741	50	36	)	)	PUNCT
ajlm-741	50	37	a	a	DET
ajlm-741	50	38	standardised	standardised	ADJ
ajlm-741	50	39	laboratory	laboratory	NOUN
ajlm-741	50	40	-	-	PUNCT
ajlm-741	50	41	based	base	VERB
ajlm-741	50	42	antimicrobial	antimicrobial	ADJ
ajlm-741	50	43	resistance	resistance	NOUN
ajlm-741	50	44	surveillance	surveillance	NOUN
ajlm-741	50	45	(	(	PUNCT
ajlm-741	50	46	lars	lars	PROPN
ajlm-741	50	47	)	)	PUNCT
ajlm-741	50	48	programme	programme	NOUN
ajlm-741	50	49	of	of	ADP
ajlm-741	50	50	pathogens	pathogen	NOUN
ajlm-741	50	51	causing	cause	VERB
ajlm-741	50	52	healthcare	healthcare	NOUN
ajlm-741	50	53	-	-	PUNCT
ajlm-741	50	54	associated	associate	VERB
ajlm-741	50	55	infections	infection	NOUN
ajlm-741	50	56	such	such	ADJ
ajlm-741	50	57	as	as	ADP
ajlm-741	50	58	the	the	DET
ajlm-741	50	59	eskape	eskape	NOUN
ajlm-741	50	60	pathogens	pathogen	NOUN
ajlm-741	50	61	(	(	PUNCT
ajlm-741	50	62	enterococcus	enterococcus	NOUN
ajlm-741	50	63	faecium	faecium	NOUN
ajlm-741	50	64	,	,	PUNCT
ajlm-741	50	65	staphylococcus	staphylococcus	NOUN
ajlm-741	50	66	aureus	aureus	NOUN
ajlm-741	50	67	,	,	PUNCT
ajlm-741	50	68	klebsiella	klebsiella	PROPN
ajlm-741	50	69	pnemoniae	pnemoniae	PROPN
ajlm-741	50	70	,	,	PUNCT
ajlm-741	50	71	acinetobacter	acinetobacter	NOUN
ajlm-741	50	72	baumanii	baumanii	NOUN
ajlm-741	50	73	,	,	PUNCT
ajlm-741	50	74	pseudomonas	pseudomona	VERB
ajlm-741	50	75	aeruginosa	aeruginosa	NOUN
ajlm-741	50	76	and	and	CCONJ
ajlm-741	50	77	enterobacter	enterobacter	NOUN
ajlm-741	50	78	species	specie	NOUN
ajlm-741	50	79	)	)	PUNCT
ajlm-741	50	80	at	at	ADP
ajlm-741	50	81	sentinel	sentinel	ADJ
ajlm-741	50	82	sites	site	NOUN
ajlm-741	50	83	in	in	ADP
ajlm-741	50	84	2010	2010	NUM
ajlm-741	50	85	and	and	CCONJ
ajlm-741	50	86	electronic	electronic	ADJ
ajlm-741	50	87	surveillance	surveillance	NOUN
ajlm-741	50	88	from	from	ADP
ajlm-741	50	89	routine	routine	ADJ
ajlm-741	50	90	laboratories	laboratory	NOUN
ajlm-741	50	91	in	in	ADP
ajlm-741	50	92	2013	2013	NUM
ajlm-741	50	93	.	.	PUNCT
ajlm-741	51	1	the	the	DET
ajlm-741	51	2	primary	primary	ADJ
ajlm-741	51	3	objectives	objective	NOUN
ajlm-741	51	4	of	of	ADP
ajlm-741	51	5	the	the	DET
ajlm-741	51	6	lars	lars	PROPN
ajlm-741	51	7	programme	programme	PROPN
ajlm-741	51	8	were	be	AUX
ajlm-741	51	9	to	to	PART
ajlm-741	51	10	determine	determine	VERB
ajlm-741	51	11	the	the	DET
ajlm-741	51	12	number	number	NOUN
ajlm-741	51	13	of	of	ADP
ajlm-741	51	14	cases	case	NOUN
ajlm-741	51	15	reported	report	VERB
ajlm-741	51	16	from	from	ADP
ajlm-741	51	17	selected	select	VERB
ajlm-741	51	18	hospitals	hospital	NOUN
ajlm-741	51	19	for	for	ADP
ajlm-741	51	20	selected	select	VERB
ajlm-741	51	21	pathogens	pathogen	NOUN
ajlm-741	51	22	,	,	PUNCT
ajlm-741	51	23	to	to	PART
ajlm-741	51	24	describe	describe	VERB
ajlm-741	51	25	antimicrobial	antimicrobial	ADJ
ajlm-741	51	26	susceptibility	susceptibility	NOUN
ajlm-741	51	27	of	of	ADP
ajlm-741	51	28	the	the	DET
ajlm-741	51	29	significant	significant	ADJ
ajlm-741	51	30	treatment	treatment	NOUN
ajlm-741	51	31	regimens	regimen	NOUN
ajlm-741	51	32	for	for	ADP
ajlm-741	51	33	the	the	DET
ajlm-741	51	34	pathogens45	pathogens45	NOUN
ajlm-741	51	35	and	and	CCONJ
ajlm-741	51	36	a	a	DET
ajlm-741	51	37	secondary	secondary	ADJ
ajlm-741	51	38	objective	objective	NOUN
ajlm-741	51	39	was	be	AUX
ajlm-741	51	40	molecular	molecular	ADJ
ajlm-741	51	41	characterisation	characterisation	NOUN
ajlm-741	51	42	of	of	ADP
ajlm-741	51	43	resistance	resistance	NOUN
ajlm-741	51	44	genes.26,27,30	genes.26,27,30	PROPN
ajlm-741	51	45	in	in	ADP
ajlm-741	51	46	2014	2014	NUM
ajlm-741	51	47	,	,	PUNCT
ajlm-741	51	48	antimicrobial	antimicrobial	ADJ
ajlm-741	51	49	resistance	resistance	NOUN
ajlm-741	51	50	surveillance	surveillance	NOUN
ajlm-741	51	51	data	datum	NOUN
ajlm-741	51	52	on	on	ADP
ajlm-741	51	53	klebsiella	klebsiella	NOUN
ajlm-741	51	54	pneumoniae	pneumoniae	ADJ
ajlm-741	51	55	isolates	isolate	NOUN
ajlm-741	51	56	from	from	ADP
ajlm-741	51	57	patients	patient	NOUN
ajlm-741	51	58	with	with	ADP
ajlm-741	51	59	bacteraemia	bacteraemia	NOUN
ajlm-741	51	60	were	be	AUX
ajlm-741	51	61	published30	published30	ADJ
ajlm-741	51	62	;	;	PUNCT
ajlm-741	51	63	isolates	isolate	NOUN
ajlm-741	51	64	were	be	AUX
ajlm-741	51	65	submitted	submit	VERB
ajlm-741	51	66	by	by	ADP
ajlm-741	51	67	sentinel	sentinel	ADJ
ajlm-741	51	68	laboratories	laboratory	NOUN
ajlm-741	51	69	in	in	ADP
ajlm-741	51	70	five	five	NUM
ajlm-741	51	71	regions	region	NOUN
ajlm-741	51	72	of	of	ADP
ajlm-741	51	73	south	south	PROPN
ajlm-741	51	74	africa	africa	PROPN
ajlm-741	51	75	from	from	ADP
ajlm-741	51	76	mid-2010	mid-2010	NOUN
ajlm-741	51	77	to	to	ADP
ajlm-741	51	78	mid-2012	mid-2012	NOUN
ajlm-741	51	79	.	.	PUNCT
ajlm-741	52	1	this	this	PRON
ajlm-741	52	2	included	include	VERB
ajlm-741	52	3	13	13	NUM
ajlm-741	52	4	academic	academic	ADJ
ajlm-741	52	5	centres	centre	NOUN
ajlm-741	52	6	serving	serve	VERB
ajlm-741	52	7	the	the	DET
ajlm-741	52	8	public	public	ADJ
ajlm-741	52	9	healthcare	healthcare	NOUN
ajlm-741	52	10	sector	sector	NOUN
ajlm-741	52	11	in	in	ADP
ajlm-741	52	12	the	the	DET
ajlm-741	52	13	gauteng	gauteng	PROPN
ajlm-741	52	14	,	,	PUNCT
ajlm-741	52	15	kwazulu	kwazulu	PROPN
ajlm-741	52	16	-	-	PUNCT
ajlm-741	52	17	natal	natal	ADJ
ajlm-741	52	18	,	,	PUNCT
ajlm-741	52	19	free	free	ADJ
ajlm-741	52	20	state	state	NOUN
ajlm-741	52	21	,	,	PUNCT
ajlm-741	52	22	limpopo	limpopo	PROPN
ajlm-741	52	23	and	and	CCONJ
ajlm-741	52	24	western	western	ADJ
ajlm-741	52	25	cape	cape	NOUN
ajlm-741	52	26	provinces	province	NOUN
ajlm-741	52	27	.	.	PUNCT
ajlm-741	53	1	findings	finding	NOUN
ajlm-741	53	2	from	from	ADP
ajlm-741	53	3	this	this	DET
ajlm-741	53	4	study	study	NOUN
ajlm-741	53	5	showed	show	VERB
ajlm-741	53	6	that	that	SCONJ
ajlm-741	53	7	of	of	ADP
ajlm-741	53	8	the	the	DET
ajlm-741	53	9	2774	2774	NUM
ajlm-741	53	10	isolates	isolate	NOUN
ajlm-741	53	11	,	,	PUNCT
ajlm-741	53	12	1895	1895	NUM
ajlm-741	53	13	(	(	PUNCT
ajlm-741	53	14	68	68	NUM
ajlm-741	53	15	%	%	NOUN
ajlm-741	53	16	)	)	PUNCT
ajlm-741	53	17	expressed	express	VERB
ajlm-741	53	18	esbls	esbls	PROPN
ajlm-741	53	19	and	and	CCONJ
ajlm-741	53	20	displayed	display	VERB
ajlm-741	53	21	resistance	resistance	NOUN
ajlm-741	53	22	to	to	ADP
ajlm-741	53	23	cefotaxime	cefotaxime	NOUN
ajlm-741	53	24	,	,	PUNCT
ajlm-741	53	25	ceftazidime	ceftazidime	NOUN
ajlm-741	53	26	and	and	CCONJ
ajlm-741	53	27	cefepime	cefepime	NOUN
ajlm-741	53	28	.	.	PUNCT
ajlm-741	54	1	more	more	ADV
ajlm-741	54	2	so	so	ADV
ajlm-741	54	3	,	,	PUNCT
ajlm-741	54	4	46	46	NUM
ajlm-741	54	5	%	%	NOUN
ajlm-741	54	6	of	of	ADP
ajlm-741	54	7	all	all	DET
ajlm-741	54	8	isolates	isolate	NOUN
ajlm-741	54	9	were	be	AUX
ajlm-741	54	10	resistant	resistant	ADJ
ajlm-741	54	11	to	to	ADP
ajlm-741	54	12	ciprofloxacin	ciprofloxacin	PROPN
ajlm-741	54	13	and	and	CCONJ
ajlm-741	54	14	33	33	NUM
ajlm-741	54	15	%	%	NOUN
ajlm-741	54	16	to	to	ADP
ajlm-741	54	17	piperacillin	piperacillin	NOUN
ajlm-741	54	18	-	-	PUNCT
ajlm-741	54	19	tazobactam	tazobactam	NOUN
ajlm-741	54	20	.	.	PUNCT
ajlm-741	55	1	susceptibility	susceptibility	NOUN
ajlm-741	55	2	to	to	ADP
ajlm-741	55	3	aminoglycosides	aminoglycoside	NOUN
ajlm-741	55	4	was	be	AUX
ajlm-741	55	5	variable	variable	ADJ
ajlm-741	55	6	:	:	PUNCT
ajlm-741	55	7	an	an	DET
ajlm-741	55	8	average	average	NOUN
ajlm-741	55	9	of	of	ADP
ajlm-741	55	10	95	95	NUM
ajlm-741	55	11	%	%	NOUN
ajlm-741	55	12	were	be	AUX
ajlm-741	55	13	susceptible	susceptible	ADJ
ajlm-741	55	14	to	to	ADP
ajlm-741	55	15	amikacin	amikacin	PROPN
ajlm-741	55	16	but	but	CCONJ
ajlm-741	55	17	only	only	ADV
ajlm-741	55	18	31	31	NUM
ajlm-741	55	19	%	%	NOUN
ajlm-741	55	20	were	be	AUX
ajlm-741	55	21	susceptible	susceptible	ADJ
ajlm-741	55	22	to	to	ADP
ajlm-741	55	23	tobramycin	tobramycin	NOUN
ajlm-741	55	24	and	and	CCONJ
ajlm-741	55	25	gentamicin	gentamicin	NOUN
ajlm-741	55	26	.	.	PUNCT
ajlm-741	56	1	susceptibility	susceptibility	NOUN
ajlm-741	56	2	to	to	ADP
ajlm-741	56	3	ciprofloxacin	ciprofloxacin	PROPN
ajlm-741	56	4	(	(	PUNCT
ajlm-741	56	5	53	53	NUM
ajlm-741	56	6	%	%	NOUN
ajlm-741	56	7	)	)	PUNCT
ajlm-741	56	8	was	be	AUX
ajlm-741	56	9	lower	low	ADJ
ajlm-741	56	10	than	than	ADP
ajlm-741	56	11	to	to	ADP
ajlm-741	56	12	levofloxacin	levofloxacin	PROPN
ajlm-741	56	13	(	(	PUNCT
ajlm-741	56	14	75	75	NUM
ajlm-741	56	15	%	%	NOUN
ajlm-741	56	16	)	)	PUNCT
ajlm-741	56	17	while	while	SCONJ
ajlm-741	56	18	susceptibility	susceptibility	NOUN
ajlm-741	56	19	to	to	ADP
ajlm-741	56	20	cefoxitin	cefoxitin	NOUN
ajlm-741	56	21	was	be	AUX
ajlm-741	56	22	higher	high	ADJ
ajlm-741	56	23	(	(	PUNCT
ajlm-741	56	24	87	87	NUM
ajlm-741	56	25	%	%	NOUN
ajlm-741	56	26	)	)	PUNCT
ajlm-741	56	27	.	.	PUNCT
ajlm-741	57	1	the	the	DET
ajlm-741	57	2	minimal	minimal	ADJ
ajlm-741	57	3	inhibitory	inhibitory	ADJ
ajlm-741	57	4	concentration	concentration	NOUN
ajlm-741	57	5	(	(	PUNCT
ajlm-741	57	6	mic	mic	ADJ
ajlm-741	57	7	)	)	PUNCT
ajlm-741	57	8	measures	measure	NOUN
ajlm-741	57	9	,	,	PUNCT
ajlm-741	57	10	the	the	DET
ajlm-741	57	11	lowest	low	ADJ
ajlm-741	57	12	concentration	concentration	NOUN
ajlm-741	57	13	required	require	VERB
ajlm-741	57	14	to	to	PART
ajlm-741	57	15	inhibit	inhibit	VERB
ajlm-741	57	16	the	the	DET
ajlm-741	57	17	growth	growth	NOUN
ajlm-741	57	18	of	of	ADP
ajlm-741	57	19	50	50	NUM
ajlm-741	57	20	%	%	NOUN
ajlm-741	57	21	(	(	PUNCT
ajlm-741	57	22	mic50	mic50	NOUN
ajlm-741	57	23	)	)	PUNCT
ajlm-741	57	24	and	and	CCONJ
ajlm-741	57	25	90	90	NUM
ajlm-741	57	26	%	%	NOUN
ajlm-741	57	27	(	(	PUNCT
ajlm-741	57	28	mic90	mic90	PROPN
ajlm-741	57	29	)	)	PUNCT
ajlm-741	57	30	of	of	ADP
ajlm-741	57	31	the	the	DET
ajlm-741	57	32	isolates	isolate	NOUN
ajlm-741	57	33	,	,	PUNCT
ajlm-741	57	34	were	be	AUX
ajlm-741	57	35	stable	stable	ADJ
ajlm-741	57	36	over	over	ADP
ajlm-741	57	37	the	the	DET
ajlm-741	57	38	3	3	NUM
ajlm-741	57	39	-	-	PUNCT
ajlm-741	57	40	year	year	NOUN
ajlm-741	57	41	period	period	NOUN
ajlm-741	57	42	and	and	CCONJ
ajlm-741	57	43	there	there	PRON
ajlm-741	57	44	was	be	VERB
ajlm-741	57	45	a	a	DET
ajlm-741	57	46	small	small	ADJ
ajlm-741	57	47	but	but	CCONJ
ajlm-741	57	48	statistically	statistically	ADV
ajlm-741	57	49	significant	significant	ADJ
ajlm-741	57	50	trend	trend	NOUN
ajlm-741	57	51	(	(	PUNCT
ajlm-741	57	52	p	p	X
ajlm-741	57	53	<	<	X
ajlm-741	57	54	0.001–0.41	0.001–0.41	NOUN
ajlm-741	57	55	)	)	PUNCT
ajlm-741	57	56	towards	towards	ADP
ajlm-741	57	57	a	a	DET
ajlm-741	57	58	decrease	decrease	NOUN
ajlm-741	57	59	in	in	ADP
ajlm-741	57	60	susceptibility	susceptibility	NOUN
ajlm-741	57	61	to	to	ADP
ajlm-741	57	62	many	many	ADJ
ajlm-741	57	63	antimicrobial	antimicrobial	ADJ
ajlm-741	57	64	agents	agent	NOUN
ajlm-741	57	65	.	.	PUNCT
ajlm-741	58	1	molecular	molecular	ADJ
ajlm-741	58	2	characterisation	characterisation	NOUN
ajlm-741	58	3	was	be	AUX
ajlm-741	58	4	performed	perform	VERB
ajlm-741	58	5	on	on	ADP
ajlm-741	58	6	270	270	NUM
ajlm-741	58	7	phenotypically	phenotypically	ADV
ajlm-741	58	8	esbl	esbl	NOUN
ajlm-741	58	9	-	-	PUNCT
ajlm-741	58	10	producing	produce	VERB
ajlm-741	58	11	isolates	isolate	NOUN
ajlm-741	58	12	.	.	PUNCT
ajlm-741	59	1	the	the	DET
ajlm-741	59	2	presence	presence	NOUN
ajlm-741	59	3	of	of	ADP
ajlm-741	59	4	esbls	esbls	PROPN
ajlm-741	59	5	(	(	PUNCT
ajlm-741	59	6	blactx	blactx	NOUN
ajlm-741	59	7	-	-	PUNCT
ajlm-741	59	8	m	m	PROPN
ajlm-741	59	9	,	,	PUNCT
ajlm-741	59	10	blashv	blashv	NOUN
ajlm-741	59	11	and	and	CCONJ
ajlm-741	59	12	blatem	blatem	NOUN
ajlm-741	59	13	genes	gene	NOUN
ajlm-741	59	14	)	)	PUNCT
ajlm-741	59	15	were	be	AUX
ajlm-741	59	16	confirmed	confirm	VERB
ajlm-741	59	17	in	in	ADP
ajlm-741	59	18	all	all	DET
ajlm-741	59	19	270	270	NUM
ajlm-741	59	20	isolates	isolate	NOUN
ajlm-741	59	21	with	with	ADP
ajlm-741	59	22	93	93	NUM
ajlm-741	59	23	%	%	NOUN
ajlm-741	59	24	of	of	ADP
ajlm-741	59	25	the	the	DET
ajlm-741	59	26	isolates	isolate	NOUN
ajlm-741	59	27	tested	test	VERB
ajlm-741	59	28	expressing	express	VERB
ajlm-741	59	29	more	more	ADJ
ajlm-741	59	30	than	than	ADP
ajlm-741	59	31	one	one	NUM
ajlm-741	59	32	resistance	resistance	NOUN
ajlm-741	59	33	gene	gene	NOUN
ajlm-741	59	34	.	.	PUNCT
ajlm-741	60	1	the	the	DET
ajlm-741	60	2	majority	majority	NOUN
ajlm-741	60	3	of	of	ADP
ajlm-741	60	4	the	the	DET
ajlm-741	60	5	isolates	isolate	NOUN
ajlm-741	60	6	(	(	PUNCT
ajlm-741	60	7	95	95	NUM
ajlm-741	60	8	%	%	NOUN
ajlm-741	60	9	)	)	PUNCT
ajlm-741	60	10	were	be	AUX
ajlm-741	60	11	phenotypically	phenotypically	ADV
ajlm-741	60	12	susceptible	susceptible	ADJ
ajlm-741	60	13	to	to	ADP
ajlm-741	60	14	the	the	DET
ajlm-741	60	15	carbapenems	carbapenem	NOUN
ajlm-741	60	16	tested	test	VERB
ajlm-741	60	17	,	,	PUNCT
ajlm-741	60	18	and	and	CCONJ
ajlm-741	60	19	no	no	DET
ajlm-741	60	20	isolate	isolate	NOUN
ajlm-741	60	21	contained	contain	VERB
ajlm-741	60	22	blakpc	blakpc	NOUN
ajlm-741	60	23	or	or	CCONJ
ajlm-741	60	24	blandm-1	blandm-1	PROPN
ajlm-741	60	25	,	,	PUNCT
ajlm-741	60	26	which	which	PRON
ajlm-741	60	27	were	be	AUX
ajlm-741	60	28	the	the	DET
ajlm-741	60	29	only	only	ADJ
ajlm-741	60	30	carbapenemases	carbapenemase	NOUN
ajlm-741	60	31	screened	screen	VERB
ajlm-741	60	32	for	for	ADP
ajlm-741	60	33	.	.	PUNCT
ajlm-741	61	1	the	the	DET
ajlm-741	61	2	authors	author	NOUN
ajlm-741	61	3	stated	state	VERB
ajlm-741	61	4	that	that	SCONJ
ajlm-741	61	5	the	the	DET
ajlm-741	61	6	high	high	ADJ
ajlm-741	61	7	proportion	proportion	NOUN
ajlm-741	61	8	of	of	ADP
ajlm-741	61	9	esbl	esbl	NOUN
ajlm-741	61	10	-	-	PUNCT
ajlm-741	61	11	producing	produce	VERB
ajlm-741	61	12	k.	k.	NOUN
ajlm-741	61	13	pneumoniae	pneumoniae	ADJ
ajlm-741	61	14	isolates	isolate	NOUN
ajlm-741	61	15	and	and	CCONJ
ajlm-741	61	16	the	the	DET
ajlm-741	61	17	prevalence	prevalence	NOUN
ajlm-741	61	18	of	of	ADP
ajlm-741	61	19	esbl	esbl	NOUN
ajlm-741	61	20	genes	gene	NOUN
ajlm-741	61	21	is	be	AUX
ajlm-741	61	22	of	of	ADP
ajlm-741	61	23	great	great	ADJ
ajlm-741	61	24	concern.30	concern.30	ADJ
ajlm-741	61	25	more	more	ADV
ajlm-741	61	26	recently	recently	ADV
ajlm-741	61	27	data	datum	NOUN
ajlm-741	61	28	from	from	ADP
ajlm-741	61	29	a	a	DET
ajlm-741	61	30	cross	cross	ADJ
ajlm-741	61	31	-	-	ADJ
ajlm-741	61	32	sectional	sectional	ADJ
ajlm-741	61	33	study	study	NOUN
ajlm-741	61	34	on	on	ADP
ajlm-741	61	35	carbapenem	carbapenem	NOUN
ajlm-741	61	36	-	-	PUNCT
ajlm-741	61	37	resistant	resistant	ADJ
ajlm-741	61	38	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-741	61	39	(	(	PUNCT
ajlm-741	61	40	cre	cre	PROPN
ajlm-741	61	41	)	)	PUNCT
ajlm-741	61	42	isolates	isolate	NOUN
ajlm-741	61	43	showed	show	VERB
ajlm-741	61	44	a	a	DET
ajlm-741	61	45	1.9	1.9	NUM
ajlm-741	61	46	%	%	NOUN
ajlm-741	61	47	prevalence	prevalence	NOUN
ajlm-741	61	48	of	of	ADP
ajlm-741	61	49	carbapenemases	carbapenemase	NOUN
ajlm-741	61	50	in	in	ADP
ajlm-741	61	51	blood	blood	NOUN
ajlm-741	61	52	culture	culture	NOUN
ajlm-741	61	53	isolates.26	isolates.26	VERB
ajlm-741	61	54	another	another	DET
ajlm-741	61	55	publication	publication	NOUN
ajlm-741	61	56	from	from	ADP
ajlm-741	61	57	lars	lars	PROPN
ajlm-741	61	58	-	-	PUNCT
ajlm-741	61	59	generated	generate	VERB
ajlm-741	61	60	surveillance	surveillance	NOUN
ajlm-741	61	61	data	datum	NOUN
ajlm-741	61	62	investigated	investigate	VERB
ajlm-741	61	63	staphylococcus	staphylococcus	NOUN
ajlm-741	61	64	aureus	aureus	NOUN
ajlm-741	61	65	bacteraemia	bacteraemia	NOUN
ajlm-741	61	66	in	in	ADP
ajlm-741	61	67	academic	academic	ADJ
ajlm-741	61	68	hospitals	hospital	NOUN
ajlm-741	61	69	from	from	ADP
ajlm-741	61	70	gauteng	gauteng	PROPN
ajlm-741	61	71	,	,	PUNCT
ajlm-741	61	72	south	south	ADJ
ajlm-741	61	73	africa.46	africa.46	NOUN
ajlm-741	61	74	in	in	ADP
ajlm-741	61	75	this	this	DET
ajlm-741	61	76	study	study	NOUN
ajlm-741	61	77	,	,	PUNCT
ajlm-741	61	78	the	the	DET
ajlm-741	61	79	epidemiology	epidemiology	NOUN
ajlm-741	61	80	of	of	ADP
ajlm-741	61	81	s.	s.	PROPN
ajlm-741	61	82	aureus	aureus	PROPN
ajlm-741	61	83	bacteraemia	bacteraemia	PROPN
ajlm-741	61	84	was	be	AUX
ajlm-741	61	85	described	describe	VERB
ajlm-741	61	86	and	and	CCONJ
ajlm-741	61	87	factors	factor	NOUN
ajlm-741	61	88	associated	associate	VERB
ajlm-741	61	89	with	with	ADP
ajlm-741	61	90	mrsa	mrsa	NOUN
ajlm-741	61	91	infection	infection	NOUN
ajlm-741	61	92	were	be	AUX
ajlm-741	61	93	determined	determine	VERB
ajlm-741	61	94	.	.	PUNCT
ajlm-741	62	1	cases	case	NOUN
ajlm-741	62	2	of	of	ADP
ajlm-741	62	3	s.	s.	PROPN
ajlm-741	62	4	aureus	aureus	PROPN
ajlm-741	62	5	bacteraemia	bacteraemia	PROPN
ajlm-741	62	6	over	over	ADP
ajlm-741	62	7	1	1	NUM
ajlm-741	62	8	year	year	NOUN
ajlm-741	62	9	(	(	PUNCT
ajlm-741	62	10	september	september	PROPN
ajlm-741	62	11	2012	2012	NUM
ajlm-741	62	12	to	to	ADP
ajlm-741	62	13	september	september	PROPN
ajlm-741	62	14	2013	2013	NUM
ajlm-741	62	15	)	)	PUNCT
ajlm-741	62	16	were	be	AUX
ajlm-741	62	17	reported	report	VERB
ajlm-741	62	18	from	from	ADP
ajlm-741	62	19	three	three	NUM
ajlm-741	62	20	sentinel	sentinel	ADJ
ajlm-741	62	21	sites	site	NOUN
ajlm-741	62	22	and	and	CCONJ
ajlm-741	62	23	detailed	detailed	ADJ
ajlm-741	62	24	clinical	clinical	ADJ
ajlm-741	62	25	information	information	NOUN
ajlm-741	62	26	was	be	AUX
ajlm-741	62	27	collected	collect	VERB
ajlm-741	62	28	.	.	PUNCT
ajlm-741	63	1	statistical	statistical	ADJ
ajlm-741	63	2	analysis	analysis	NOUN
ajlm-741	63	3	included	include	VERB
ajlm-741	63	4	multivariable	multivariable	ADJ
ajlm-741	63	5	logistic	logistic	ADJ
ajlm-741	63	6	regression	regression	NOUN
ajlm-741	63	7	to	to	PART
ajlm-741	63	8	determine	determine	VERB
ajlm-741	63	9	factors	factor	NOUN
ajlm-741	63	10	associated	associate	VERB
ajlm-741	63	11	with	with	ADP
ajlm-741	63	12	mrsa	mrsa	NOUN
ajlm-741	63	13	infection	infection	NOUN
ajlm-741	63	14	and	and	CCONJ
ajlm-741	63	15	mortality	mortality	NOUN
ajlm-741	63	16	.	.	PUNCT
ajlm-741	64	1	this	this	DET
ajlm-741	64	2	study	study	NOUN
ajlm-741	64	3	showed	show	VERB
ajlm-741	64	4	that	that	SCONJ
ajlm-741	64	5	442	442	NUM
ajlm-741	64	6	cases	case	NOUN
ajlm-741	64	7	of	of	ADP
ajlm-741	64	8	s.	s.	PROPN
ajlm-741	64	9	aureus	aureus	PROPN
ajlm-741	64	10	bacteraemia	bacteraemia	PROPN
ajlm-741	64	11	were	be	AUX
ajlm-741	64	12	reported	report	VERB
ajlm-741	64	13	and	and	CCONJ
ajlm-741	64	14	antimicrobial	antimicrobial	ADJ
ajlm-741	64	15	susceptibility	susceptibility	NOUN
ajlm-741	64	16	testing	testing	NOUN
ajlm-741	64	17	was	be	AUX
ajlm-741	64	18	performed	perform	VERB
ajlm-741	64	19	on	on	ADP
ajlm-741	64	20	54	54	NUM
ajlm-741	64	21	%	%	NOUN
ajlm-741	64	22	of	of	ADP
ajlm-741	64	23	the	the	DET
ajlm-741	64	24	isolates	isolate	NOUN
ajlm-741	64	25	(	(	PUNCT
ajlm-741	64	26	n	n	NOUN
ajlm-741	64	27	=	=	SYM
ajlm-741	64	28	240	240	NUM
ajlm-741	64	29	)	)	PUNCT
ajlm-741	64	30	.	.	PUNCT
ajlm-741	65	1	methicillin	methicillin	NOUN
ajlm-741	65	2	-	-	PUNCT
ajlm-741	65	3	resistant	resistant	ADJ
ajlm-741	65	4	staphylococcus	staphylococcus	NOUN
ajlm-741	65	5	aureus	aureus	NOUN
ajlm-741	65	6	infection	infection	NOUN
ajlm-741	65	7	was	be	AUX
ajlm-741	65	8	noted	note	VERB
ajlm-741	65	9	in	in	ADP
ajlm-741	65	10	36	36	NUM
ajlm-741	65	11	%	%	NOUN
ajlm-741	65	12	(	(	PUNCT
ajlm-741	65	13	n	n	NOUN
ajlm-741	65	14	=	=	SYM
ajlm-741	65	15	86	86	NUM
ajlm-741	65	16	)	)	PUNCT
ajlm-741	65	17	of	of	ADP
ajlm-741	65	18	cases	case	NOUN
ajlm-741	65	19	.	.	PUNCT
ajlm-741	66	1	independent	independent	ADJ
ajlm-741	66	2	predictors	predictor	NOUN
ajlm-741	66	3	of	of	ADP
ajlm-741	66	4	mrsa	mrsa	NOUN
ajlm-741	66	5	included	include	VERB
ajlm-741	66	6	a	a	DET
ajlm-741	66	7	longer	long	ADJ
ajlm-741	66	8	hospital	hospital	NOUN
ajlm-741	66	9	stay	stay	NOUN
ajlm-741	66	10	before	before	ADP
ajlm-741	66	11	positive	positive	ADJ
ajlm-741	66	12	specimen	speciman	NOUN
ajlm-741	66	13	collection	collection	NOUN
ajlm-741	66	14	,	,	PUNCT
ajlm-741	66	15	hospitalisation	hospitalisation	NOUN
ajlm-741	66	16	in	in	ADP
ajlm-741	66	17	the	the	DET
ajlm-741	66	18	last	last	ADJ
ajlm-741	66	19	year	year	NOUN
ajlm-741	66	20	,	,	PUNCT
ajlm-741	66	21	human	human	ADJ
ajlm-741	66	22	immunodeficiency	immunodeficiency	NOUN
ajlm-741	66	23	virus	virus	NOUN
ajlm-741	66	24	(	(	PUNCT
ajlm-741	66	25	hiv	hiv	NOUN
ajlm-741	66	26	)	)	PUNCT
ajlm-741	66	27	infection	infection	NOUN
ajlm-741	66	28	and	and	CCONJ
ajlm-741	66	29	antimicrobial	antimicrobial	ADJ
ajlm-741	66	30	use	use	NOUN
ajlm-741	66	31	in	in	ADP
ajlm-741	66	32	the	the	DET
ajlm-741	66	33	previous	previous	ADJ
ajlm-741	66	34	2	2	NUM
ajlm-741	66	35	months	month	NOUN
ajlm-741	66	36	.	.	PUNCT
ajlm-741	67	1	the	the	DET
ajlm-741	67	2	only	only	ADJ
ajlm-741	67	3	independent	independent	ADJ
ajlm-741	67	4	predictor	predictor	NOUN
ajlm-741	67	5	of	of	ADP
ajlm-741	67	6	mortality	mortality	NOUN
ajlm-741	67	7	among	among	ADP
ajlm-741	67	8	cases	case	NOUN
ajlm-741	67	9	with	with	ADP
ajlm-741	67	10	s.	s.	PROPN
ajlm-741	67	11	aureus	aureus	PROPN
ajlm-741	67	12	bacteraemia	bacteraemia	PROPN
ajlm-741	67	13	was	be	AUX
ajlm-741	67	14	being	be	AUX
ajlm-741	67	15	elderly	elderly	ADJ
ajlm-741	67	16	.	.	PUNCT
ajlm-741	68	1	antimicrobial	antimicrobial	ADJ
ajlm-741	68	2	susceptibility	susceptibility	NOUN
ajlm-741	68	3	testing	testing	NOUN
ajlm-741	68	4	results	result	NOUN
ajlm-741	68	5	showed	show	VERB
ajlm-741	68	6	that	that	SCONJ
ajlm-741	68	7	mrsa	mrsa	NOUN
ajlm-741	68	8	isolates	isolate	NOUN
ajlm-741	68	9	were	be	AUX
ajlm-741	68	10	non	non	ADJ
ajlm-741	68	11	-	-	ADJ
ajlm-741	68	12	susceptible	susceptible	ADJ
ajlm-741	68	13	to	to	ADP
ajlm-741	68	14	more	more	ADJ
ajlm-741	68	15	antimicrobial	antimicrobial	ADJ
ajlm-741	68	16	agents	agent	NOUN
ajlm-741	68	17	compared	compare	VERB
ajlm-741	68	18	to	to	ADP
ajlm-741	68	19	methicillin	methicillin	NOUN
ajlm-741	68	20	-	-	PUNCT
ajlm-741	68	21	susceptible	susceptible	ADJ
ajlm-741	68	22	s.	s.	PROPN
ajlm-741	68	23	aureus	aureus	PROPN
ajlm-741	68	24	(	(	PUNCT
ajlm-741	68	25	mssa	mssa	ADJ
ajlm-741	68	26	)	)	PUNCT
ajlm-741	68	27	isolates	isolate	NOUN
ajlm-741	68	28	.	.	PUNCT
ajlm-741	69	1	all	all	DET
ajlm-741	69	2	isolates	isolate	NOUN
ajlm-741	69	3	were	be	AUX
ajlm-741	69	4	susceptible	susceptible	ADJ
ajlm-741	69	5	to	to	ADP
ajlm-741	69	6	daptomycin	daptomycin	PROPN
ajlm-741	69	7	and	and	CCONJ
ajlm-741	69	8	linezolid	linezolid	NOUN
ajlm-741	69	9	.	.	PUNCT
ajlm-741	70	1	four	four	NUM
ajlm-741	70	2	isolates	isolate	NOUN
ajlm-741	70	3	were	be	AUX
ajlm-741	70	4	non	non	ADJ
ajlm-741	70	5	-	-	ADJ
ajlm-741	70	6	susceptible	susceptible	ADJ
ajlm-741	70	7	to	to	ADP
ajlm-741	70	8	vancomycin	vancomycin	PROPN
ajlm-741	70	9	and	and	CCONJ
ajlm-741	70	10	teicoplanin	teicoplanin	PROPN
ajlm-741	70	11	(	(	PUNCT
ajlm-741	70	12	mic	mic	ADJ
ajlm-741	70	13	16	16	NUM
ajlm-741	70	14	mg	mg	NUM
ajlm-741	70	15	/	/	SYM
ajlm-741	70	16	ml	ml	NOUN
ajlm-741	70	17	)	)	PUNCT
ajlm-741	70	18	while	while	SCONJ
ajlm-741	70	19	13	13	NUM
ajlm-741	70	20	cases	case	NOUN
ajlm-741	70	21	(	(	PUNCT
ajlm-741	70	22	6	6	NUM
ajlm-741	70	23	%	%	NOUN
ajlm-741	70	24	)	)	PUNCT
ajlm-741	70	25	(	(	PUNCT
ajlm-741	70	26	five	five	NUM
ajlm-741	70	27	mrsa	mrsa	NOUN
ajlm-741	70	28	and	and	CCONJ
ajlm-741	70	29	eight	eight	NUM
ajlm-741	70	30	mssa	mssa	ADJ
ajlm-741	70	31	isolates	isolate	NOUN
ajlm-741	70	32	)	)	PUNCT
ajlm-741	70	33	showed	show	VERB
ajlm-741	70	34	a	a	DET
ajlm-741	70	35	susceptible	susceptible	ADJ
ajlm-741	70	36	breakpoint	breakpoint	NOUN
ajlm-741	70	37	value	value	NOUN
ajlm-741	70	38	(	(	PUNCT
ajlm-741	70	39	mic	mic	ADJ
ajlm-741	70	40	2	2	NUM
ajlm-741	70	41	mg	mg	NUM
ajlm-741	70	42	/	/	SYM
ajlm-741	70	43	ml	ml	NOUN
ajlm-741	70	44	)	)	PUNCT
ajlm-741	70	45	.	.	PUNCT
ajlm-741	71	1	for	for	ADP
ajlm-741	71	2	molecular	molecular	ADJ
ajlm-741	71	3	characterisation	characterisation	NOUN
ajlm-741	71	4	,	,	PUNCT
ajlm-741	71	5	sccmec	sccmec	NOUN
ajlm-741	71	6	typing	typing	NOUN
ajlm-741	71	7	was	be	AUX
ajlm-741	71	8	performed	perform	VERB
ajlm-741	71	9	on	on	ADP
ajlm-741	71	10	82	82	NUM
ajlm-741	71	11	mrsa	mrsa	NOUN
ajlm-741	71	12	isolates	isolate	NOUN
ajlm-741	71	13	.	.	PUNCT
ajlm-741	72	1	nine	nine	NUM
ajlm-741	72	2	isolates	isolate	NOUN
ajlm-741	72	3	were	be	AUX
ajlm-741	72	4	non	non	ADJ
ajlm-741	72	5	-	-	ADJ
ajlm-741	72	6	typeable	typeable	ADJ
ajlm-741	72	7	;	;	PUNCT
ajlm-741	72	8	the	the	DET
ajlm-741	72	9	most	most	ADV
ajlm-741	72	10	common	common	ADJ
ajlm-741	72	11	sccmec	sccmec	NOUN
ajlm-741	72	12	type	type	NOUN
ajlm-741	72	13	was	be	AUX
ajlm-741	72	14	type	type	NOUN
ajlm-741	72	15	iii	iii	X
ajlm-741	72	16	(	(	PUNCT
ajlm-741	72	17	56	56	NUM
ajlm-741	72	18	%	%	NOUN
ajlm-741	72	19	)	)	PUNCT
ajlm-741	72	20	,	,	PUNCT
ajlm-741	72	21	followed	follow	VERB
ajlm-741	72	22	by	by	ADP
ajlm-741	72	23	type	type	NOUN
ajlm-741	72	24	iv	iv	NUM
ajlm-741	72	25	(	(	PUNCT
ajlm-741	72	26	29	29	NUM
ajlm-741	72	27	%	%	NOUN
ajlm-741	72	28	)	)	PUNCT
ajlm-741	72	29	typically	typically	ADV
ajlm-741	72	30	associated	associate	VERB
ajlm-741	72	31	with	with	ADP
ajlm-741	72	32	hospitaland	hospitaland	NOUN
ajlm-741	72	33	community	community	NOUN
ajlm-741	72	34	-	-	PUNCT
ajlm-741	72	35	acquired	acquire	VERB
ajlm-741	72	36	infections	infection	NOUN
ajlm-741	72	37	,	,	PUNCT
ajlm-741	72	38	respectively	respectively	ADV
ajlm-741	72	39	.	.	PUNCT
ajlm-741	73	1	type	type	PROPN
ajlm-741	73	2	ii	ii	PROPN
ajlm-741	73	3	accounted	account	VERB
ajlm-741	73	4	for	for	ADP
ajlm-741	73	5	only	only	ADV
ajlm-741	73	6	four	four	NUM
ajlm-741	73	7	isolates	isolate	NOUN
ajlm-741	73	8	and	and	CCONJ
ajlm-741	73	9	no	no	DET
ajlm-741	73	10	type	type	NOUN
ajlm-741	73	11	i	i	PRON
ajlm-741	73	12	isolates	isolate	NOUN
ajlm-741	73	13	were	be	AUX
ajlm-741	73	14	found	find	VERB
ajlm-741	73	15	.	.	PUNCT
ajlm-741	74	1	clinical	clinical	ADJ
ajlm-741	74	2	information	information	NOUN
ajlm-741	74	3	was	be	AUX
ajlm-741	74	4	available	available	ADJ
ajlm-741	74	5	for	for	ADP
ajlm-741	74	6	140	140	NUM
ajlm-741	74	7	cases	case	NOUN
ajlm-741	74	8	.	.	PUNCT
ajlm-741	75	1	according	accord	VERB
ajlm-741	75	2	to	to	ADP
ajlm-741	75	3	the	the	DET
ajlm-741	75	4	authors	author	NOUN
ajlm-741	75	5	,	,	PUNCT
ajlm-741	75	6	majority	majority	NOUN
ajlm-741	75	7	of	of	ADP
ajlm-741	75	8	patients	patient	NOUN
ajlm-741	75	9	(	(	PUNCT
ajlm-741	75	10	86	86	NUM
ajlm-741	75	11	%	%	NOUN
ajlm-741	75	12	,	,	PUNCT
ajlm-741	75	13	121/140	121/140	NUM
ajlm-741	75	14	)	)	PUNCT
ajlm-741	75	15	received	receive	VERB
ajlm-741	75	16	one	one	NUM
ajlm-741	75	17	or	or	CCONJ
ajlm-741	75	18	more	more	ADJ
ajlm-741	75	19	antimicrobial	antimicrobial	ADJ
ajlm-741	75	20	agents	agent	NOUN
ajlm-741	75	21	,	,	PUNCT
ajlm-741	75	22	95	95	NUM
ajlm-741	75	23	cases	case	NOUN
ajlm-741	75	24	received	receive	VERB
ajlm-741	75	25	empirical	empirical	ADJ
ajlm-741	75	26	treatment	treatment	NOUN
ajlm-741	75	27	while	while	SCONJ
ajlm-741	75	28	42	42	NUM
ajlm-741	75	29	received	receive	VERB
ajlm-741	75	30	directed	direct	VERB
ajlm-741	75	31	treatment	treatment	NOUN
ajlm-741	75	32	.	.	PUNCT
ajlm-741	76	1	of	of	ADP
ajlm-741	76	2	those	those	PRON
ajlm-741	76	3	that	that	PRON
ajlm-741	76	4	received	receive	VERB
ajlm-741	76	5	empirical	empirical	ADJ
ajlm-741	76	6	treatment	treatment	NOUN
ajlm-741	76	7	(	(	PUNCT
ajlm-741	76	8	n	n	NOUN
ajlm-741	76	9	=	=	SYM
ajlm-741	76	10	95	95	NUM
ajlm-741	76	11	)	)	PUNCT
ajlm-741	76	12	,	,	PUNCT
ajlm-741	76	13	a	a	DET
ajlm-741	76	14	greater	great	ADJ
ajlm-741	76	15	proportion	proportion	NOUN
ajlm-741	76	16	of	of	ADP
ajlm-741	76	17	mssa	mssa	ADJ
ajlm-741	76	18	cases	case	NOUN
ajlm-741	76	19	(	(	PUNCT
ajlm-741	76	20	95	95	NUM
ajlm-741	76	21	%	%	NOUN
ajlm-741	76	22	,	,	PUNCT
ajlm-741	76	23	55/58	55/58	NUM
ajlm-741	76	24	)	)	PUNCT
ajlm-741	76	25	received	receive	VERB
ajlm-741	76	26	appropriate	appropriate	ADJ
ajlm-741	76	27	empirical	empirical	ADJ
ajlm-741	76	28	therapy	therapy	NOUN
ajlm-741	76	29	compared	compare	VERB
ajlm-741	76	30	to	to	ADP
ajlm-741	76	31	mrsa	mrsa	NOUN
ajlm-741	76	32	cases	case	NOUN
ajlm-741	76	33	(	(	PUNCT
ajlm-741	76	34	57	57	NUM
ajlm-741	76	35	%	%	NOUN
ajlm-741	76	36	,	,	PUNCT
ajlm-741	76	37	21/37	21/37	NUM
ajlm-741	76	38	)	)	PUNCT
ajlm-741	76	39	and	and	CCONJ
ajlm-741	76	40	this	this	PRON
ajlm-741	76	41	was	be	AUX
ajlm-741	76	42	statistically	statistically	ADV
ajlm-741	76	43	significant	significant	ADJ
ajlm-741	76	44	(	(	PUNCT
ajlm-741	76	45	p	p	X
ajlm-741	76	46	<	<	X
ajlm-741	76	47	0.001	0.001	NUM
ajlm-741	76	48	)	)	PUNCT
ajlm-741	76	49	.	.	PUNCT
ajlm-741	77	1	of	of	ADP
ajlm-741	77	2	those	those	PRON
ajlm-741	77	3	that	that	PRON
ajlm-741	77	4	received	receive	VERB
ajlm-741	77	5	directed	direct	VERB
ajlm-741	77	6	treatment	treatment	NOUN
ajlm-741	77	7	(	(	PUNCT
ajlm-741	77	8	n	n	NOUN
ajlm-741	77	9	=	=	SYM
ajlm-741	77	10	42	42	NUM
ajlm-741	77	11	)	)	PUNCT
ajlm-741	77	12	,	,	PUNCT
ajlm-741	77	13	all	all	DET
ajlm-741	77	14	mssa	mssa	ADJ
ajlm-741	77	15	cases	case	NOUN
ajlm-741	77	16	(	(	PUNCT
ajlm-741	77	17	25/25	25/25	NUM
ajlm-741	77	18	)	)	PUNCT
ajlm-741	77	19	received	receive	VERB
ajlm-741	77	20	appropriate	appropriate	ADJ
ajlm-741	77	21	directed	direct	VERB
ajlm-741	77	22	therapy	therapy	NOUN
ajlm-741	77	23	while	while	SCONJ
ajlm-741	77	24	this	this	PRON
ajlm-741	77	25	was	be	AUX
ajlm-741	77	26	true	true	ADJ
ajlm-741	77	27	for	for	ADP
ajlm-741	77	28	only	only	ADV
ajlm-741	77	29	59	59	NUM
ajlm-741	77	30	%	%	NOUN
ajlm-741	77	31	(	(	PUNCT
ajlm-741	77	32	10/17	10/17	NUM
ajlm-741	77	33	)	)	PUNCT
ajlm-741	77	34	of	of	ADP
ajlm-741	77	35	mrsa	mrsa	NOUN
ajlm-741	77	36	cases	case	NOUN
ajlm-741	77	37	;	;	PUNCT
ajlm-741	77	38	again	again	ADV
ajlm-741	77	39	,	,	PUNCT
ajlm-741	77	40	this	this	PRON
ajlm-741	77	41	was	be	AUX
ajlm-741	77	42	statistically	statistically	ADV
ajlm-741	77	43	significant	significant	ADJ
ajlm-741	77	44	(	(	PUNCT
ajlm-741	77	45	p	p	X
ajlm-741	77	46	<	<	X
ajlm-741	77	47	0.001	0.001	NUM
ajlm-741	77	48	)	)	PUNCT
ajlm-741	77	49	.	.	PUNCT
ajlm-741	78	1	this	this	DET
ajlm-741	78	2	study	study	NOUN
ajlm-741	78	3	demonstrated	demonstrate	VERB
ajlm-741	78	4	that	that	SCONJ
ajlm-741	78	5	antimicrobial	antimicrobial	ADJ
ajlm-741	78	6	prescription	prescription	NOUN
ajlm-741	78	7	practices	practice	NOUN
ajlm-741	78	8	should	should	AUX
ajlm-741	78	9	be	be	AUX
ajlm-741	78	10	monitored	monitor	VERB
ajlm-741	78	11	and	and	CCONJ
ajlm-741	78	12	that	that	SCONJ
ajlm-741	78	13	knowledge	knowledge	NOUN
ajlm-741	78	14	of	of	ADP
ajlm-741	78	15	local	local	ADJ
ajlm-741	78	16	epidemiology	epidemiology	NOUN
ajlm-741	78	17	as	as	ADV
ajlm-741	78	18	well	well	ADV
ajlm-741	78	19	as	as	ADP
ajlm-741	78	20	factors	factor	NOUN
ajlm-741	78	21	predictive	predictive	ADJ
ajlm-741	78	22	of	of	ADP
ajlm-741	78	23	mrsa	mrsa	NOUN
ajlm-741	78	24	infection	infection	NOUN
ajlm-741	78	25	is	be	AUX
ajlm-741	78	26	important	important	ADJ
ajlm-741	78	27	as	as	SCONJ
ajlm-741	78	28	it	it	PRON
ajlm-741	78	29	will	will	AUX
ajlm-741	78	30	assist	assist	VERB
ajlm-741	78	31	in	in	ADP
ajlm-741	78	32	guiding	guide	VERB
ajlm-741	78	33	the	the	DET
ajlm-741	78	34	use	use	NOUN
ajlm-741	78	35	of	of	ADP
ajlm-741	78	36	appropriate	appropriate	ADJ
ajlm-741	78	37	empirical	empirical	ADJ
ajlm-741	78	38	treatment	treatment	NOUN
ajlm-741	78	39	.	.	PUNCT
ajlm-741	79	1	the	the	DET
ajlm-741	79	2	importance	importance	NOUN
ajlm-741	79	3	of	of	ADP
ajlm-741	79	4	antimicrobial	antimicrobial	ADJ
ajlm-741	79	5	resistance	resistance	NOUN
ajlm-741	79	6	surveillance	surveillance	NOUN
ajlm-741	79	7	as	as	ADP
ajlm-741	79	8	a	a	DET
ajlm-741	79	9	public	public	ADJ
ajlm-741	79	10	health	health	NOUN
ajlm-741	79	11	measure	measure	NOUN
ajlm-741	79	12	was	be	AUX
ajlm-741	79	13	also	also	ADV
ajlm-741	79	14	highlighted.46	highlighted.46	NOUN
ajlm-741	79	15	a	a	DET
ajlm-741	79	16	more	more	ADV
ajlm-741	79	17	recent	recent	ADJ
ajlm-741	79	18	lars	lars	PROPN
ajlm-741	79	19	study	study	NOUN
ajlm-741	79	20	published	publish	VERB
ajlm-741	79	21	in	in	ADP
ajlm-741	79	22	201527	201527	NUM
ajlm-741	79	23	investigating	investigate	VERB
ajlm-741	79	24	the	the	DET
ajlm-741	79	25	prevalence	prevalence	NOUN
ajlm-741	79	26	and	and	CCONJ
ajlm-741	79	27	trends	trend	NOUN
ajlm-741	79	28	of	of	ADP
ajlm-741	79	29	s.	s.	PROPN
ajlm-741	79	30	aureus	aureus	PROPN
ajlm-741	79	31	bacteraemia	bacteraemia	PROPN
ajlm-741	79	32	in	in	ADP
ajlm-741	79	33	2709	2709	NUM
ajlm-741	79	34	hospitalised	hospitalise	VERB
ajlm-741	79	35	patients	patient	NOUN
ajlm-741	79	36	from	from	ADP
ajlm-741	79	37	13	13	NUM
ajlm-741	79	38	academic	academic	ADJ
ajlm-741	79	39	centres	centre	NOUN
ajlm-741	79	40	in	in	ADP
ajlm-741	79	41	south	south	PROPN
ajlm-741	79	42	africa	africa	PROPN
ajlm-741	79	43	in	in	ADP
ajlm-741	79	44	2010	2010	NUM
ajlm-741	79	45	to	to	ADP
ajlm-741	79	46	2012	2012	NUM
ajlm-741	79	47	examined	examine	VERB
ajlm-741	79	48	antimicrobial	antimicrobial	ADJ
ajlm-741	79	49	resistance	resistance	NOUN
ajlm-741	79	50	and	and	CCONJ
ajlm-741	79	51	the	the	DET
ajlm-741	79	52	molecular	molecular	ADJ
ajlm-741	79	53	epidemiology	epidemiology	NOUN
ajlm-741	79	54	for	for	ADP
ajlm-741	79	55	laboratory	laboratory	NOUN
ajlm-741	79	56	-	-	PUNCT
ajlm-741	79	57	based	base	VERB
ajlm-741	79	58	surveillance	surveillance	NOUN
ajlm-741	79	59	.	.	PUNCT
ajlm-741	80	1	forty	forty	NUM
ajlm-741	80	2	-	-	PUNCT
ajlm-741	80	3	six	six	NUM
ajlm-741	80	4	per	per	ADP
ajlm-741	80	5	cent	cent	NOUN
ajlm-741	80	6	of	of	ADP
ajlm-741	80	7	cases	case	NOUN
ajlm-741	80	8	were	be	AUX
ajlm-741	80	9	mrsa	mrsa	NOUN
ajlm-741	80	10	and	and	CCONJ
ajlm-741	80	11	there	there	PRON
ajlm-741	80	12	was	be	VERB
ajlm-741	80	13	a	a	DET
ajlm-741	80	14	significant	significant	ADJ
ajlm-741	80	15	decline	decline	NOUN
ajlm-741	80	16	of	of	ADP
ajlm-741	80	17	mrsa	mrsa	NOUN
ajlm-741	80	18	from	from	ADP
ajlm-741	80	19	53	53	NUM
ajlm-741	80	20	%	%	NOUN
ajlm-741	80	21	to	to	PART
ajlm-741	80	22	40	40	NUM
ajlm-741	80	23	%	%	NOUN
ajlm-741	80	24	over	over	ADP
ajlm-741	80	25	the	the	DET
ajlm-741	80	26	3	3	NUM
ajlm-741	80	27	-	-	PUNCT
ajlm-741	80	28	year	year	NOUN
ajlm-741	80	29	period	period	NOUN
ajlm-741	80	30	.	.	PUNCT
ajlm-741	81	1	geographical	geographical	ADJ
ajlm-741	81	2	distribution	distribution	NOUN
ajlm-741	81	3	showed	show	VERB
ajlm-741	81	4	that	that	SCONJ
ajlm-741	81	5	mrsa	mrsa	NOUN
ajlm-741	81	6	was	be	AUX
ajlm-741	81	7	significantly	significantly	ADV
ajlm-741	81	8	higher	high	ADJ
ajlm-741	81	9	in	in	ADP
ajlm-741	81	10	gauteng	gauteng	PROPN
ajlm-741	81	11	compared	compare	VERB
ajlm-741	81	12	to	to	ADP
ajlm-741	81	13	the	the	DET
ajlm-741	81	14	other	other	ADJ
ajlm-741	81	15	provinces	province	NOUN
ajlm-741	81	16	and	and	CCONJ
ajlm-741	81	17	children	child	NOUN
ajlm-741	81	18	younger	young	ADJ
ajlm-741	81	19	than	than	ADP
ajlm-741	81	20	5	5	NUM
ajlm-741	81	21	years	year	NOUN
ajlm-741	81	22	of	of	ADP
ajlm-741	81	23	age	age	NOUN
ajlm-741	81	24	were	be	AUX
ajlm-741	81	25	associated	associate	VERB
ajlm-741	81	26	with	with	ADP
ajlm-741	81	27	higher	high	ADJ
ajlm-741	81	28	mrsa	mrsa	NOUN
ajlm-741	81	29	rates	rate	NOUN
ajlm-741	81	30	compared	compare	VERB
ajlm-741	81	31	to	to	ADP
ajlm-741	81	32	all	all	DET
ajlm-741	81	33	other	other	ADJ
ajlm-741	81	34	age	age	NOUN
ajlm-741	81	35	groups	group	NOUN
ajlm-741	81	36	.	.	PUNCT
ajlm-741	82	1	methicillin	methicillin	NOUN
ajlm-741	82	2	-	-	PUNCT
ajlm-741	82	3	resistant	resistant	ADJ
ajlm-741	82	4	staphylococcus	staphylococcus	NOUN
ajlm-741	82	5	aureus	aureus	NOUN
ajlm-741	82	6	isolates	isolate	NOUN
ajlm-741	82	7	were	be	AUX
ajlm-741	82	8	resistant	resistant	ADJ
ajlm-741	82	9	to	to	ADP
ajlm-741	82	10	more	more	ADJ
ajlm-741	82	11	classes	class	NOUN
ajlm-741	82	12	of	of	ADP
ajlm-741	82	13	antimicrobial	antimicrobial	ADJ
ajlm-741	82	14	agents	agent	NOUN
ajlm-741	82	15	compared	compare	VERB
ajlm-741	82	16	to	to	ADP
ajlm-741	82	17	mssa	mssa	ADJ
ajlm-741	82	18	isolates	isolate	NOUN
ajlm-741	82	19	.	.	PUNCT
ajlm-741	83	1	isolates	isolate	NOUN
ajlm-741	83	2	were	be	AUX
ajlm-741	83	3	fully	fully	ADV
ajlm-741	83	4	susceptible	susceptible	ADJ
ajlm-741	83	5	to	to	ADP
ajlm-741	83	6	glycopeptides	glycopeptide	NOUN
ajlm-741	83	7	,	,	PUNCT
ajlm-741	83	8	daptomycin	daptomycin	PROPN
ajlm-741	83	9	,	,	PUNCT
ajlm-741	83	10	linezolid	linezolid	NOUN
ajlm-741	83	11	and	and	CCONJ
ajlm-741	83	12	quinupristin	quinupristin	NOUN
ajlm-741	83	13	-	-	PUNCT
ajlm-741	83	14	dalfopristin	dalfopristin	NOUN
ajlm-741	83	15	.	.	PUNCT
ajlm-741	84	1	while	while	SCONJ
ajlm-741	84	2	ciprofloxacin	ciprofloxacin	NOUN
ajlm-741	84	3	and	and	CCONJ
ajlm-741	84	4	trimethoprim	trimethoprim	ADJ
ajlm-741	84	5	-	-	PUNCT
ajlm-741	84	6	sufamethoxazole	sufamethoxazole	NOUN
ajlm-741	84	7	resistance	resistance	NOUN
ajlm-741	84	8	declined	decline	VERB
ajlm-741	84	9	significantly	significantly	ADV
ajlm-741	84	10	over	over	ADP
ajlm-741	84	11	the	the	DET
ajlm-741	84	12	surveillance	surveillance	NOUN
ajlm-741	84	13	period	period	NOUN
ajlm-741	84	14	,	,	PUNCT
ajlm-741	84	15	resistance	resistance	NOUN
ajlm-741	84	16	to	to	ADP
ajlm-741	84	17	macrolides	macrolide	NOUN
ajlm-741	84	18	,	,	PUNCT
ajlm-741	84	19	aminoglycosides	aminoglycoside	NOUN
ajlm-741	84	20	,	,	PUNCT
ajlm-741	84	21	tetracycline	tetracycline	NOUN
ajlm-741	84	22	,	,	PUNCT
ajlm-741	84	23	rifampin	rifampin	NOUN
ajlm-741	84	24	and	and	CCONJ
ajlm-741	84	25	mupirocin	mupirocin	NOUN
ajlm-741	84	26	remained	remain	VERB
ajlm-741	84	27	comparable	comparable	ADJ
ajlm-741	84	28	.	.	PUNCT
ajlm-741	85	1	the	the	DET
ajlm-741	85	2	mic50	mic50	NOUN
ajlm-741	85	3	and	and	CCONJ
ajlm-741	85	4	mic90	mic90	PROPN
ajlm-741	85	5	for	for	ADP
ajlm-741	85	6	all	all	DET
ajlm-741	85	7	agents	agent	NOUN
ajlm-741	85	8	remained	remain	VERB
ajlm-741	85	9	stable	stable	ADJ
ajlm-741	85	10	from	from	ADP
ajlm-741	85	11	2010	2010	NUM
ajlm-741	85	12	to	to	ADP
ajlm-741	85	13	2012	2012	NUM
ajlm-741	85	14	.	.	PUNCT
ajlm-741	86	1	the	the	DET
ajlm-741	86	2	most	most	ADV
ajlm-741	86	3	prevalent	prevalent	ADJ
ajlm-741	86	4	sccmec	sccmec	NOUN
ajlm-741	86	5	type	type	NOUN
ajlm-741	86	6	distribution	distribution	NOUN
ajlm-741	86	7	was	be	AUX
ajlm-741	86	8	consistent	consistent	ADJ
ajlm-741	86	9	with	with	ADP
ajlm-741	86	10	the	the	DET
ajlm-741	86	11	previous	previous	ADJ
ajlm-741	86	12	study,41	study,41	PROPN
ajlm-741	86	13	with	with	ADP
ajlm-741	86	14	type	type	NOUN
ajlm-741	86	15	iii	iii	NOUN
ajlm-741	86	16	predominating	predominate	VERB
ajlm-741	86	17	(	(	PUNCT
ajlm-741	86	18	41	41	NUM
ajlm-741	86	19	%	%	NOUN
ajlm-741	86	20	)	)	PUNCT
ajlm-741	86	21	followed	follow	VERB
ajlm-741	86	22	by	by	ADP
ajlm-741	86	23	type	type	NOUN
ajlm-741	86	24	iv	iv	NUM
ajlm-741	86	25	(	(	PUNCT
ajlm-741	86	26	31	31	NUM
ajlm-741	86	27	%	%	NOUN
ajlm-741	86	28	)	)	PUNCT
ajlm-741	86	29	.	.	PUNCT
ajlm-741	87	1	further	far	ADV
ajlm-741	87	2	molecular	molecular	ADJ
ajlm-741	87	3	studies	study	NOUN
ajlm-741	87	4	found	find	VERB
ajlm-741	87	5	47	47	NUM
ajlm-741	87	6	different	different	ADJ
ajlm-741	87	7	spa	spa	NOUN
ajlm-741	87	8	-	-	PUNCT
ajlm-741	87	9	types	type	NOUN
ajlm-741	87	10	with	with	ADP
ajlm-741	87	11	the	the	DET
ajlm-741	87	12	five	five	NUM
ajlm-741	87	13	most	most	ADV
ajlm-741	87	14	common	common	ADJ
ajlm-741	87	15	spa	spa	NOUN
ajlm-741	87	16	-	-	PUNCT
ajlm-741	87	17	types	type	NOUN
ajlm-741	87	18	accounting	account	VERB
ajlm-741	87	19	for	for	ADP
ajlm-741	87	20	87	87	NUM
ajlm-741	87	21	%	%	NOUN
ajlm-741	87	22	of	of	ADP
ajlm-741	87	23	the	the	DET
ajlm-741	87	24	isolates	isolate	NOUN
ajlm-741	87	25	and	and	CCONJ
ajlm-741	87	26	were	be	AUX
ajlm-741	87	27	t037	t037	NUM
ajlm-741	87	28	,	,	PUNCT
ajlm-741	87	29	t1257	t1257	PROPN
ajlm-741	87	30	,	,	PUNCT
ajlm-741	87	31	t045	t045	NUM
ajlm-741	87	32	,	,	PUNCT
ajlm-741	87	33	t064	t064	PROPN
ajlm-741	87	34	and	and	CCONJ
ajlm-741	87	35	t012	t012	PROPN
ajlm-741	87	36	.	.	PUNCT
ajlm-741	88	1	the	the	DET
ajlm-741	88	2	most	most	ADV
ajlm-741	88	3	common	common	ADJ
ajlm-741	88	4	multilocus	multilocus	NOUN
ajlm-741	88	5	sequence	sequence	NOUN
ajlm-741	88	6	type	type	NOUN
ajlm-741	88	7	(	(	PUNCT
ajlm-741	88	8	mlst	mlst	NOUN
ajlm-741	88	9	)	)	PUNCT
ajlm-741	88	10	was	be	AUX
ajlm-741	88	11	st612	st612	PROPN
ajlm-741	88	12	clonal	clonal	ADJ
ajlm-741	88	13	complex	complex	ADJ
ajlm-741	88	14	8	8	NUM
ajlm-741	88	15	(	(	PUNCT
ajlm-741	88	16	cc8	cc8	NOUN
ajlm-741	88	17	)	)	PUNCT
ajlm-741	88	18	(	(	PUNCT
ajlm-741	88	19	n	n	NOUN
ajlm-741	88	20	=	=	SYM
ajlm-741	88	21	7	7	NUM
ajlm-741	88	22	)	)	PUNCT
ajlm-741	88	23	,	,	PUNCT
ajlm-741	88	24	followed	follow	VERB
ajlm-741	88	25	by	by	ADP
ajlm-741	88	26	st5	st5	PROPN
ajlm-741	88	27	(	(	PUNCT
ajlm-741	88	28	cc5	cc5	PROPN
ajlm-741	88	29	)	)	PUNCT
ajlm-741	88	30	(	(	PUNCT
ajlm-741	88	31	n	n	NOUN
ajlm-741	88	32	=	=	SYM
ajlm-741	88	33	4	4	NUM
ajlm-741	88	34	)	)	PUNCT
ajlm-741	88	35	,	,	PUNCT
ajlm-741	88	36	st36	st36	PROPN
ajlm-741	88	37	(	(	PUNCT
ajlm-741	88	38	cc30	cc30	PROPN
ajlm-741	88	39	)	)	PUNCT
ajlm-741	88	40	(	(	PUNCT
ajlm-741	88	41	n	n	NOUN
ajlm-741	88	42	=	=	SYM
ajlm-741	88	43	4	4	NUM
ajlm-741	88	44	)	)	PUNCT
ajlm-741	88	45	and	and	CCONJ
ajlm-741	88	46	st239	st239	VERB
ajlm-741	88	47	(	(	PUNCT
ajlm-741	88	48	cc8	cc8	NOUN
ajlm-741	88	49	)	)	PUNCT
ajlm-741	88	50	(	(	PUNCT
ajlm-741	88	51	n	n	NOUN
ajlm-741	88	52	=	=	SYM
ajlm-741	88	53	3	3	NUM
ajlm-741	88	54	)	)	PUNCT
ajlm-741	88	55	.	.	PUNCT
ajlm-741	89	1	overall	overall	ADV
ajlm-741	89	2	,	,	PUNCT
ajlm-741	89	3	this	this	DET
ajlm-741	89	4	study	study	NOUN
ajlm-741	89	5	revealed	reveal	VERB
ajlm-741	89	6	the	the	DET
ajlm-741	89	7	presence	presence	NOUN
ajlm-741	89	8	of	of	ADP
ajlm-741	89	9	a	a	DET
ajlm-741	89	10	variety	variety	NOUN
ajlm-741	89	11	of	of	ADP
ajlm-741	89	12	hospital	hospital	NOUN
ajlm-741	89	13	-	-	PUNCT
ajlm-741	89	14	acquired	acquire	VERB
ajlm-741	89	15	mrsa	mrsa	NOUN
ajlm-741	89	16	clones	clone	NOUN
ajlm-741	89	17	in	in	ADP
ajlm-741	89	18	south	south	PROPN
ajlm-741	89	19	africa	africa	PROPN
ajlm-741	89	20	and	and	CCONJ
ajlm-741	89	21	a	a	DET
ajlm-741	89	22	dominance	dominance	NOUN
ajlm-741	89	23	of	of	ADP
ajlm-741	89	24	a	a	DET
ajlm-741	89	25	few	few	ADJ
ajlm-741	89	26	clones	clone	NOUN
ajlm-741	89	27	,	,	PUNCT
ajlm-741	89	28	a	a	DET
ajlm-741	89	29	result	result	NOUN
ajlm-741	89	30	that	that	PRON
ajlm-741	89	31	was	be	AUX
ajlm-741	89	32	similar	similar	ADJ
ajlm-741	89	33	to	to	ADP
ajlm-741	89	34	previous	previous	ADJ
ajlm-741	89	35	findings	finding	NOUN
ajlm-741	89	36	in	in	ADP
ajlm-741	89	37	south	south	ADJ
ajlm-741	89	38	africa,47,48,49	africa,47,48,49	PROPN
ajlm-741	89	39	indicating	indicate	VERB
ajlm-741	89	40	a	a	DET
ajlm-741	89	41	slow	slow	ADJ
ajlm-741	89	42	evolution	evolution	NOUN
ajlm-741	89	43	of	of	ADP
ajlm-741	89	44	circulating	circulate	VERB
ajlm-741	89	45	clonal	clonal	ADJ
ajlm-741	89	46	types	type	NOUN
ajlm-741	89	47	.	.	PUNCT
ajlm-741	90	1	this	this	DET
ajlm-741	90	2	study	study	NOUN
ajlm-741	90	3	demonstrated	demonstrate	VERB
ajlm-741	90	4	the	the	DET
ajlm-741	90	5	importance	importance	NOUN
ajlm-741	90	6	of	of	ADP
ajlm-741	90	7	monitoring	monitor	VERB
ajlm-741	90	8	trends	trend	NOUN
ajlm-741	90	9	in	in	ADP
ajlm-741	90	10	resistance	resistance	NOUN
ajlm-741	90	11	and	and	CCONJ
ajlm-741	90	12	molecular	molecular	ADJ
ajlm-741	90	13	typing	typing	NOUN
ajlm-741	90	14	to	to	PART
ajlm-741	90	15	detect	detect	VERB
ajlm-741	90	16	changing	change	VERB
ajlm-741	90	17	epidemiological	epidemiological	ADJ
ajlm-741	90	18	trends	trend	NOUN
ajlm-741	90	19	in	in	ADP
ajlm-741	90	20	antimicrobial	antimicrobial	ADJ
ajlm-741	90	21	resistance	resistance	NOUN
ajlm-741	90	22	patterns.27	patterns.27	PROPN
ajlm-741	90	23	in	in	ADP
ajlm-741	90	24	south	south	PROPN
ajlm-741	90	25	africa	africa	PROPN
ajlm-741	90	26	,	,	PUNCT
ajlm-741	90	27	the	the	DET
ajlm-741	90	28	antimicrobial	antimicrobial	ADJ
ajlm-741	90	29	resistance	resistance	NOUN
ajlm-741	90	30	laboratory	laboratory	NOUN
ajlm-741	90	31	at	at	ADP
ajlm-741	90	32	the	the	DET
ajlm-741	90	33	nicd	nicd	NOUN
ajlm-741	90	34	has	have	AUX
ajlm-741	90	35	been	be	AUX
ajlm-741	90	36	assigned	assign	VERB
ajlm-741	90	37	as	as	ADP
ajlm-741	90	38	the	the	DET
ajlm-741	90	39	who	who	PRON
ajlm-741	90	40	collaborating	collaborate	VERB
ajlm-741	90	41	centre	centre	NOUN
ajlm-741	90	42	for	for	ADP
ajlm-741	90	43	antimicrobial	antimicrobial	ADJ
ajlm-741	90	44	resistance	resistance	NOUN
ajlm-741	90	45	surveillance	surveillance	NOUN
ajlm-741	90	46	and	and	CCONJ
ajlm-741	90	47	in	in	ADP
ajlm-741	90	48	april	april	PROPN
ajlm-741	90	49	2017	2017	NUM
ajlm-741	90	50	,	,	PUNCT
ajlm-741	90	51	responded	respond	VERB
ajlm-741	90	52	to	to	ADP
ajlm-741	90	53	the	the	DET
ajlm-741	90	54	first	first	ADJ
ajlm-741	90	55	data	datum	NOUN
ajlm-741	90	56	call	call	NOUN
ajlm-741	90	57	from	from	ADP
ajlm-741	90	58	the	the	DET
ajlm-741	90	59	glass.22	glass.22	PROPN
ajlm-741	90	60	germs	germs	PROPN
ajlm-741	90	61	-	-	PUNCT
ajlm-741	90	62	sa	sa	NOUN
ajlm-741	90	63	data	datum	NOUN
ajlm-741	90	64	for	for	ADP
ajlm-741	90	65	s.	s.	PROPN
ajlm-741	90	66	aureus	aureus	PROPN
ajlm-741	90	67	isolated	isolate	VERB
ajlm-741	90	68	from	from	ADP
ajlm-741	90	69	blood	blood	NOUN
ajlm-741	90	70	culture	culture	NOUN
ajlm-741	90	71	specimens	specimen	NOUN
ajlm-741	90	72	submitted	submit	VERB
ajlm-741	90	73	from	from	ADP
ajlm-741	90	74	2015	2015	NUM
ajlm-741	90	75	to	to	ADP
ajlm-741	90	76	2016	2016	NUM
ajlm-741	90	77	showed	show	VERB
ajlm-741	90	78	a	a	DET
ajlm-741	90	79	decrease	decrease	NOUN
ajlm-741	90	80	in	in	ADP
ajlm-741	90	81	cefoxitin	cefoxitin	NOUN
ajlm-741	90	82	resistance	resistance	NOUN
ajlm-741	90	83	,	,	PUNCT
ajlm-741	90	84	from	from	ADP
ajlm-741	90	85	31.4	31.4	NUM
ajlm-741	90	86	%	%	NOUN
ajlm-741	90	87	(	(	PUNCT
ajlm-741	90	88	n	n	NOUN
ajlm-741	90	89	=	=	SYM
ajlm-741	90	90	225/882	225/882	NUM
ajlm-741	90	91	)	)	PUNCT
ajlm-741	90	92	to	to	ADP
ajlm-741	90	93	24.9	24.9	NUM
ajlm-741	90	94	%	%	NOUN
ajlm-741	90	95	(	(	PUNCT
ajlm-741	90	96	n	n	NOUN
ajlm-741	90	97	=	=	SYM
ajlm-741	90	98	182/867	182/867	NUM
ajlm-741	90	99	)	)	PUNCT
ajlm-741	90	100	(	(	PUNCT
ajlm-741	90	101	unpublished	unpublished	ADJ
ajlm-741	90	102	data	datum	NOUN
ajlm-741	90	103	)	)	PUNCT
ajlm-741	90	104	.	.	PUNCT
ajlm-741	91	1	secondary	secondary	ADJ
ajlm-741	91	2	electronic	electronic	ADJ
ajlm-741	91	3	surveillance	surveillance	NOUN
ajlm-741	91	4	for	for	ADP
ajlm-741	91	5	a	a	DET
ajlm-741	91	6	select	select	ADJ
ajlm-741	91	7	panel	panel	NOUN
ajlm-741	91	8	of	of	ADP
ajlm-741	91	9	bacteria	bacteria	NOUN
ajlm-741	91	10	(	(	PUNCT
ajlm-741	91	11	eskape	eskape	NOUN
ajlm-741	91	12	)	)	PUNCT
ajlm-741	91	13	modelled	model	VERB
ajlm-741	91	14	on	on	ADP
ajlm-741	91	15	the	the	DET
ajlm-741	91	16	glass	glass	NOUN
ajlm-741	91	17	pathogen	pathogen	NOUN
ajlm-741	91	18	-	-	PUNCT
ajlm-741	91	19	antimicrobial	antimicrobial	ADJ
ajlm-741	91	20	combination	combination	NOUN
ajlm-741	91	21	is	be	AUX
ajlm-741	91	22	utilised	utilise	VERB
ajlm-741	91	23	for	for	ADP
ajlm-741	91	24	the	the	DET
ajlm-741	91	25	purpose	purpose	NOUN
ajlm-741	91	26	of	of	ADP
ajlm-741	91	27	complementing	complement	VERB
ajlm-741	91	28	the	the	DET
ajlm-741	91	29	well	well	ADV
ajlm-741	91	30	-	-	PUNCT
ajlm-741	91	31	established	establish	VERB
ajlm-741	91	32	germs	germ	NOUN
ajlm-741	91	33	-	-	PUNCT
ajlm-741	91	34	sa	sa	NOUN
ajlm-741	91	35	surveillance	surveillance	NOUN
ajlm-741	91	36	system	system	NOUN
ajlm-741	91	37	.	.	PUNCT
ajlm-741	92	1	antimicrobial	antimicrobial	ADJ
ajlm-741	92	2	resistance	resistance	NOUN
ajlm-741	92	3	data	datum	NOUN
ajlm-741	92	4	are	be	AUX
ajlm-741	92	5	channelled	channel	VERB
ajlm-741	92	6	and	and	CCONJ
ajlm-741	92	7	formatted	format	VERB
ajlm-741	92	8	as	as	ADP
ajlm-741	92	9	antimicrobial	antimicrobial	ADJ
ajlm-741	92	10	resistance	resistance	NOUN
ajlm-741	92	11	maps	map	NOUN
ajlm-741	92	12	for	for	ADP
ajlm-741	92	13	both	both	CCONJ
ajlm-741	92	14	public	public	ADJ
ajlm-741	92	15	and	and	CCONJ
ajlm-741	92	16	private	private	ADJ
ajlm-741	92	17	healthcare	healthcare	NOUN
ajlm-741	92	18	sector	sector	NOUN
ajlm-741	92	19	laboratory	laboratory	NOUN
ajlm-741	92	20	results	result	NOUN
ajlm-741	92	21	,	,	PUNCT
ajlm-741	92	22	and	and	CCONJ
ajlm-741	92	23	are	be	AUX
ajlm-741	92	24	made	make	VERB
ajlm-741	92	25	available	available	ADJ
ajlm-741	92	26	on	on	ADP
ajlm-741	92	27	the	the	DET
ajlm-741	92	28	nicd	nicd	NOUN
ajlm-741	92	29	website.14	website.14	PROPN
ajlm-741	92	30	these	these	DET
ajlm-741	92	31	antimicrobial	antimicrobial	ADJ
ajlm-741	92	32	resistance	resistance	NOUN
ajlm-741	92	33	maps	map	NOUN
ajlm-741	92	34	are	be	AUX
ajlm-741	92	35	summarised	summarise	VERB
ajlm-741	92	36	and	and	CCONJ
ajlm-741	92	37	published	publish	VERB
ajlm-741	92	38	as	as	ADP
ajlm-741	92	39	annual	annual	ADJ
ajlm-741	92	40	reports	report	NOUN
ajlm-741	92	41	on	on	ADP
ajlm-741	92	42	the	the	DET
ajlm-741	92	43	federation	federation	NOUN
ajlm-741	92	44	of	of	ADP
ajlm-741	92	45	infectious	infectious	ADJ
ajlm-741	92	46	diseases	disease	NOUN
ajlm-741	92	47	societies	society	NOUN
ajlm-741	92	48	of	of	ADP
ajlm-741	92	49	southern	southern	PROPN
ajlm-741	92	50	africa	africa	PROPN
ajlm-741	92	51	(	(	PUNCT
ajlm-741	92	52	fidssa	fidssa	NOUN
ajlm-741	92	53	)	)	PUNCT
ajlm-741	92	54	website10	website10	NOUN
ajlm-741	92	55	.	.	PUNCT
ajlm-741	93	1	in	in	ADP
ajlm-741	93	2	2016	2016	NUM
ajlm-741	93	3	,	,	PUNCT
ajlm-741	93	4	klebsiella	klebsiella	NOUN
ajlm-741	93	5	pneumoniae	pneumoniae	ADJ
ajlm-741	93	6	isolates	isolate	NOUN
ajlm-741	93	7	demonstrated	demonstrate	VERB
ajlm-741	93	8	65	65	NUM
ajlm-741	93	9	%	%	NOUN
ajlm-741	93	10	susceptibility	susceptibility	NOUN
ajlm-741	93	11	to	to	PART
ajlm-741	93	12	cefepime	cefepime	VERB
ajlm-741	93	13	,	,	PUNCT
ajlm-741	93	14	44	44	NUM
ajlm-741	93	15	%	%	NOUN
ajlm-741	93	16	to	to	ADP
ajlm-741	93	17	piperacillin	piperacillin	NOUN
ajlm-741	93	18	-	-	PUNCT
ajlm-741	93	19	tazobactam	tazobactam	NOUN
ajlm-741	93	20	and	and	CCONJ
ajlm-741	93	21	41	41	NUM
ajlm-741	93	22	%	%	NOUN
ajlm-741	93	23	to	to	ADP
ajlm-741	93	24	gentamicin	gentamicin	NOUN
ajlm-741	93	25	,	,	PUNCT
ajlm-741	93	26	while	while	SCONJ
ajlm-741	93	27	less	less	ADJ
ajlm-741	93	28	than	than	ADP
ajlm-741	93	29	30	30	NUM
ajlm-741	93	30	%	%	NOUN
ajlm-741	93	31	of	of	ADP
ajlm-741	93	32	escherichia	escherichia	NOUN
ajlm-741	93	33	coli	coli	NOUN
ajlm-741	93	34	isolates	isolate	NOUN
ajlm-741	93	35	were	be	AUX
ajlm-741	93	36	non	non	ADJ
ajlm-741	93	37	-	-	ADJ
ajlm-741	93	38	susceptible	susceptible	ADJ
ajlm-741	93	39	to	to	ADP
ajlm-741	93	40	cephalosporins	cephalosporin	NOUN
ajlm-741	93	41	.	.	PUNCT
ajlm-741	94	1	for	for	ADP
ajlm-741	94	2	the	the	DET
ajlm-741	94	3	non	non	ADJ
ajlm-741	94	4	-	-	ADJ
ajlm-741	94	5	fermentative	fermentative	ADJ
ajlm-741	94	6	gram	gram	NOUN
ajlm-741	94	7	-	-	PUNCT
ajlm-741	94	8	negative	negative	ADJ
ajlm-741	94	9	bacteria	bacteria	NOUN
ajlm-741	94	10	,	,	PUNCT
ajlm-741	94	11	more	more	ADJ
ajlm-741	94	12	than	than	ADP
ajlm-741	94	13	80	80	NUM
ajlm-741	94	14	%	%	NOUN
ajlm-741	94	15	of	of	ADP
ajlm-741	94	16	acinetobacter	acinetobacter	ADJ
ajlm-741	94	17	baumannii	baumannii	ADJ
ajlm-741	94	18	isolates	isolate	NOUN
ajlm-741	94	19	were	be	AUX
ajlm-741	94	20	non	non	ADJ
ajlm-741	94	21	-	-	ADJ
ajlm-741	94	22	susceptible	susceptible	ADJ
ajlm-741	94	23	to	to	ADP
ajlm-741	94	24	carbapenems	carbapenem	NOUN
ajlm-741	94	25	,	,	PUNCT
ajlm-741	94	26	while	while	SCONJ
ajlm-741	94	27	80	80	NUM
ajlm-741	94	28	%	%	NOUN
ajlm-741	94	29	and	and	CCONJ
ajlm-741	94	30	75	75	NUM
ajlm-741	94	31	%	%	NOUN
ajlm-741	94	32	of	of	ADP
ajlm-741	94	33	pseudomonas	pseudomona	NOUN
ajlm-741	94	34	aeruginosa	aeruginosa	NOUN
ajlm-741	94	35	isolates	isolate	NOUN
ajlm-741	94	36	were	be	AUX
ajlm-741	94	37	susceptible	susceptible	ADJ
ajlm-741	94	38	to	to	ADP
ajlm-741	94	39	cephalosporins	cephalosporin	NOUN
ajlm-741	94	40	and	and	CCONJ
ajlm-741	94	41	carbepenems	carbepenem	NOUN
ajlm-741	94	42	respectively	respectively	ADV
ajlm-741	94	43	.	.	PUNCT
ajlm-741	95	1	for	for	ADP
ajlm-741	95	2	the	the	DET
ajlm-741	95	3	gram	gram	NOUN
ajlm-741	95	4	-	-	PUNCT
ajlm-741	95	5	positive	positive	ADJ
ajlm-741	95	6	bacteria	bacteria	NOUN
ajlm-741	95	7	,	,	PUNCT
ajlm-741	95	8	more	more	ADJ
ajlm-741	95	9	than	than	ADP
ajlm-741	95	10	99	99	NUM
ajlm-741	95	11	%	%	NOUN
ajlm-741	95	12	of	of	ADP
ajlm-741	95	13	enterococcus	enterococcus	NOUN
ajlm-741	95	14	faecalis	faecali	NOUN
ajlm-741	95	15	and	and	CCONJ
ajlm-741	95	16	enterococcus	enterococcus	NOUN
ajlm-741	95	17	faecium	faecium	NOUN
ajlm-741	95	18	isolates	isolate	NOUN
ajlm-741	95	19	demonstrated	demonstrate	VERB
ajlm-741	95	20	susceptibility	susceptibility	NOUN
ajlm-741	95	21	to	to	ADP
ajlm-741	95	22	oxazolidinones	oxazolidinone	NOUN
ajlm-741	95	23	and	and	CCONJ
ajlm-741	95	24	1	1	NUM
ajlm-741	95	25	%	%	NOUN
ajlm-741	95	26	and	and	CCONJ
ajlm-741	95	27	5	5	NUM
ajlm-741	95	28	%	%	NOUN
ajlm-741	95	29	of	of	ADP
ajlm-741	95	30	e.	e.	PROPN
ajlm-741	95	31	faecalis	faecalis	PROPN
ajlm-741	95	32	and	and	CCONJ
ajlm-741	95	33	e.	e.	PROPN
ajlm-741	95	34	faecium	faecium	PROPN
ajlm-741	95	35	isolates	isolate	NOUN
ajlm-741	95	36	demonstrated	demonstrate	VERB
ajlm-741	95	37	susceptibility	susceptibility	NOUN
ajlm-741	95	38	to	to	PART
ajlm-741	95	39	glycopeptides	glycopeptide	VERB
ajlm-741	95	40	respectively	respectively	ADV
ajlm-741	95	41	.	.	PUNCT
ajlm-741	96	1	staphylococcus	staphylococcus	NOUN
ajlm-741	96	2	aureus	aureus	PROPN
ajlm-741	96	3	isolates	isolate	NOUN
ajlm-741	96	4	demonstrated	demonstrate	VERB
ajlm-741	96	5	higher	high	ADJ
ajlm-741	96	6	susceptibility	susceptibility	NOUN
ajlm-741	96	7	to	to	ADP
ajlm-741	96	8	cloxacillin	cloxacillin	NOUN
ajlm-741	96	9	,	,	PUNCT
ajlm-741	96	10	from	from	ADP
ajlm-741	96	11	65	65	NUM
ajlm-741	96	12	%	%	NOUN
ajlm-741	96	13	in	in	ADP
ajlm-741	96	14	2015	2015	NUM
ajlm-741	96	15	to	to	PART
ajlm-741	96	16	69	69	NUM
ajlm-741	96	17	%	%	NOUN
ajlm-741	96	18	in	in	ADP
ajlm-741	96	19	2016	2016	NUM
ajlm-741	96	20	(	(	PUNCT
ajlm-741	96	21	unpublished	unpublished	ADJ
ajlm-741	96	22	data	datum	NOUN
ajlm-741	96	23	)	)	PUNCT
ajlm-741	96	24	.	.	PUNCT
ajlm-741	97	1	the	the	DET
ajlm-741	97	2	findings	finding	NOUN
ajlm-741	97	3	from	from	ADP
ajlm-741	97	4	these	these	DET
ajlm-741	97	5	studies	study	NOUN
ajlm-741	97	6	and	and	CCONJ
ajlm-741	97	7	other	other	ADJ
ajlm-741	97	8	ongoing	ongoing	ADJ
ajlm-741	97	9	studies	study	NOUN
ajlm-741	97	10	which	which	PRON
ajlm-741	97	11	have	have	AUX
ajlm-741	97	12	not	not	PART
ajlm-741	97	13	as	as	ADV
ajlm-741	97	14	yet	yet	ADV
ajlm-741	97	15	been	be	AUX
ajlm-741	97	16	published	publish	VERB
ajlm-741	97	17	show	show	VERB
ajlm-741	97	18	that	that	SCONJ
ajlm-741	97	19	south	south	ADJ
ajlm-741	97	20	african	african	ADJ
ajlm-741	97	21	data	datum	NOUN
ajlm-741	97	22	is	be	AUX
ajlm-741	97	23	being	be	AUX
ajlm-741	97	24	generated	generate	VERB
ajlm-741	97	25	from	from	ADP
ajlm-741	97	26	the	the	DET
ajlm-741	97	27	expanding	expand	VERB
ajlm-741	97	28	surveillance	surveillance	NOUN
ajlm-741	97	29	programme	programme	NOUN
ajlm-741	97	30	in	in	ADP
ajlm-741	97	31	the	the	DET
ajlm-741	97	32	hope	hope	NOUN
ajlm-741	97	33	of	of	ADP
ajlm-741	97	34	elucidating	elucidate	VERB
ajlm-741	97	35	the	the	DET
ajlm-741	97	36	situation	situation	NOUN
ajlm-741	97	37	of	of	ADP
ajlm-741	97	38	antimicrobial	antimicrobial	ADJ
ajlm-741	97	39	resistance	resistance	NOUN
ajlm-741	97	40	in	in	ADP
ajlm-741	97	41	healthcare	healthcare	NOUN
ajlm-741	97	42	-	-	PUNCT
ajlm-741	97	43	associated	associate	VERB
ajlm-741	97	44	pathogens	pathogen	NOUN
ajlm-741	97	45	in	in	ADP
ajlm-741	97	46	south	south	PROPN
ajlm-741	97	47	africa	africa	PROPN
ajlm-741	97	48	.	.	PUNCT
ajlm-741	98	1	conclusion	conclusion	NOUN
ajlm-741	98	2	antimicrobial	antimicrobial	ADJ
ajlm-741	98	3	resistance	resistance	NOUN
ajlm-741	98	4	surveillance	surveillance	NOUN
ajlm-741	98	5	in	in	ADP
ajlm-741	98	6	healthcare	healthcare	NOUN
ajlm-741	98	7	-	-	PUNCT
ajlm-741	98	8	associated	associate	VERB
ajlm-741	98	9	settings	setting	NOUN
ajlm-741	98	10	,	,	PUNCT
ajlm-741	98	11	e.g.	e.g.	ADV
ajlm-741	98	12	hospitals	hospital	NOUN
ajlm-741	98	13	,	,	PUNCT
ajlm-741	98	14	long	long	ADJ
ajlm-741	98	15	-	-	PUNCT
ajlm-741	98	16	term	term	NOUN
ajlm-741	98	17	care	care	NOUN
ajlm-741	98	18	facilities	facility	NOUN
ajlm-741	98	19	,	,	PUNCT
ajlm-741	98	20	dialysis	dialysis	NOUN
ajlm-741	98	21	clinics	clinic	NOUN
ajlm-741	98	22	,	,	PUNCT
ajlm-741	98	23	etc	etc	X
ajlm-741	98	24	.	.	X
ajlm-741	98	25	,	,	PUNCT
ajlm-741	98	26	is	be	AUX
ajlm-741	98	27	essential	essential	ADJ
ajlm-741	98	28	in	in	ADP
ajlm-741	98	29	order	order	NOUN
ajlm-741	98	30	to	to	PART
ajlm-741	98	31	gain	gain	VERB
ajlm-741	98	32	an	an	DET
ajlm-741	98	33	understanding	understanding	NOUN
ajlm-741	98	34	of	of	ADP
ajlm-741	98	35	the	the	DET
ajlm-741	98	36	prevalent	prevalent	ADJ
ajlm-741	98	37	healthcare	healthcare	PROPN
ajlm-741	98	38	-	-	PUNCT
ajlm-741	98	39	associated	associate	VERB
ajlm-741	98	40	pathogens	pathogen	NOUN
ajlm-741	98	41	such	such	ADJ
ajlm-741	98	42	as	as	ADP
ajlm-741	98	43	the	the	DET
ajlm-741	98	44	eskape	eskape	NOUN
ajlm-741	98	45	organisms	organism	NOUN
ajlm-741	98	46	,	,	PUNCT
ajlm-741	98	47	the	the	DET
ajlm-741	98	48	antimicrobial	antimicrobial	ADJ
ajlm-741	98	49	resistance	resistance	NOUN
ajlm-741	98	50	patterns	pattern	NOUN
ajlm-741	98	51	of	of	ADP
ajlm-741	98	52	critical	critical	ADJ
ajlm-741	98	53	organisms	organism	NOUN
ajlm-741	98	54	and	and	CCONJ
ajlm-741	98	55	their	their	PRON
ajlm-741	98	56	mechanisms	mechanism	NOUN
ajlm-741	98	57	of	of	ADP
ajlm-741	98	58	resistance	resistance	NOUN
ajlm-741	98	59	.	.	PUNCT
ajlm-741	99	1	national	national	PROPN
ajlm-741	99	2	laboratory	laboratory	PROPN
ajlm-741	99	3	systems	system	NOUN
ajlm-741	99	4	should	should	AUX
ajlm-741	99	5	support	support	VERB
ajlm-741	99	6	the	the	DET
ajlm-741	99	7	surveillance	surveillance	NOUN
ajlm-741	99	8	for	for	ADP
ajlm-741	99	9	antimicrobial	antimicrobial	ADJ
ajlm-741	99	10	resistance	resistance	NOUN
ajlm-741	99	11	and	and	CCONJ
ajlm-741	99	12	implement	implement	VERB
ajlm-741	99	13	standardised	standardised	ADJ
ajlm-741	99	14	practices	practice	NOUN
ajlm-741	99	15	,	,	PUNCT
ajlm-741	99	16	manuals	manual	NOUN
ajlm-741	99	17	and	and	CCONJ
ajlm-741	99	18	quality	quality	NOUN
ajlm-741	99	19	systems	system	NOUN
ajlm-741	99	20	.	.	PUNCT
ajlm-741	100	1	in	in	ADP
ajlm-741	100	2	addition	addition	NOUN
ajlm-741	100	3	,	,	PUNCT
ajlm-741	100	4	this	this	DET
ajlm-741	100	5	information	information	NOUN
ajlm-741	100	6	will	will	AUX
ajlm-741	100	7	assist	assist	VERB
ajlm-741	100	8	in	in	ADP
ajlm-741	100	9	the	the	DET
ajlm-741	100	10	development	development	NOUN
ajlm-741	100	11	of	of	ADP
ajlm-741	100	12	national	national	ADJ
ajlm-741	100	13	treatment	treatment	NOUN
ajlm-741	100	14	guidelines	guideline	NOUN
ajlm-741	100	15	,	,	PUNCT
ajlm-741	100	16	inform	inform	VERB
ajlm-741	100	17	policies	policy	NOUN
ajlm-741	100	18	and	and	CCONJ
ajlm-741	100	19	strategies	strategy	NOUN
ajlm-741	100	20	for	for	ADP
ajlm-741	100	21	antimicrobial	antimicrobial	ADJ
ajlm-741	100	22	stewardship	stewardship	NOUN
ajlm-741	100	23	programmes	programme	NOUN
ajlm-741	100	24	and	and	CCONJ
ajlm-741	100	25	infection	infection	NOUN
ajlm-741	100	26	prevention	prevention	NOUN
ajlm-741	100	27	and	and	CCONJ
ajlm-741	100	28	control	control	NOUN
ajlm-741	100	29	.	.	PUNCT
ajlm-741	101	1	due	due	ADP
ajlm-741	101	2	to	to	ADP
ajlm-741	101	3	the	the	DET
ajlm-741	101	4	lack	lack	NOUN
ajlm-741	101	5	of	of	ADP
ajlm-741	101	6	reliable	reliable	ADJ
ajlm-741	101	7	and	and	CCONJ
ajlm-741	101	8	accurate	accurate	ADJ
ajlm-741	101	9	information	information	NOUN
ajlm-741	101	10	in	in	ADP
ajlm-741	101	11	african	african	ADJ
ajlm-741	101	12	countries	country	NOUN
ajlm-741	101	13	,	,	PUNCT
ajlm-741	101	14	there	there	PRON
ajlm-741	101	15	is	be	VERB
ajlm-741	101	16	an	an	DET
ajlm-741	101	17	urgent	urgent	ADJ
ajlm-741	101	18	need	need	NOUN
ajlm-741	101	19	for	for	ADP
ajlm-741	101	20	the	the	DET
ajlm-741	101	21	implementation	implementation	NOUN
ajlm-741	101	22	of	of	ADP
ajlm-741	101	23	standardised	standardised	ADJ
ajlm-741	101	24	surveillance	surveillance	NOUN
ajlm-741	101	25	programmes	programme	NOUN
ajlm-741	101	26	.	.	PUNCT
ajlm-741	102	1	acknowledgements	acknowledgement	NOUN
ajlm-741	102	2	competing	compete	VERB
ajlm-741	102	3	interests	interest	NOUN
ajlm-741	102	4	the	the	DET
ajlm-741	102	5	authors	author	NOUN
ajlm-741	102	6	declare	declare	VERB
ajlm-741	102	7	that	that	SCONJ
ajlm-741	102	8	they	they	PRON
ajlm-741	102	9	have	have	VERB
ajlm-741	102	10	no	no	DET
ajlm-741	102	11	financial	financial	ADJ
ajlm-741	102	12	or	or	CCONJ
ajlm-741	102	13	personal	personal	ADJ
ajlm-741	102	14	relationships	relationship	NOUN
ajlm-741	102	15	which	which	PRON
ajlm-741	102	16	may	may	AUX
ajlm-741	102	17	have	have	AUX
ajlm-741	102	18	inappropriately	inappropriately	ADV
ajlm-741	102	19	influenced	influence	VERB
ajlm-741	102	20	them	they	PRON
ajlm-741	102	21	in	in	ADP
ajlm-741	102	22	writing	write	VERB
ajlm-741	102	23	this	this	DET
ajlm-741	102	24	article	article	NOUN
ajlm-741	102	25	.	.	PUNCT
ajlm-741	103	1	sources	source	NOUN
ajlm-741	103	2	of	of	ADP
ajlm-741	103	3	support	support	NOUN
ajlm-741	103	4	none	none	NOUN
ajlm-741	103	5	.	.	PUNCT
ajlm-741	104	1	authors	author	NOUN
ajlm-741	104	2	’	'	PUNCT
ajlm-741	104	3	contributions	contribution	NOUN
ajlm-741	104	4	a.s.-m	a.s.-m	PROPN
ajlm-741	104	5	.	.	PUNCT
ajlm-741	104	6	conceptualised	conceptualise	VERB
ajlm-741	104	7	and	and	CCONJ
ajlm-741	104	8	wrote	write	VERB
ajlm-741	104	9	the	the	DET
ajlm-741	104	10	review	review	NOUN
ajlm-741	104	11	manuscript	manuscript	NOUN
ajlm-741	104	12	.	.	PUNCT
ajlm-741	105	1	h.i	h.i	PROPN
ajlm-741	105	2	.	.	PROPN
ajlm-741	105	3	wrote	write	VERB
ajlm-741	105	4	and	and	CCONJ
ajlm-741	105	5	edited	edit	VERB
ajlm-741	105	6	the	the	DET
ajlm-741	105	7	manuscript	manuscript	NOUN
ajlm-741	105	8	.	.	PUNCT
ajlm-741	106	1	o.p	o.p	PROPN
ajlm-741	106	2	.	.	PROPN
ajlm-741	106	3	was	be	AUX
ajlm-741	106	4	instrumental	instrumental	ADJ
ajlm-741	106	5	in	in	ADP
ajlm-741	106	6	coordination	coordination	NOUN
ajlm-741	106	7	and	and	CCONJ
ajlm-741	106	8	editing	editing	NOUN
ajlm-741	106	9	of	of	ADP
ajlm-741	106	10	the	the	DET
ajlm-741	106	11	manuscript	manuscript	NOUN
ajlm-741	106	12	.	.	PUNCT
ajlm-741	107	1	references	reference	NOUN
ajlm-741	107	2	sonmezer	sonmezer	PROPN
ajlm-741	107	3	mc	mc	PROPN
ajlm-741	107	4	,	,	PUNCT
ajlm-741	107	5	ertem	ertem	NOUN
ajlm-741	107	6	g	g	NOUN
ajlm-741	107	7	,	,	PUNCT
ajlm-741	107	8	erdinc	erdinc	VERB
ajlm-741	107	9	fs	fs	PROPN
ajlm-741	107	10	,	,	PUNCT
ajlm-741	107	11	et	et	PROPN
ajlm-741	107	12	al	al	PROPN
ajlm-741	107	13	.	.	PUNCT
ajlm-741	107	14	evaluation	evaluation	NOUN
ajlm-741	107	15	of	of	ADP
ajlm-741	107	16	risk	risk	NOUN
ajlm-741	107	17	factors	factor	NOUN
ajlm-741	107	18	for	for	ADP
ajlm-741	107	19	antibiotic	antibiotic	ADJ
ajlm-741	107	20	resistance	resistance	NOUN
ajlm-741	107	21	in	in	ADP
ajlm-741	107	22	patients	patient	NOUN
ajlm-741	107	23	with	with	ADP
ajlm-741	107	24	nosocomial	nosocomial	ADJ
ajlm-741	107	25	infections	infection	NOUN
ajlm-741	107	26	caused	cause	VERB
ajlm-741	107	27	by	by	ADP
ajlm-741	107	28	pseudomonas	pseudomona	NOUN
ajlm-741	107	29	aeruginosa	aeruginosa	NOUN
ajlm-741	107	30	.	.	PUNCT
ajlm-741	108	1	can	can	AUX
ajlm-741	108	2	j	j	PROPN
ajlm-741	108	3	infect	infect	VERB
ajlm-741	108	4	dis	dis	PROPN
ajlm-741	108	5	med	med	PROPN
ajlm-741	108	6	microbiol	microbiol	PROPN
ajlm-741	108	7	.	.	PUNCT
ajlm-741	109	1	2016;2016:1321487	2016;2016:1321487	NUM
ajlm-741	109	2	.	.	PUNCT
ajlm-741	110	1	brink	brink	PROPN
ajlm-741	110	2	a	a	PROPN
ajlm-741	110	3	,	,	PUNCT
ajlm-741	110	4	feldman	feldman	PROPN
ajlm-741	110	5	c	c	PROPN
ajlm-741	110	6	,	,	PUNCT
ajlm-741	110	7	duse	duse	PROPN
ajlm-741	110	8	a	a	PRON
ajlm-741	110	9	,	,	PUNCT
ajlm-741	110	10	et	et	PROPN
ajlm-741	110	11	al	al	PROPN
ajlm-741	110	12	.	.	PROPN
ajlm-741	110	13	guideline	guideline	NOUN
ajlm-741	110	14	for	for	ADP
ajlm-741	110	15	the	the	DET
ajlm-741	110	16	management	management	NOUN
ajlm-741	110	17	of	of	ADP
ajlm-741	110	18	nosocomial	nosocomial	ADJ
ajlm-741	110	19	infections	infection	NOUN
ajlm-741	110	20	in	in	ADP
ajlm-741	110	21	south	south	PROPN
ajlm-741	110	22	africa	africa	PROPN
ajlm-741	110	23	.	.	PUNCT
ajlm-741	111	1	s	s	PROPN
ajlm-741	111	2	afr	afr	PROPN
ajlm-741	111	3	med	med	PROPN
ajlm-741	111	4	j.	j.	PROPN
ajlm-741	111	5	2006;96(7	2006;96(7	PROPN
ajlm-741	111	6	pt	pt	PROPN
ajlm-741	111	7	2):642–652	2):642–652	NUM
ajlm-741	111	8	.	.	PUNCT
ajlm-741	112	1	https://doi.org/10.1080/10158782.2006.11441269	https://doi.org/10.1080/10158782.2006.11441269	PROPN
ajlm-741	112	2	cui	cui	PROPN
ajlm-741	112	3	d	d	PROPN
ajlm-741	112	4	,	,	PUNCT
ajlm-741	112	5	liu	liu	PROPN
ajlm-741	112	6	x	x	PROPN
ajlm-741	112	7	,	,	PUNCT
ajlm-741	112	8	hawkey	hawkey	VERB
ajlm-741	112	9	p	p	NOUN
ajlm-741	112	10	,	,	PUNCT
ajlm-741	112	11	et	et	PROPN
ajlm-741	112	12	al	al	PROPN
ajlm-741	112	13	.	.	PUNCT
ajlm-741	112	14	use	use	NOUN
ajlm-741	112	15	of	of	ADP
ajlm-741	112	16	and	and	CCONJ
ajlm-741	112	17	microbial	microbial	ADJ
ajlm-741	112	18	resistance	resistance	NOUN
ajlm-741	112	19	to	to	ADP
ajlm-741	112	20	antibiotics	antibiotic	NOUN
ajlm-741	112	21	in	in	ADP
ajlm-741	112	22	china	china	PROPN
ajlm-741	112	23	:	:	PUNCT
ajlm-741	112	24	a	a	DET
ajlm-741	112	25	path	path	NOUN
ajlm-741	112	26	to	to	ADP
ajlm-741	112	27	reducing	reduce	VERB
ajlm-741	112	28	antimcobial	antimcobial	ADJ
ajlm-741	112	29	resistance	resistance	NOUN
ajlm-741	112	30	.	.	PUNCT
ajlm-741	113	1	j	j	PROPN
ajlm-741	113	2	int	int	PROPN
ajlm-741	113	3	med	med	PROPN
ajlm-741	113	4	res	re	NOUN
ajlm-741	113	5	.	.	PUNCT
ajlm-741	114	1	2017;0(0):1–11	2017;0(0):1–11	NUM
ajlm-741	114	2	.	.	PUNCT
ajlm-741	115	1	https://doi.org/10.1177/0300060516686230	https://doi.org/10.1177/0300060516686230	NUM
ajlm-741	115	2	world	world	PROPN
ajlm-741	115	3	health	health	NOUN
ajlm-741	115	4	organization	organization	NOUN
ajlm-741	115	5	(	(	PUNCT
ajlm-741	115	6	who	who	PRON
ajlm-741	115	7	)	)	PUNCT
ajlm-741	115	8	.	.	PUNCT
ajlm-741	116	1	antimicrobial	antimicrobial	ADJ
ajlm-741	116	2	resistance	resistance	NOUN
ajlm-741	116	3	:	:	PUNCT
ajlm-741	116	4	global	global	ADJ
ajlm-741	116	5	report	report	NOUN
ajlm-741	116	6	on	on	ADP
ajlm-741	116	7	surveillance	surveillance	NOUN
ajlm-741	116	8	.	.	PUNCT
ajlm-741	117	1	france	france	PROPN
ajlm-741	117	2	:	:	PUNCT
ajlm-741	117	3	world	world	PROPN
ajlm-741	117	4	health	health	PROPN
ajlm-741	117	5	organization	organization	NOUN
ajlm-741	117	6	;	;	PUNCT
ajlm-741	117	7	2014	2014	NUM
ajlm-741	117	8	.	.	PUNCT
ajlm-741	118	1	centres	centre	NOUN
ajlm-741	118	2	for	for	ADP
ajlm-741	118	3	disease	disease	NOUN
ajlm-741	118	4	control	control	NOUN
ajlm-741	118	5	and	and	CCONJ
ajlm-741	118	6	prevention	prevention	NOUN
ajlm-741	118	7	(	(	PUNCT
ajlm-741	118	8	cdc	cdc	PROPN
ajlm-741	118	9	)	)	PUNCT
ajlm-741	118	10	.	.	PUNCT
ajlm-741	119	1	morbidity	morbidity	NOUN
ajlm-741	119	2	and	and	CCONJ
ajlm-741	119	3	mortality	mortality	NOUN
ajlm-741	119	4	weekly	weekly	ADJ
ajlm-741	119	5	report	report	NOUN
ajlm-741	119	6	,	,	PUNCT
ajlm-741	119	7	cdc	cdc	PROPN
ajlm-741	119	8	’s	’s	PART
ajlm-741	119	9	vision	vision	NOUN
ajlm-741	119	10	for	for	ADP
ajlm-741	119	11	public	public	ADJ
ajlm-741	119	12	health	health	NOUN
ajlm-741	119	13	surveillance	surveillance	NOUN
ajlm-741	119	14	in	in	ADP
ajlm-741	119	15	the	the	DET
ajlm-741	119	16	21st	21st	ADJ
ajlm-741	119	17	century	century	NOUN
ajlm-741	119	18	.	.	PUNCT
ajlm-741	120	1	atlanta	atlanta	PROPN
ajlm-741	120	2	:	:	PUNCT
ajlm-741	120	3	centres	centre	NOUN
ajlm-741	120	4	for	for	ADP
ajlm-741	120	5	disease	disease	NOUN
ajlm-741	120	6	control	control	NOUN
ajlm-741	120	7	and	and	CCONJ
ajlm-741	120	8	prevention	prevention	NOUN
ajlm-741	120	9	;	;	PUNCT
ajlm-741	120	10	2012	2012	NUM
ajlm-741	120	11	.	.	PUNCT
ajlm-741	121	1	khan	khan	PROPN
ajlm-741	121	2	ha	ha	INTJ
ajlm-741	121	3	,	,	PUNCT
ajlm-741	121	4	ahmad	ahmad	PROPN
ajlm-741	121	5	a	a	PRON
ajlm-741	121	6	,	,	PUNCT
ajlm-741	121	7	mehboob	mehboob	PROPN
ajlm-741	121	8	r.	r.	PROPN
ajlm-741	121	9	nosocomial	nosocomial	ADJ
ajlm-741	121	10	infections	infection	NOUN
ajlm-741	121	11	and	and	CCONJ
ajlm-741	121	12	their	their	PRON
ajlm-741	121	13	control	control	NOUN
ajlm-741	121	14	strategies	strategy	NOUN
ajlm-741	121	15	.	.	PUNCT
ajlm-741	122	1	asian	asian	PROPN
ajlm-741	122	2	pac	pac	PROPN
ajlm-741	122	3	j	j	PROPN
ajlm-741	122	4	trop	trop	X
ajlm-741	122	5	biomed	biome	VERB
ajlm-741	122	6	.	.	PUNCT
ajlm-741	123	1	2015;5(7):509–514	2015;5(7):509–514	X
ajlm-741	123	2	.	.	X
ajlm-741	123	3	https://doi.org/10.1016/j.apjtb.2015.05.001	https://doi.org/10.1016/j.apjtb.2015.05.001	PROPN
ajlm-741	123	4	duse	duse	NOUN
ajlm-741	123	5	a.	a.	NOUN
ajlm-741	123	6	infection	infection	NOUN
ajlm-741	123	7	control	control	NOUN
ajlm-741	123	8	in	in	ADP
ajlm-741	123	9	developing	develop	VERB
ajlm-741	123	10	countries	country	NOUN
ajlm-741	123	11	with	with	ADP
ajlm-741	123	12	particular	particular	ADJ
ajlm-741	123	13	emphasis	emphasis	NOUN
ajlm-741	123	14	on	on	ADP
ajlm-741	123	15	south	south	PROPN
ajlm-741	123	16	africa	africa	PROPN
ajlm-741	123	17	.	.	PUNCT
ajlm-741	124	1	south	south	PROPN
ajlm-741	124	2	afr	afr	PROPN
ajlm-741	124	3	j	j	PROPN
ajlm-741	124	4	epidemiol	epidemiol	PROPN
ajlm-741	124	5	infect	infect	PROPN
ajlm-741	124	6	.	.	PUNCT
ajlm-741	125	1	2005;20(2):37–41	2005;20(2):37–41	X
ajlm-741	125	2	.	.	PUNCT
ajlm-741	126	1	https://doi.org/10.1080/10158782.2005.11441230	https://doi.org/10.1080/10158782.2005.11441230	X
ajlm-741	127	1	rothe	rothe	PROPN
ajlm-741	127	2	c	c	PROPN
ajlm-741	127	3	,	,	PUNCT
ajlm-741	127	4	schlaich	schlaich	PROPN
ajlm-741	127	5	c	c	X
ajlm-741	127	6	,	,	PUNCT
ajlm-741	127	7	thompson	thompson	PROPN
ajlm-741	127	8	s.	s.	PROPN
ajlm-741	127	9	healthcare	healthcare	PROPN
ajlm-741	127	10	-	-	PUNCT
ajlm-741	127	11	associated	associate	VERB
ajlm-741	127	12	infections	infection	NOUN
ajlm-741	127	13	in	in	ADP
ajlm-741	127	14	sub	sub	ADJ
ajlm-741	127	15	-	-	ADJ
ajlm-741	127	16	saharan	saharan	ADJ
ajlm-741	127	17	africa	africa	PROPN
ajlm-741	127	18	.	.	PUNCT
ajlm-741	128	1	j	j	PROPN
ajlm-741	128	2	hosp	hosp	PROPN
ajlm-741	128	3	infect	infect	PROPN
ajlm-741	128	4	.	.	PUNCT
ajlm-741	129	1	2013;85(4):257–267	2013;85(4):257–267	X
ajlm-741	129	2	.	.	PUNCT
ajlm-741	130	1	https://doi.org/10.1016/j.jhin.2013.09.008	https://doi.org/10.1016/j.jhin.2013.09.008	PROPN
ajlm-741	130	2	leopold	leopold	PROPN
ajlm-741	130	3	sj	sj	PROPN
ajlm-741	130	4	,	,	PUNCT
ajlm-741	130	5	van	van	PROPN
ajlm-741	130	6	leth	leth	PROPN
ajlm-741	130	7	f	f	PROPN
ajlm-741	130	8	,	,	PUNCT
ajlm-741	130	9	tarekegn	tarekegn	NOUN
ajlm-741	130	10	h	h	NOUN
ajlm-741	130	11	,	,	PUNCT
ajlm-741	130	12	schultsz	schultsz	PROPN
ajlm-741	130	13	c.	c.	PROPN
ajlm-741	130	14	antimicrobial	antimicrobial	ADJ
ajlm-741	130	15	drug	drug	NOUN
ajlm-741	130	16	resistance	resistance	NOUN
ajlm-741	130	17	among	among	ADP
ajlm-741	130	18	clinically	clinically	ADV
ajlm-741	130	19	relevant	relevant	ADJ
ajlm-741	130	20	bacterial	bacterial	ADJ
ajlm-741	130	21	isolates	isolate	NOUN
ajlm-741	130	22	in	in	ADP
ajlm-741	130	23	sub	sub	ADJ
ajlm-741	130	24	-	-	ADJ
ajlm-741	130	25	saharan	saharan	ADJ
ajlm-741	130	26	africa	africa	PROPN
ajlm-741	130	27	:	:	PUNCT
ajlm-741	130	28	a	a	DET
ajlm-741	130	29	systematic	systematic	ADJ
ajlm-741	130	30	review	review	NOUN
ajlm-741	130	31	.	.	PUNCT
ajlm-741	131	1	j	j	PROPN
ajlm-741	131	2	antimicrob	antimicrob	PROPN
ajlm-741	131	3	chemother	chemother	PROPN
ajlm-741	131	4	.	.	PUNCT
ajlm-741	132	1	2014;69:2337–2353	2014;69:2337–2353	NUM
ajlm-741	132	2	.	.	PUNCT
ajlm-741	133	1	https://doi.org/10.1093/jac/dku176	https://doi.org/10.1093/jac/dku176	PROPN
ajlm-741	133	2	federation	federation	PROPN
ajlm-741	133	3	of	of	ADP
ajlm-741	133	4	infectious	infectious	ADJ
ajlm-741	133	5	diseases	disease	NOUN
ajlm-741	133	6	societies	society	NOUN
ajlm-741	133	7	of	of	ADP
ajlm-741	133	8	south	south	PROPN
ajlm-741	133	9	africa	africa	PROPN
ajlm-741	133	10	:	:	PUNCT
ajlm-741	133	11	surveillance	surveillance	NOUN
ajlm-741	133	12	data	datum	NOUN
ajlm-741	134	1	[	[	X
ajlm-741	134	2	about	about	ADP
ajlm-741	134	3	fidssa	fidssa	NOUN
ajlm-741	134	4	]	]	X
ajlm-741	134	5	c2018	c2018	NOUN
ajlm-741	134	6	.	.	PUNCT
ajlm-741	135	1	[	[	X
ajlm-741	135	2	cited	cite	VERB
ajlm-741	135	3	2018	2018	NUM
ajlm-741	135	4	oct	oct	NOUN
ajlm-741	135	5	3	3	NUM
ajlm-741	135	6	]	]	PUNCT
ajlm-741	135	7	.	.	PUNCT
ajlm-741	136	1	available	available	ADJ
ajlm-741	136	2	from	from	ADP
ajlm-741	136	3	:	:	PUNCT
ajlm-741	136	4	http://www.fidssa.co.za/about/surveillance	http://www.fidssa.co.za/about/surveillance	PROPN
ajlm-741	136	5	federation	federation	NOUN
ajlm-741	136	6	of	of	ADP
ajlm-741	136	7	infectious	infectious	ADJ
ajlm-741	136	8	diseases	disease	NOUN
ajlm-741	136	9	societies	society	NOUN
ajlm-741	136	10	of	of	ADP
ajlm-741	136	11	south	south	PROPN
ajlm-741	136	12	africa	africa	PROPN
ajlm-741	136	13	:	:	PUNCT
ajlm-741	137	1	sascm	sascm	VERB
ajlm-741	137	2	public	public	ADJ
ajlm-741	137	3	sector	sector	NOUN
ajlm-741	137	4	report	report	NOUN
ajlm-741	137	5	.	.	PUNCT
ajlm-741	138	1	c2015	c2015	PROPN
ajlm-741	138	2	.	.	PUNCT
ajlm-741	139	1	[	[	X
ajlm-741	139	2	cited	cite	VERB
ajlm-741	139	3	2018	2018	NUM
ajlm-741	139	4	oct	oct	NOUN
ajlm-741	139	5	3	3	NUM
ajlm-741	139	6	]	]	PUNCT
ajlm-741	139	7	.	.	PUNCT
ajlm-741	140	1	available	available	ADJ
ajlm-741	140	2	from	from	ADP
ajlm-741	140	3	:	:	PUNCT
ajlm-741	140	4	http://www.fidssa.co.za/content/images/2015_sascm_public_sector_reportfinal.pdf	http://www.fidssa.co.za/content/images/2015_sascm_public_sector_reportfinal.pdf	PROPN
ajlm-741	140	5	.	.	PUNCT
ajlm-741	141	1	federation	federation	NOUN
ajlm-741	141	2	of	of	ADP
ajlm-741	141	3	infectious	infectious	ADJ
ajlm-741	141	4	diseases	disease	NOUN
ajlm-741	141	5	societies	society	NOUN
ajlm-741	141	6	of	of	ADP
ajlm-741	141	7	south	south	PROPN
ajlm-741	141	8	africa	africa	PROPN
ajlm-741	141	9	:	:	PUNCT
ajlm-741	142	1	sascm	sascm	PROPN
ajlm-741	142	2	private	private	ADJ
ajlm-741	142	3	sector	sector	NOUN
ajlm-741	142	4	report	report	NOUN
ajlm-741	142	5	.	.	PUNCT
ajlm-741	143	1	c2013	c2013	NOUN
ajlm-741	143	2	.	.	PUNCT
ajlm-741	144	1	[	[	X
ajlm-741	144	2	cited	cite	VERB
ajlm-741	144	3	2018	2018	NUM
ajlm-741	144	4	oct	oct	NOUN
ajlm-741	144	5	3	3	NUM
ajlm-741	144	6	]	]	PUNCT
ajlm-741	144	7	.	.	PUNCT
ajlm-741	145	1	available	available	ADJ
ajlm-741	145	2	from	from	ADP
ajlm-741	145	3	:	:	PUNCT
ajlm-741	145	4	http://www.fidssa.co.za/content/documents/surveillance_data_pirvate_sector_jan_dec_2013.pdf	http://www.fidssa.co.za/content/documents/surveillance_data_pirvate_sector_jan_dec_2013.pdf	PROPN
ajlm-741	145	5	national	national	PROPN
ajlm-741	145	6	department	department	PROPN
ajlm-741	145	7	of	of	ADP
ajlm-741	145	8	health	health	PROPN
ajlm-741	145	9	(	(	PUNCT
ajlm-741	145	10	ndoh	ndoh	PROPN
ajlm-741	145	11	)	)	PUNCT
ajlm-741	145	12	,	,	PUNCT
ajlm-741	145	13	south	south	PROPN
ajlm-741	145	14	africa	africa	PROPN
ajlm-741	145	15	.	.	PUNCT
ajlm-741	146	1	antimicrobial	antimicrobial	ADJ
ajlm-741	146	2	resistance	resistance	NOUN
ajlm-741	146	3	background	background	NOUN
ajlm-741	146	4	document	document	NOUN
ajlm-741	146	5	.	.	PUNCT
ajlm-741	147	1	south	south	PROPN
ajlm-741	147	2	africa	africa	PROPN
ajlm-741	147	3	:	:	PUNCT
ajlm-741	147	4	ndoh	ndoh	PROPN
ajlm-741	147	5	;	;	PUNCT
ajlm-741	147	6	2016	2016	NUM
ajlm-741	147	7	.	.	PUNCT
ajlm-741	148	1	national	national	PROPN
ajlm-741	148	2	institute	institute	PROPN
ajlm-741	148	3	for	for	ADP
ajlm-741	148	4	communicable	communicable	NOUN
ajlm-741	148	5	diseases	disease	NOUN
ajlm-741	148	6	:	:	PUNCT
ajlm-741	148	7	antimicrobial	antimicrobial	ADJ
ajlm-741	148	8	resistance	resistance	NOUN
ajlm-741	148	9	c2016	c2016	PROPN
ajlm-741	149	1	[	[	X
ajlm-741	149	2	updated	update	VERB
ajlm-741	149	3	2016	2016	NUM
ajlm-741	149	4	sept	sept	NOUN
ajlm-741	149	5	]	]	X
ajlm-741	150	1	[	[	X
ajlm-741	150	2	cited	cite	VERB
ajlm-741	150	3	2018	2018	NUM
ajlm-741	150	4	oct	oct	NOUN
ajlm-741	150	5	3	3	NUM
ajlm-741	150	6	]	]	PUNCT
ajlm-741	150	7	.	.	PUNCT
ajlm-741	151	1	available	available	ADJ
ajlm-741	151	2	from	from	ADP
ajlm-741	151	3	:	:	PUNCT
ajlm-741	151	4	http://www.nicd.ac.za/index.php/httpscdwmicrostrategy-nhls-ac-zamicrostrategyaspmain-aspxservernhlssandmicsi03projectnhlsbiport0evt2048001srcmain-aspx-2048001documentid10c27d0e4b424b217efdc086730cd76dcurrentvie/	http://www.nicd.ac.za/index.php/httpscdwmicrostrategy-nhls-ac-zamicrostrategyaspmain-aspxservernhlssandmicsi03projectnhlsbiport0evt2048001srcmain-aspx-2048001documentid10c27d0e4b424b217efdc086730cd76dcurrentvie/	PROPN
ajlm-741	151	5	european	european	ADJ
ajlm-741	151	6	antimicrobial	antimicrobial	ADJ
ajlm-741	151	7	resistance	resistance	NOUN
ajlm-741	151	8	surveillance	surveillance	NOUN
ajlm-741	151	9	system	system	NOUN
ajlm-741	151	10	(	(	PUNCT
ajlm-741	151	11	earss	earss	ADJ
ajlm-741	151	12	)	)	PUNCT
ajlm-741	151	13	.	.	PUNCT
ajlm-741	152	1	quarterly	quarterly	ADJ
ajlm-741	152	2	surveillance	surveillance	NOUN
ajlm-741	152	3	report	report	NOUN
ajlm-741	152	4	1999	1999	NUM
ajlm-741	152	5	.	.	PUNCT
ajlm-741	153	1	solna	solna	PROPN
ajlm-741	153	2	,	,	PUNCT
ajlm-741	153	3	sweden	sweden	PROPN
ajlm-741	153	4	:	:	PUNCT
ajlm-741	153	5	ecdc	ecdc	NOUN
ajlm-741	153	6	;	;	PUNCT
ajlm-741	153	7	1999	1999	NUM
ajlm-741	153	8	.	.	PUNCT
ajlm-741	154	1	european	european	ADJ
ajlm-741	154	2	antimicrobial	antimicrobial	ADJ
ajlm-741	154	3	resistance	resistance	NOUN
ajlm-741	154	4	surveillance	surveillance	NOUN
ajlm-741	154	5	system	system	NOUN
ajlm-741	154	6	(	(	PUNCT
ajlm-741	154	7	earss	earss	ADJ
ajlm-741	154	8	)	)	PUNCT
ajlm-741	154	9	.	.	PUNCT
ajlm-741	155	1	quarterly	quarterly	ADJ
ajlm-741	155	2	report	report	NOUN
ajlm-741	155	3	2015	2015	NUM
ajlm-741	155	4	.	.	PUNCT
ajlm-741	156	1	solna	solna	PROPN
ajlm-741	156	2	,	,	PUNCT
ajlm-741	156	3	sweden	sweden	PROPN
ajlm-741	156	4	:	:	PUNCT
ajlm-741	156	5	ecdc	ecdc	NOUN
ajlm-741	156	6	;	;	PUNCT
ajlm-741	156	7	2016	2016	NUM
ajlm-741	156	8	.	.	PUNCT
ajlm-741	157	1	world	world	PROPN
ajlm-741	157	2	health	health	PROPN
ajlm-741	157	3	organization	organization	NOUN
ajlm-741	157	4	(	(	PUNCT
ajlm-741	157	5	who	who	PRON
ajlm-741	157	6	)	)	PUNCT
ajlm-741	157	7	.	.	PUNCT
ajlm-741	158	1	global	global	ADJ
ajlm-741	158	2	antimicrobial	antimicrobial	ADJ
ajlm-741	158	3	resistance	resistance	NOUN
ajlm-741	158	4	surveillance	surveillance	NOUN
ajlm-741	158	5	system	system	NOUN
ajlm-741	158	6	:	:	PUNCT
ajlm-741	158	7	manual	manual	NOUN
ajlm-741	158	8	for	for	ADP
ajlm-741	158	9	early	early	ADJ
ajlm-741	158	10	implementation	implementation	NOUN
ajlm-741	158	11	.	.	PUNCT
ajlm-741	159	1	geneva	geneva	PROPN
ajlm-741	159	2	,	,	PUNCT
ajlm-741	159	3	switzerland	switzerland	PROPN
ajlm-741	159	4	:	:	PUNCT
ajlm-741	159	5	world	world	PROPN
ajlm-741	159	6	health	health	PROPN
ajlm-741	159	7	organization	organization	NOUN
ajlm-741	159	8	;	;	PUNCT
ajlm-741	159	9	2015	2015	NUM
ajlm-741	159	10	.	.	PUNCT
ajlm-741	160	1	flemming	flemming	PROPN
ajlm-741	160	2	fund	fund	PROPN
ajlm-741	160	3	.	.	PUNCT
ajlm-741	161	1	amr	amr	ADJ
ajlm-741	161	2	surveillance	surveillance	NOUN
ajlm-741	161	3	in	in	ADP
ajlm-741	161	4	lowand	lowand	ADJ
ajlm-741	161	5	middle	middle	ADJ
ajlm-741	161	6	-	-	PUNCT
ajlm-741	161	7	income	income	NOUN
ajlm-741	161	8	settings	setting	NOUN
ajlm-741	161	9	:	:	PUNCT
ajlm-741	161	10	a	a	DET
ajlm-741	161	11	roadmap	roadmap	NOUN
ajlm-741	161	12	for	for	ADP
ajlm-741	161	13	participation	participation	NOUN
ajlm-741	161	14	in	in	ADP
ajlm-741	161	15	the	the	DET
ajlm-741	161	16	global	global	ADJ
ajlm-741	161	17	antimicrobial	antimicrobial	ADJ
ajlm-741	161	18	surveillance	surveillance	NOUN
ajlm-741	161	19	system	system	NOUN
ajlm-741	161	20	(	(	PUNCT
ajlm-741	161	21	glass	glass	NOUN
ajlm-741	161	22	)	)	PUNCT
ajlm-741	161	23	.	.	PUNCT
ajlm-741	162	1	uk	uk	PROPN
ajlm-741	162	2	:	:	PUNCT
ajlm-741	162	3	flemming	flemming	NOUN
ajlm-741	162	4	fund	fund	PROPN
ajlm-741	162	5	;	;	PUNCT
ajlm-741	162	6	2016	2016	NUM
ajlm-741	162	7	.	.	PUNCT
ajlm-741	163	1	african	african	ADJ
ajlm-741	163	2	society	society	NOUN
ajlm-741	163	3	for	for	ADP
ajlm-741	163	4	laboratory	laboratory	NOUN
ajlm-741	163	5	medicine	medicine	NOUN
ajlm-741	163	6	:	:	PUNCT
ajlm-741	163	7	press	press	NOUN
ajlm-741	163	8	release	release	NOUN
ajlm-741	164	1	[	[	X
ajlm-741	164	2	cited	cite	VERB
ajlm-741	164	3	2018	2018	NUM
ajlm-741	164	4	oct	oct	NOUN
ajlm-741	164	5	3	3	NUM
ajlm-741	164	6	]	]	PUNCT
ajlm-741	164	7	.	.	PUNCT
ajlm-741	165	1	available	available	ADJ
ajlm-741	165	2	from	from	ADP
ajlm-741	165	3	:	:	PUNCT
ajlm-741	165	4	http://www.aslm.org/stay-informed/press-room/news-articles/combatting-drug-resistance-in-africa/	http://www.aslm.org/stay-informed/press-room/news-articles/combatting-drug-resistance-in-africa/	VERB
ajlm-741	165	5	perovic	perovic	ADJ
ajlm-741	165	6	o	o	NOUN
ajlm-741	165	7	,	,	PUNCT
ajlm-741	165	8	schultsz	schultsz	PROPN
ajlm-741	165	9	c.	c.	PROPN
ajlm-741	165	10	stepwaise	stepwaise	PROPN
ajlm-741	165	11	approach	approach	NOUN
ajlm-741	165	12	for	for	ADP
ajlm-741	165	13	implementation	implementation	NOUN
ajlm-741	165	14	of	of	ADP
ajlm-741	165	15	antimicrobial	antimicrobial	ADJ
ajlm-741	165	16	resistance	resistance	NOUN
ajlm-741	165	17	surveillance	surveillance	NOUN
ajlm-741	165	18	in	in	ADP
ajlm-741	165	19	africa	africa	PROPN
ajlm-741	165	20	.	.	PUNCT
ajlm-741	166	1	afr	afr	PROPN
ajlm-741	166	2	j	j	PROPN
ajlm-741	166	3	lab	lab	PROPN
ajlm-741	166	4	med	med	PROPN
ajlm-741	166	5	.	.	PUNCT
ajlm-741	166	6	2016;5(3	2016;5(3	NUM
ajlm-741	166	7	)	)	PUNCT
ajlm-741	166	8	.	.	PUNCT
ajlm-741	167	1	https://doi.org/10.4102/ajlm.v5i3.482	https://doi.org/10.4102/ajlm.v5i3.482	PROPN
ajlm-741	167	2	frean	frean	PROPN
ajlm-741	167	3	j	j	PROPN
ajlm-741	167	4	,	,	PUNCT
ajlm-741	167	5	perovic	perovic	ADJ
ajlm-741	167	6	o	o	NOUN
ajlm-741	167	7	,	,	PUNCT
ajlm-741	167	8	fensham	fensham	PROPN
ajlm-741	167	9	v	v	PROPN
ajlm-741	167	10	,	,	PUNCT
ajlm-741	167	11	et	et	PROPN
ajlm-741	167	12	al	al	PROPN
ajlm-741	167	13	.	.	PUNCT
ajlm-741	167	14	external	external	ADJ
ajlm-741	167	15	quality	quality	NOUN
ajlm-741	167	16	assessment	assessment	NOUN
ajlm-741	167	17	of	of	ADP
ajlm-741	167	18	national	national	ADJ
ajlm-741	167	19	public	public	ADJ
ajlm-741	167	20	health	health	NOUN
ajlm-741	167	21	laboratories	laboratory	NOUN
ajlm-741	167	22	in	in	ADP
ajlm-741	167	23	africa	africa	PROPN
ajlm-741	167	24	,	,	PUNCT
ajlm-741	167	25	2002	2002	NUM
ajlm-741	167	26	-	-	SYM
ajlm-741	167	27	2009	2009	NUM
ajlm-741	167	28	.	.	PUNCT
ajlm-741	168	1	bull	bull	PROPN
ajlm-741	168	2	world	world	PROPN
ajlm-741	168	3	health	health	NOUN
ajlm-741	168	4	organ	organ	NOUN
ajlm-741	168	5	.	.	PUNCT
ajlm-741	169	1	2012;90(3):191a–199a	2012;90(3):191a–199a	NUM
ajlm-741	169	2	.	.	PUNCT
ajlm-741	169	3	https://doi.org/10.2471/blt.11.091876	https://doi.org/10.2471/blt.11.091876	VERB
ajlm-741	169	4	world	world	NOUN
ajlm-741	169	5	health	health	NOUN
ajlm-741	169	6	organization	organization	NOUN
ajlm-741	169	7	(	(	PUNCT
ajlm-741	169	8	who	who	PRON
ajlm-741	169	9	)	)	PUNCT
ajlm-741	169	10	.	.	PUNCT
ajlm-741	170	1	call	call	VERB
ajlm-741	170	2	for	for	ADP
ajlm-741	170	3	participation	participation	NOUN
ajlm-741	170	4	:	:	PUNCT
ajlm-741	170	5	global	global	ADJ
ajlm-741	170	6	antimicrobial	antimicrobial	ADJ
ajlm-741	170	7	resistance	resistance	NOUN
ajlm-741	170	8	surveillance	surveillance	NOUN
ajlm-741	170	9	system	system	NOUN
ajlm-741	170	10	(	(	PUNCT
ajlm-741	170	11	glass	glass	NOUN
ajlm-741	170	12	)	)	PUNCT
ajlm-741	171	1	[	[	X
ajlm-741	171	2	homepage	homepage	NOUN
ajlm-741	171	3	on	on	ADP
ajlm-741	171	4	the	the	DET
ajlm-741	171	5	internet	internet	NOUN
ajlm-741	171	6	]	]	PUNCT
ajlm-741	171	7	.	.	PUNCT
ajlm-741	172	1	2015	2015	NUM
ajlm-741	172	2	.	.	PUNCT
ajlm-741	173	1	available	available	ADJ
ajlm-741	173	2	from	from	ADP
ajlm-741	173	3	:	:	PUNCT
ajlm-741	173	4	http://www.who.int/drugresistance/surveillance/glass-enrolment/en/	http://www.who.int/drugresistance/surveillance/glass-enrolment/en/	NOUN
ajlm-741	173	5	ampaire	ampaire	NOUN
ajlm-741	173	6	l	l	NOUN
ajlm-741	173	7	,	,	PUNCT
ajlm-741	173	8	muhindo	muhindo	NOUN
ajlm-741	173	9	a	a	NOUN
ajlm-741	173	10	,	,	PUNCT
ajlm-741	173	11	orikiriza	orikiriza	NOUN
ajlm-741	173	12	p	p	X
ajlm-741	173	13	,	,	PUNCT
ajlm-741	173	14	mwanga	mwanga	ADV
ajlm-741	173	15	-	-	PUNCT
ajlm-741	173	16	amumpaire	amumpaire	NOUN
ajlm-741	173	17	j	j	PROPN
ajlm-741	173	18	,	,	PUNCT
ajlm-741	173	19	belbell	belbell	PROPN
ajlm-741	173	20	l	l	PROPN
ajlm-741	173	21	,	,	PUNCT
ajlm-741	173	22	boum	boum	PROPN
ajlm-741	173	23	y.	y.	AUX
ajlm-741	173	24	a	a	DET
ajlm-741	173	25	review	review	NOUN
ajlm-741	173	26	of	of	ADP
ajlm-741	173	27	antimicrobial	antimicrobial	ADJ
ajlm-741	173	28	resistance	resistance	NOUN
ajlm-741	173	29	in	in	ADP
ajlm-741	173	30	east	east	PROPN
ajlm-741	173	31	africa	africa	PROPN
ajlm-741	173	32	.	.	PUNCT
ajlm-741	174	1	afr	afr	PROPN
ajlm-741	174	2	j	j	PROPN
ajlm-741	174	3	lab	lab	PROPN
ajlm-741	174	4	med	med	PROPN
ajlm-741	174	5	.	.	PROPN
ajlm-741	174	6	2016;5(1	2016;5(1	NUM
ajlm-741	174	7	)	)	PUNCT
ajlm-741	174	8	.	.	PUNCT
ajlm-741	175	1	https://doi.org/10.4102/ajlm.v5i1.432	https://doi.org/10.4102/ajlm.v5i1.432	NOUN
ajlm-741	175	2	mwanyika	mwanyika	X
ajlm-741	175	3	go	go	VERB
ajlm-741	175	4	,	,	PUNCT
ajlm-741	175	5	subbiah	subbiah	PROPN
ajlm-741	175	6	m	m	PROPN
ajlm-741	175	7	,	,	PUNCT
ajlm-741	175	8	buza	buza	PROPN
ajlm-741	175	9	j	j	PROPN
ajlm-741	175	10	,	,	PUNCT
ajlm-741	175	11	rugumisa	rugumisa	VERB
ajlm-741	175	12	bt	bt	NOUN
ajlm-741	175	13	,	,	PUNCT
ajlm-741	175	14	call	call	PROPN
ajlm-741	175	15	dr	dr	PROPN
ajlm-741	175	16	.	.	PROPN
ajlm-741	176	1	a	a	DET
ajlm-741	176	2	systematic	systematic	ADJ
ajlm-741	176	3	review	review	NOUN
ajlm-741	176	4	of	of	ADP
ajlm-741	176	5	antibiotic	antibiotic	ADJ
ajlm-741	176	6	-	-	PUNCT
ajlm-741	176	7	resistant	resistant	ADJ
ajlm-741	176	8	escherichia	escherichia	NOUN
ajlm-741	176	9	coli	coli	NOUN
ajlm-741	176	10	and	and	CCONJ
ajlm-741	176	11	salmonella	salmonella	NOUN
ajlm-741	176	12	data	datum	NOUN
ajlm-741	176	13	obtained	obtain	VERB
ajlm-741	176	14	from	from	ADP
ajlm-741	176	15	tanzanian	tanzanian	ADJ
ajlm-741	176	16	healthcare	healthcare	PROPN
ajlm-741	176	17	settings	setting	NOUN
ajlm-741	176	18	(	(	PUNCT
ajlm-741	176	19	2004	2004	NUM
ajlm-741	176	20	-	-	SYM
ajlm-741	176	21	2014	2014	NUM
ajlm-741	176	22	)	)	PUNCT
ajlm-741	176	23	.	.	PUNCT
ajlm-741	177	1	afr	afr	PROPN
ajlm-741	177	2	j	j	PROPN
ajlm-741	177	3	microbiol	microbiol	PROPN
ajlm-741	177	4	res	re	NOUN
ajlm-741	177	5	.	.	PUNCT
ajlm-741	178	1	2017;11(2):45–54	2017;11(2):45–54	NUM
ajlm-741	178	2	.	.	PUNCT
ajlm-741	179	1	https://doi.org/10.5897/ajmr2016.8282	https://doi.org/10.5897/ajmr2016.8282	PROPN
ajlm-741	179	2	crowther	crowther	PROPN
ajlm-741	179	3	-	-	PROPN
ajlm-741	179	4	gibson	gibson	PROPN
ajlm-741	179	5	p	p	PROPN
ajlm-741	179	6	,	,	PUNCT
ajlm-741	179	7	govender	govender	NOUN
ajlm-741	179	8	n	n	CCONJ
ajlm-741	179	9	,	,	PUNCT
ajlm-741	179	10	lewis	lewis	PROPN
ajlm-741	179	11	da	da	PROPN
ajlm-741	179	12	,	,	PUNCT
ajlm-741	179	13	et	et	PROPN
ajlm-741	179	14	al	al	PROPN
ajlm-741	179	15	.	.	PUNCT
ajlm-741	180	1	human	human	ADJ
ajlm-741	180	2	infections	infection	NOUN
ajlm-741	180	3	and	and	CCONJ
ajlm-741	180	4	antibiotic	antibiotic	ADJ
ajlm-741	180	5	resistance	resistance	NOUN
ajlm-741	180	6	.	.	PUNCT
ajlm-741	181	1	samj	samj	NOUN
ajlm-741	181	2	.	.	PUNCT
ajlm-741	182	1	2011;101(8	2011;101(8	NUM
ajlm-741	182	2	)	)	PUNCT
ajlm-741	182	3	.	.	PUNCT
ajlm-741	183	1	perovic	perovic	ADJ
ajlm-741	183	2	o	o	NOUN
ajlm-741	183	3	,	,	PUNCT
ajlm-741	183	4	britz	britz	PROPN
ajlm-741	183	5	e	e	PROPN
ajlm-741	183	6	,	,	PUNCT
ajlm-741	183	7	chetty	chetty	VERB
ajlm-741	183	8	v	v	NOUN
ajlm-741	183	9	,	,	PUNCT
ajlm-741	183	10	singh	singh	ADJ
ajlm-741	183	11	-	-	PUNCT
ajlm-741	183	12	moodley	moodley	NOUN
ajlm-741	183	13	a.	a.	NOUN
ajlm-741	183	14	molecular	molecular	ADJ
ajlm-741	183	15	detection	detection	NOUN
ajlm-741	183	16	of	of	ADP
ajlm-741	183	17	carbapenemase	carbapenemase	NOUN
ajlm-741	183	18	-	-	PUNCT
ajlm-741	183	19	producing	produce	VERB
ajlm-741	183	20	genes	gene	NOUN
ajlm-741	183	21	in	in	ADP
ajlm-741	183	22	referral	referral	ADJ
ajlm-741	183	23	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-741	183	24	in	in	ADP
ajlm-741	183	25	south	south	PROPN
ajlm-741	183	26	africa	africa	PROPN
ajlm-741	183	27	:	:	PUNCT
ajlm-741	183	28	a	a	DET
ajlm-741	183	29	short	short	ADJ
ajlm-741	183	30	report	report	NOUN
ajlm-741	183	31	.	.	PUNCT
ajlm-741	184	1	s	s	PROPN
ajlm-741	184	2	afr	afr	PROPN
ajlm-741	184	3	med	med	PROPN
ajlm-741	184	4	j.	j.	PROPN
ajlm-741	184	5	2016;106(10):975–977	2016;106(10):975–977	PROPN
ajlm-741	184	6	.	.	PUNCT
ajlm-741	185	1	https://doi.org/10.7196/samj.2016.v106i10.11300	https://doi.org/10.7196/samj.2016.v106i10.11300	PROPN
ajlm-741	185	2	perovic	perovic	ADJ
ajlm-741	185	3	o	o	NOUN
ajlm-741	185	4	,	,	PUNCT
ajlm-741	185	5	iyaloo	iyaloo	PROPN
ajlm-741	185	6	s	s	PROPN
ajlm-741	185	7	,	,	PUNCT
ajlm-741	185	8	kularatne	kularatne	PROPN
ajlm-741	185	9	r	r	NOUN
ajlm-741	185	10	,	,	PUNCT
ajlm-741	185	11	et	et	PROPN
ajlm-741	185	12	al	al	PROPN
ajlm-741	185	13	.	.	PUNCT
ajlm-741	186	1	prevalence	prevalence	NOUN
ajlm-741	186	2	and	and	CCONJ
ajlm-741	186	3	trends	trend	NOUN
ajlm-741	186	4	of	of	ADP
ajlm-741	186	5	staphylococcus	staphylococcus	NOUN
ajlm-741	186	6	aureus	aureus	NOUN
ajlm-741	186	7	bacteraemia	bacteraemia	NOUN
ajlm-741	186	8	in	in	ADP
ajlm-741	186	9	hospitalized	hospitalize	VERB
ajlm-741	186	10	patients	patient	NOUN
ajlm-741	186	11	in	in	ADP
ajlm-741	186	12	south	south	PROPN
ajlm-741	186	13	africa	africa	PROPN
ajlm-741	186	14	,	,	PUNCT
ajlm-741	186	15	2010	2010	NUM
ajlm-741	186	16	to	to	ADP
ajlm-741	186	17	2012	2012	NUM
ajlm-741	186	18	:	:	PUNCT
ajlm-741	186	19	laboratory	laboratory	NOUN
ajlm-741	186	20	-	-	PUNCT
ajlm-741	186	21	based	base	VERB
ajlm-741	186	22	surveillance	surveillance	NOUN
ajlm-741	186	23	mapping	mapping	NOUN
ajlm-741	186	24	of	of	ADP
ajlm-741	186	25	antimicrobial	antimicrobial	ADJ
ajlm-741	186	26	resistance	resistance	NOUN
ajlm-741	186	27	and	and	CCONJ
ajlm-741	186	28	molecular	molecular	ADJ
ajlm-741	186	29	epidemiology	epidemiology	NOUN
ajlm-741	186	30	.	.	PUNCT
ajlm-741	187	1	plos	plos	PROPN
ajlm-741	187	2	one	one	NUM
ajlm-741	187	3	.	.	PUNCT
ajlm-741	188	1	2015;10(12	2015;10(12	NUM
ajlm-741	188	2	)	)	PUNCT
ajlm-741	188	3	.	.	PUNCT
ajlm-741	189	1	https://doi.org/10.1371/journal.pone.0145429	https://doi.org/10.1371/journal.pone.0145429	PROPN
ajlm-741	189	2	perovic	perovic	ADJ
ajlm-741	189	3	o	o	NOUN
ajlm-741	189	4	,	,	PUNCT
ajlm-741	189	5	koornhof	koornhof	PROPN
ajlm-741	189	6	h	h	PROPN
ajlm-741	189	7	,	,	PUNCT
ajlm-741	189	8	black	black	ADJ
ajlm-741	189	9	v	v	NOUN
ajlm-741	189	10	,	,	PUNCT
ajlm-741	189	11	moodley	moodley	PROPN
ajlm-741	189	12	i	i	PROPN
ajlm-741	189	13	,	,	PUNCT
ajlm-741	189	14	duse	duse	PROPN
ajlm-741	189	15	a	a	DET
ajlm-741	189	16	,	,	PUNCT
ajlm-741	189	17	galpin	galpin	PROPN
ajlm-741	189	18	j.	j.	PROPN
ajlm-741	189	19	staphylococcus	staphylococcus	PROPN
ajlm-741	189	20	aureus	aureus	PROPN
ajlm-741	189	21	bacteraemia	bacteraemia	NOUN
ajlm-741	189	22	at	at	ADP
ajlm-741	189	23	two	two	NUM
ajlm-741	189	24	academic	academic	ADJ
ajlm-741	189	25	hospitals	hospital	NOUN
ajlm-741	189	26	in	in	ADP
ajlm-741	189	27	johannesburg	johannesburg	PROPN
ajlm-741	189	28	.	.	PUNCT
ajlm-741	190	1	s	s	PROPN
ajlm-741	190	2	afr	afr	PROPN
ajlm-741	190	3	med	med	PROPN
ajlm-741	190	4	j.	j.	PROPN
ajlm-741	190	5	2006;96(8):714–717	2006;96(8):714–717	PROPN
ajlm-741	190	6	.	.	PUNCT
ajlm-741	191	1	perovic	perovic	ADJ
ajlm-741	191	2	o	o	NOUN
ajlm-741	191	3	,	,	PUNCT
ajlm-741	191	4	koornhof	koornhof	PROPN
ajlm-741	191	5	hj	hj	PROPN
ajlm-741	191	6	,	,	PUNCT
ajlm-741	191	7	crewe	crewe	PROPN
ajlm-741	191	8	-	-	PUNCT
ajlm-741	191	9	brown	brown	PROPN
ajlm-741	191	10	hh	hh	PROPN
ajlm-741	191	11	,	,	PUNCT
ajlm-741	191	12	duse	duse	PROPN
ajlm-741	191	13	ag	ag	PROPN
ajlm-741	191	14	,	,	PUNCT
ajlm-741	191	15	van	van	PROPN
ajlm-741	191	16	nierop	nierop	PROPN
ajlm-741	191	17	w	w	PROPN
ajlm-741	191	18	,	,	PUNCT
ajlm-741	191	19	galpin	galpin	NOUN
ajlm-741	191	20	js	js	PROPN
ajlm-741	191	21	.	.	PUNCT
ajlm-741	192	1	pseudomonas	pseudomonas	PROPN
ajlm-741	192	2	aeruginosa	aeruginosa	PROPN
ajlm-741	192	3	bacteraemia	bacteraemia	NOUN
ajlm-741	192	4	in	in	ADP
ajlm-741	192	5	an	an	DET
ajlm-741	192	6	academic	academic	ADJ
ajlm-741	192	7	hospital	hospital	NOUN
ajlm-741	192	8	in	in	ADP
ajlm-741	192	9	south	south	PROPN
ajlm-741	192	10	africa	africa	PROPN
ajlm-741	192	11	.	.	PUNCT
ajlm-741	193	1	s	s	PROPN
ajlm-741	193	2	afr	afr	PROPN
ajlm-741	193	3	med	med	PROPN
ajlm-741	193	4	j.	j.	PROPN
ajlm-741	193	5	2008;98(8):626–632	2008;98(8):626–632	PROPN
ajlm-741	193	6	.	.	PUNCT
ajlm-741	193	7	perovic	perovic	ADJ
ajlm-741	193	8	o	o	NOUN
ajlm-741	193	9	,	,	PUNCT
ajlm-741	193	10	singh	singh	ADJ
ajlm-741	193	11	-	-	PUNCT
ajlm-741	193	12	moodley	moodley	NOUN
ajlm-741	193	13	a	a	NOUN
ajlm-741	193	14	,	,	PUNCT
ajlm-741	193	15	duse	duse	PROPN
ajlm-741	193	16	a	a	PRON
ajlm-741	193	17	,	,	PUNCT
ajlm-741	193	18	et	et	PROPN
ajlm-741	193	19	al	al	PROPN
ajlm-741	193	20	.	.	PUNCT
ajlm-741	193	21	national	national	ADJ
ajlm-741	193	22	sentinel	sentinel	PROPN
ajlm-741	193	23	site	site	NOUN
ajlm-741	193	24	surveillance	surveillance	NOUN
ajlm-741	193	25	for	for	ADP
ajlm-741	193	26	antimicrobial	antimicrobial	ADJ
ajlm-741	193	27	resistance	resistance	NOUN
ajlm-741	193	28	in	in	ADP
ajlm-741	193	29	klebsiella	klebsiella	NOUN
ajlm-741	193	30	pneumoniae	pneumoniae	ADJ
ajlm-741	193	31	isolates	isolate	NOUN
ajlm-741	193	32	in	in	ADP
ajlm-741	193	33	south	south	PROPN
ajlm-741	193	34	africa	africa	PROPN
ajlm-741	193	35	,	,	PUNCT
ajlm-741	193	36	2010–2012	2010–2012	NUM
ajlm-741	193	37	.	.	PUNCT
ajlm-741	194	1	s	s	PROPN
ajlm-741	194	2	afr	afr	PROPN
ajlm-741	194	3	med	med	PROPN
ajlm-741	194	4	j.	j.	PROPN
ajlm-741	194	5	2014;104(8):563–568	2014;104(8):563–568	PROPN
ajlm-741	194	6	.	.	PUNCT
ajlm-741	195	1	https://doi.org/10.7196/samj.7617	https://doi.org/10.7196/samj.7617	NOUN
ajlm-741	195	2	singh	singh	ADJ
ajlm-741	195	3	-	-	PUNCT
ajlm-741	195	4	moodley	moodley	NOUN
ajlm-741	195	5	a	a	NOUN
ajlm-741	195	6	,	,	PUNCT
ajlm-741	195	7	ekermans	ekerman	NOUN
ajlm-741	195	8	p	p	NOUN
ajlm-741	195	9	,	,	PUNCT
ajlm-741	195	10	perovic	perovic	ADJ
ajlm-741	195	11	o.	o.	NOUN
ajlm-741	195	12	emerging	emerge	VERB
ajlm-741	195	13	carbapenem	carbapenem	NOUN
ajlm-741	195	14	-	-	PUNCT
ajlm-741	195	15	resistant	resistant	ADJ
ajlm-741	195	16	enterobacter	enterobacter	ADJ
ajlm-741	195	17	cloacae	cloacae	NOUN
ajlm-741	195	18	producing	produce	VERB
ajlm-741	195	19	oxa-48-	oxa-48-	PROPN
ajlm-741	195	20	,	,	PUNCT
ajlm-741	195	21	vimand	vimand	NOUN
ajlm-741	195	22	imp	imp	ADJ
ajlm-741	195	23	-	-	PUNCT
ajlm-741	195	24	type	type	NOUN
ajlm-741	195	25	-	-	PUNCT
ajlm-741	195	26	β	β	NOUN
ajlm-741	195	27	-	-	NOUN
ajlm-741	195	28	lactamases	lactamase	NOUN
ajlm-741	195	29	in	in	ADP
ajlm-741	195	30	eastern	eastern	ADJ
ajlm-741	195	31	cape	cape	NOUN
ajlm-741	195	32	hospitals	hospital	NOUN
ajlm-741	195	33	in	in	ADP
ajlm-741	195	34	south	south	PROPN
ajlm-741	195	35	africa	africa	PROPN
ajlm-741	195	36	.	.	PUNCT
ajlm-741	196	1	open	open	PROPN
ajlm-741	196	2	j	j	PROPN
ajlm-741	196	3	med	med	PROPN
ajlm-741	196	4	microbiol	microbiol	PROPN
ajlm-741	196	5	.	.	PUNCT
ajlm-741	197	1	2015;5:246–253	2015;5:246–253	NUM
ajlm-741	197	2	.	.	PUNCT
ajlm-741	198	1	https://doi.org/10.4236/ojmm.2015.54030	https://doi.org/10.4236/ojmm.2015.54030	PROPN
ajlm-741	198	2	singh	singh	PROPN
ajlm-741	198	3	-	-	PUNCT
ajlm-741	198	4	moodley	moodley	NOUN
ajlm-741	198	5	a	a	NOUN
ajlm-741	198	6	,	,	PUNCT
ajlm-741	198	7	perovic	perovic	ADJ
ajlm-741	198	8	o.	o.	NOUN
ajlm-741	198	9	antimicrobial	antimicrobial	ADJ
ajlm-741	198	10	susceptibility	susceptibility	NOUN
ajlm-741	198	11	testing	testing	NOUN
ajlm-741	198	12	in	in	ADP
ajlm-741	198	13	predicting	predict	VERB
ajlm-741	198	14	the	the	DET
ajlm-741	198	15	presence	presence	NOUN
ajlm-741	198	16	of	of	ADP
ajlm-741	198	17	carbapenemase	carbapenemase	NOUN
ajlm-741	198	18	genes	gene	NOUN
ajlm-741	198	19	in	in	ADP
ajlm-741	198	20	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-741	198	21	in	in	ADP
ajlm-741	198	22	south	south	PROPN
ajlm-741	198	23	africa	africa	PROPN
ajlm-741	198	24	.	.	PUNCT
ajlm-741	199	1	bmc	bmc	PROPN
ajlm-741	199	2	infect	infect	PROPN
ajlm-741	199	3	dis	dis	PROPN
ajlm-741	199	4	.	.	PUNCT
ajlm-741	200	1	2016;16(536	2016;16(536	PROPN
ajlm-741	200	2	)	)	PUNCT
ajlm-741	200	3	.	.	PUNCT
ajlm-741	201	1	https://doi.org/10.1186/s12879-016-1858-7	https://doi.org/10.1186/s12879-016-1858-7	PROPN
ajlm-741	202	1	bell	bell	PROPN
ajlm-741	202	2	j	j	PROPN
ajlm-741	202	3	,	,	PUNCT
ajlm-741	202	4	turnidge	turnidge	PROPN
ajlm-741	202	5	j.	j.	PROPN
ajlm-741	202	6	sentry	sentry	PROPN
ajlm-741	202	7	antimicrobial	antimicrobial	ADJ
ajlm-741	202	8	surveillance	surveillance	NOUN
ajlm-741	202	9	program	program	NOUN
ajlm-741	202	10	asia	asia	PROPN
ajlm-741	202	11	-	-	PUNCT
ajlm-741	202	12	pacific	pacific	PROPN
ajlm-741	202	13	region	region	NOUN
ajlm-741	202	14	and	and	CCONJ
ajlm-741	202	15	south	south	PROPN
ajlm-741	202	16	africa	africa	PROPN
ajlm-741	202	17	.	.	PUNCT
ajlm-741	203	1	commun	commun	PROPN
ajlm-741	203	2	dis	dis	PROPN
ajlm-741	203	3	intell	intell	PROPN
ajlm-741	203	4	q	q	PROPN
ajlm-741	203	5	rep	rep	PROPN
ajlm-741	203	6	.	.	PROPN
ajlm-741	203	7	2003;27	2003;27	NUM
ajlm-741	203	8	suppl	suppl	ADJ
ajlm-741	203	9	:	:	PUNCT
ajlm-741	203	10	s61	s61	ADJ
ajlm-741	203	11	–	–	PUNCT
ajlm-741	203	12	s66	s66	NOUN
ajlm-741	203	13	.	.	PUNCT
ajlm-741	204	1	bell	bell	PROPN
ajlm-741	204	2	jm	jm	PROPN
ajlm-741	204	3	,	,	PUNCT
ajlm-741	204	4	turnidge	turnidge	PROPN
ajlm-741	204	5	jd	jd	PROPN
ajlm-741	204	6	,	,	PUNCT
ajlm-741	204	7	gales	gales	PROPN
ajlm-741	204	8	ac	ac	PROPN
ajlm-741	204	9	,	,	PUNCT
ajlm-741	204	10	pfaller	pfaller	PROPN
ajlm-741	204	11	ma	ma	PROPN
ajlm-741	204	12	,	,	PUNCT
ajlm-741	204	13	jones	jones	PROPN
ajlm-741	204	14	rn	rn	PROPN
ajlm-741	204	15	,	,	PUNCT
ajlm-741	204	16	sentry	sentry	PROPN
ajlm-741	204	17	asg	asg	PROPN
ajlm-741	204	18	.	.	PUNCT
ajlm-741	205	1	prevalence	prevalence	NOUN
ajlm-741	205	2	of	of	ADP
ajlm-741	205	3	extended	extended	ADJ
ajlm-741	205	4	spectrum	spectrum	NOUN
ajlm-741	205	5	beta	beta	NOUN
ajlm-741	205	6	-	-	PUNCT
ajlm-741	205	7	lactamase	lactamase	NOUN
ajlm-741	205	8	(	(	PUNCT
ajlm-741	205	9	esbl)-producing	esbl)-produce	VERB
ajlm-741	205	10	clinical	clinical	ADJ
ajlm-741	205	11	isolates	isolate	NOUN
ajlm-741	205	12	in	in	ADP
ajlm-741	205	13	the	the	DET
ajlm-741	205	14	asia	asia	PROPN
ajlm-741	205	15	-	-	PUNCT
ajlm-741	205	16	pacific	pacific	PROPN
ajlm-741	205	17	region	region	NOUN
ajlm-741	205	18	and	and	CCONJ
ajlm-741	205	19	south	south	PROPN
ajlm-741	205	20	africa	africa	PROPN
ajlm-741	205	21	:	:	PUNCT
ajlm-741	205	22	regional	regional	ADJ
ajlm-741	205	23	results	result	NOUN
ajlm-741	205	24	from	from	ADP
ajlm-741	205	25	sentry	sentry	NOUN
ajlm-741	205	26	antimicrobial	antimicrobial	ADJ
ajlm-741	205	27	surveillance	surveillance	NOUN
ajlm-741	205	28	program	program	NOUN
ajlm-741	205	29	(	(	PUNCT
ajlm-741	205	30	1998	1998	NUM
ajlm-741	205	31	-	-	SYM
ajlm-741	205	32	99	99	NUM
ajlm-741	205	33	)	)	PUNCT
ajlm-741	205	34	.	.	PUNCT
ajlm-741	206	1	diagn	diagn	PROPN
ajlm-741	206	2	microbiol	microbiol	PROPN
ajlm-741	206	3	infect	infect	VERB
ajlm-741	206	4	dis	dis	PROPN
ajlm-741	206	5	.	.	PUNCT
ajlm-741	207	1	2002;42(3):193–198	2002;42(3):193–198	X
ajlm-741	207	2	.	.	PUNCT
ajlm-741	208	1	https://doi.org/10.1016/s0732-8893(01)00353-4	https://doi.org/10.1016/s0732-8893(01)00353-4	PROPN
ajlm-741	208	2	bell	bell	PROPN
ajlm-741	208	3	jm	jm	PROPN
ajlm-741	208	4	,	,	PUNCT
ajlm-741	208	5	turnidge	turnidge	PROPN
ajlm-741	208	6	jd	jd	PROPN
ajlm-741	208	7	,	,	PUNCT
ajlm-741	208	8	jones	jones	PROPN
ajlm-741	208	9	rn	rn	PROPN
ajlm-741	208	10	,	,	PUNCT
ajlm-741	208	11	group	group	PROPN
ajlm-741	208	12	srp	srp	PROPN
ajlm-741	208	13	.	.	PUNCT
ajlm-741	209	1	antimicrobial	antimicrobial	ADJ
ajlm-741	209	2	resistance	resistance	NOUN
ajlm-741	209	3	trends	trend	NOUN
ajlm-741	209	4	in	in	ADP
ajlm-741	209	5	community	community	NOUN
ajlm-741	209	6	-	-	PUNCT
ajlm-741	209	7	acquired	acquire	VERB
ajlm-741	209	8	respiratory	respiratory	ADJ
ajlm-741	209	9	tract	tract	NOUN
ajlm-741	209	10	pathogens	pathogen	NOUN
ajlm-741	209	11	in	in	ADP
ajlm-741	209	12	the	the	DET
ajlm-741	209	13	western	western	ADJ
ajlm-741	209	14	pacific	pacific	PROPN
ajlm-741	209	15	region	region	NOUN
ajlm-741	209	16	and	and	CCONJ
ajlm-741	209	17	south	south	PROPN
ajlm-741	209	18	africa	africa	PROPN
ajlm-741	209	19	:	:	PUNCT
ajlm-741	209	20	report	report	NOUN
ajlm-741	209	21	from	from	ADP
ajlm-741	209	22	the	the	DET
ajlm-741	209	23	sentry	sentry	NOUN
ajlm-741	209	24	antimicrobial	antimicrobial	ADJ
ajlm-741	209	25	surveillance	surveillance	NOUN
ajlm-741	209	26	program	program	NOUN
ajlm-741	209	27	,	,	PUNCT
ajlm-741	209	28	(	(	PUNCT
ajlm-741	209	29	1998	1998	NUM
ajlm-741	209	30	-	-	SYM
ajlm-741	209	31	1999	1999	NUM
ajlm-741	209	32	)	)	PUNCT
ajlm-741	209	33	including	include	VERB
ajlm-741	209	34	an	an	DET
ajlm-741	209	35	in	in	ADP
ajlm-741	209	36	vitro	vitro	X
ajlm-741	209	37	evaluation	evaluation	NOUN
ajlm-741	209	38	of	of	ADP
ajlm-741	209	39	bms284756	bms284756	NOUN
ajlm-741	209	40	.	.	PUNCT
ajlm-741	210	1	int	int	PROPN
ajlm-741	210	2	j	j	PROPN
ajlm-741	210	3	antimicrob	antimicrob	PROPN
ajlm-741	210	4	agents	agent	NOUN
ajlm-741	210	5	.	.	PUNCT
ajlm-741	211	1	2002;19(2):125–132	2002;19(2):125–132	NUM
ajlm-741	211	2	.	.	PUNCT
ajlm-741	212	1	https://doi.org/10.1016/s0924-8579(01)00475-7	https://doi.org/10.1016/s0924-8579(01)00475-7	PROPN
ajlm-741	212	2	bell	bell	PROPN
ajlm-741	212	3	jm	jm	PROPN
ajlm-741	212	4	,	,	PUNCT
ajlm-741	212	5	turnidge	turnidge	PROPN
ajlm-741	212	6	jd	jd	PROPN
ajlm-741	212	7	,	,	PUNCT
ajlm-741	212	8	sentry	sentry	NOUN
ajlm-741	212	9	a.	a.	PROPN
ajlm-741	212	10	high	high	PROPN
ajlm-741	212	11	prevalence	prevalence	NOUN
ajlm-741	212	12	of	of	ADP
ajlm-741	212	13	oxacillin	oxacillin	NOUN
ajlm-741	212	14	-	-	PUNCT
ajlm-741	212	15	resistant	resistant	ADJ
ajlm-741	212	16	staphylococcus	staphylococcus	NOUN
ajlm-741	212	17	aureus	aureus	NOUN
ajlm-741	212	18	isolates	isolate	NOUN
ajlm-741	212	19	from	from	ADP
ajlm-741	212	20	hospitalized	hospitalize	VERB
ajlm-741	212	21	patients	patient	NOUN
ajlm-741	212	22	in	in	ADP
ajlm-741	212	23	asia	asia	PROPN
ajlm-741	212	24	-	-	PUNCT
ajlm-741	212	25	pacific	pacific	PROPN
ajlm-741	212	26	and	and	CCONJ
ajlm-741	212	27	south	south	PROPN
ajlm-741	212	28	africa	africa	PROPN
ajlm-741	212	29	:	:	PUNCT
ajlm-741	212	30	results	result	NOUN
ajlm-741	212	31	from	from	ADP
ajlm-741	212	32	sentry	sentry	NOUN
ajlm-741	212	33	antimicrobial	antimicrobial	ADJ
ajlm-741	212	34	surveillance	surveillance	NOUN
ajlm-741	212	35	program	program	NOUN
ajlm-741	212	36	,	,	PUNCT
ajlm-741	212	37	1998	1998	NUM
ajlm-741	212	38	-	-	SYM
ajlm-741	212	39	1999	1999	NUM
ajlm-741	212	40	.	.	PUNCT
ajlm-741	213	1	antimicrob	antimicrob	PROPN
ajlm-741	213	2	agents	agents	PROPN
ajlm-741	213	3	chemother	chemother	PROPN
ajlm-741	213	4	.	.	PUNCT
ajlm-741	214	1	2002;46(3):879–881	2002;46(3):879–881	NUM
ajlm-741	214	2	.	.	NOUN
ajlm-741	214	3	https://doi.org/10.1128/aac.46.3.880-882.2002	https://doi.org/10.1128/aac.46.3.880-882.2002	NOUN
ajlm-741	214	4	biedenbach	biedenbach	NOUN
ajlm-741	214	5	dj	dj	PROPN
ajlm-741	214	6	,	,	PUNCT
ajlm-741	214	7	flamm	flamm	PROPN
ajlm-741	214	8	rk	rk	NOUN
ajlm-741	214	9	,	,	PUNCT
ajlm-741	214	10	farrel	farrel	NOUN
ajlm-741	214	11	dj	dj	NOUN
ajlm-741	214	12	,	,	PUNCT
ajlm-741	214	13	sader	sader	PROPN
ajlm-741	214	14	hs	hs	PROPN
ajlm-741	214	15	,	,	PUNCT
ajlm-741	214	16	jones	jones	PROPN
ajlm-741	214	17	rn	rn	PROPN
ajlm-741	214	18	,	,	PUNCT
ajlm-741	214	19	editors	editor	NOUN
ajlm-741	214	20	.	.	PUNCT
ajlm-741	215	1	activity	activity	NOUN
ajlm-741	215	2	of	of	ADP
ajlm-741	215	3	ceftaroline	ceftaroline	NOUN
ajlm-741	215	4	and	and	CCONJ
ajlm-741	215	5	comparator	comparator	NOUN
ajlm-741	215	6	agents	agent	NOUN
ajlm-741	215	7	tested	test	VERB
ajlm-741	215	8	against	against	ADP
ajlm-741	215	9	contemporary	contemporary	ADJ
ajlm-741	215	10	(	(	PUNCT
ajlm-741	215	11	2010	2010	NUM
ajlm-741	215	12	)	)	PUNCT
ajlm-741	215	13	pathogens	pathogen	NOUN
ajlm-741	215	14	commonly	commonly	ADV
ajlm-741	215	15	associated	associate	VERB
ajlm-741	215	16	with	with	ADP
ajlm-741	215	17	respiratory	respiratory	ADJ
ajlm-741	215	18	tract	tract	NOUN
ajlm-741	215	19	infections	infection	NOUN
ajlm-741	215	20	in	in	ADP
ajlm-741	215	21	asia	asia	PROPN
ajlm-741	215	22	-	-	PUNCT
ajlm-741	215	23	pacific	pacific	ADJ
ajlm-741	215	24	countries	country	NOUN
ajlm-741	215	25	and	and	CCONJ
ajlm-741	215	26	south	south	PROPN
ajlm-741	215	27	africa	africa	PROPN
ajlm-741	215	28	.	.	PUNCT
ajlm-741	216	1	interscience	interscience	NOUN
ajlm-741	216	2	conference	conference	NOUN
ajlm-741	216	3	on	on	ADP
ajlm-741	216	4	antimicrobial	antimicrobial	ADJ
ajlm-741	216	5	agents	agent	NOUN
ajlm-741	216	6	and	and	CCONJ
ajlm-741	216	7	chemotherapy	chemotherapy	NOUN
ajlm-741	216	8	(	(	PUNCT
ajlm-741	216	9	icaac	icaac	PROPN
ajlm-741	216	10	)	)	PUNCT
ajlm-741	216	11	;	;	PUNCT
ajlm-741	216	12	sep	sep	PROPN
ajlm-741	216	13	9–12	9–12	PROPN
ajlm-741	216	14	;	;	PUNCT
ajlm-741	216	15	san	san	PROPN
ajlm-741	216	16	francisco	francisco	PROPN
ajlm-741	216	17	,	,	PUNCT
ajlm-741	216	18	ca	ca	NOUN
ajlm-741	216	19	;	;	PUNCT
ajlm-741	216	20	2012	2012	NUM
ajlm-741	216	21	.	.	PUNCT
ajlm-741	217	1	flamm	flamm	PROPN
ajlm-741	217	2	rk	rk	NOUN
ajlm-741	217	3	,	,	PUNCT
ajlm-741	217	4	farrel	farrel	NOUN
ajlm-741	217	5	dj	dj	NOUN
ajlm-741	217	6	,	,	PUNCT
ajlm-741	217	7	sader	sader	PROPN
ajlm-741	217	8	hs	hs	PROPN
ajlm-741	217	9	,	,	PUNCT
ajlm-741	217	10	jones	jones	PROPN
ajlm-741	217	11	rn	rn	PROPN
ajlm-741	217	12	,	,	PUNCT
ajlm-741	217	13	editors	editor	NOUN
ajlm-741	217	14	.	.	PUNCT
ajlm-741	218	1	spectrum	spectrum	NOUN
ajlm-741	218	2	and	and	CCONJ
ajlm-741	218	3	potency	potency	NOUN
ajlm-741	218	4	of	of	ADP
ajlm-741	218	5	ceftaroline	ceftaroline	NOUN
ajlm-741	218	6	against	against	ADP
ajlm-741	218	7	leading	lead	VERB
ajlm-741	218	8	pathogens	pathogen	NOUN
ajlm-741	218	9	causing	cause	VERB
ajlm-741	218	10	skin	skin	NOUN
ajlm-741	218	11	and	and	CCONJ
ajlm-741	218	12	skin	skin	NOUN
ajlm-741	218	13	structure	structure	NOUN
ajlm-741	218	14	infections	infection	NOUN
ajlm-741	218	15	in	in	ADP
ajlm-741	218	16	europe	europe	PROPN
ajlm-741	218	17	and	and	CCONJ
ajlm-741	218	18	south	south	PROPN
ajlm-741	218	19	africa	africa	PROPN
ajlm-741	218	20	,	,	PUNCT
ajlm-741	218	21	2010	2010	NUM
ajlm-741	218	22	.	.	PUNCT
ajlm-741	219	1	interscience	interscience	NOUN
ajlm-741	219	2	conference	conference	NOUN
ajlm-741	219	3	on	on	ADP
ajlm-741	219	4	antimicrobial	antimicrobial	ADJ
ajlm-741	219	5	agents	agent	NOUN
ajlm-741	219	6	and	and	CCONJ
ajlm-741	219	7	chemotherapy	chemotherapy	NOUN
ajlm-741	219	8	(	(	PUNCT
ajlm-741	219	9	icaac	icaac	PROPN
ajlm-741	219	10	)	)	PUNCT
ajlm-741	219	11	;	;	PUNCT
ajlm-741	219	12	sep	sep	PROPN
ajlm-741	219	13	9–12	9–12	PROPN
ajlm-741	219	14	;	;	PUNCT
ajlm-741	219	15	san	san	PROPN
ajlm-741	219	16	francisco	francisco	PROPN
ajlm-741	219	17	,	,	PUNCT
ajlm-741	219	18	ca	ca	NOUN
ajlm-741	219	19	;	;	PUNCT
ajlm-741	219	20	2012	2012	NUM
ajlm-741	219	21	.	.	PUNCT
ajlm-741	220	1	flamm	flamm	PROPN
ajlm-741	220	2	rk	rk	PROPN
ajlm-741	220	3	,	,	PUNCT
ajlm-741	220	4	jones	jones	PROPN
ajlm-741	220	5	rn	rn	PROPN
ajlm-741	220	6	,	,	PUNCT
ajlm-741	220	7	sader	sader	PROPN
ajlm-741	220	8	hs	hs	INTJ
ajlm-741	220	9	.	.	PROPN
ajlm-741	221	1	in	in	ADP
ajlm-741	221	2	vitro	vitro	X
ajlm-741	221	3	activity	activity	NOUN
ajlm-741	221	4	of	of	ADP
ajlm-741	221	5	ceftaroline	ceftaroline	NOUN
ajlm-741	221	6	tested	test	VERB
ajlm-741	221	7	against	against	ADP
ajlm-741	221	8	isolates	isolate	NOUN
ajlm-741	221	9	from	from	ADP
ajlm-741	221	10	the	the	DET
ajlm-741	221	11	asia	asia	PROPN
ajlm-741	221	12	-	-	PUNCT
ajlm-741	221	13	pacific	pacific	PROPN
ajlm-741	221	14	region	region	NOUN
ajlm-741	221	15	and	and	CCONJ
ajlm-741	221	16	south	south	PROPN
ajlm-741	221	17	africa	africa	PROPN
ajlm-741	221	18	(	(	PUNCT
ajlm-741	221	19	2011	2011	NUM
ajlm-741	221	20	)	)	PUNCT
ajlm-741	221	21	.	.	PUNCT
ajlm-741	222	1	j	j	PROPN
ajlm-741	222	2	glob	glob	PROPN
ajlm-741	222	3	antimicrob	antimicrob	PROPN
ajlm-741	222	4	resist	resist	VERB
ajlm-741	222	5	.	.	PUNCT
ajlm-741	223	1	2014;2(3):183–189	2014;2(3):183–189	X
ajlm-741	223	2	.	.	X
ajlm-741	224	1	https://doi.org/10.1016/j.jgar.2014.02.006	https://doi.org/10.1016/j.jgar.2014.02.006	ADJ
ajlm-741	224	2	rhomberg	rhomberg	PROPN
ajlm-741	224	3	pr	pr	PROPN
ajlm-741	224	4	,	,	PUNCT
ajlm-741	224	5	flamm	flamm	PROPN
ajlm-741	224	6	rk	rk	PROPN
ajlm-741	224	7	,	,	PUNCT
ajlm-741	224	8	jones	jones	PROPN
ajlm-741	224	9	rn	rn	PROPN
ajlm-741	224	10	,	,	PUNCT
ajlm-741	224	11	sader	sader	PROPN
ajlm-741	224	12	hs	hs	PROPN
ajlm-741	224	13	,	,	PUNCT
ajlm-741	224	14	editors	editor	NOUN
ajlm-741	224	15	.	.	PUNCT
ajlm-741	225	1	antimicrobial	antimicrobial	ADJ
ajlm-741	225	2	activity	activity	NOUN
ajlm-741	225	3	of	of	ADP
ajlm-741	225	4	ceftaroline	ceftaroline	NOUN
ajlm-741	225	5	and	and	CCONJ
ajlm-741	225	6	comparator	comparator	NOUN
ajlm-741	225	7	agents	agent	NOUN
ajlm-741	225	8	tested	test	VERB
ajlm-741	225	9	against	against	ADP
ajlm-741	225	10	contemporary	contemporary	ADJ
ajlm-741	225	11	(	(	PUNCT
ajlm-741	225	12	2010	2010	NUM
ajlm-741	225	13	)	)	PUNCT
ajlm-741	225	14	pathogens	pathogen	NOUN
ajlm-741	225	15	associated	associate	VERB
ajlm-741	225	16	with	with	ADP
ajlm-741	225	17	acute	acute	ADJ
ajlm-741	225	18	bacterial	bacterial	ADJ
ajlm-741	225	19	skin	skin	NOUN
ajlm-741	225	20	and	and	CCONJ
ajlm-741	225	21	skin	skin	NOUN
ajlm-741	225	22	structure	structure	NOUN
ajlm-741	225	23	infections	infection	NOUN
ajlm-741	225	24	(	(	PUNCT
ajlm-741	225	25	absssi	absssi	ADJ
ajlm-741	225	26	)	)	PUNCT
ajlm-741	225	27	isolated	isolate	VERB
ajlm-741	225	28	from	from	ADP
ajlm-741	225	29	the	the	DET
ajlm-741	225	30	asia	asia	PROPN
ajlm-741	225	31	-	-	PUNCT
ajlm-741	225	32	pacific	pacific	PROPN
ajlm-741	225	33	region	region	NOUN
ajlm-741	225	34	(	(	PUNCT
ajlm-741	225	35	apac	apac	PROPN
ajlm-741	225	36	)	)	PUNCT
ajlm-741	225	37	and	and	CCONJ
ajlm-741	225	38	south	south	PROPN
ajlm-741	225	39	africa	africa	PROPN
ajlm-741	225	40	(	(	PUNCT
ajlm-741	225	41	saf	saf	PROPN
ajlm-741	225	42	)	)	PUNCT
ajlm-741	225	43	.	.	PUNCT
ajlm-741	226	1	interscience	interscience	NOUN
ajlm-741	226	2	conference	conference	NOUN
ajlm-741	226	3	on	on	ADP
ajlm-741	226	4	antimicrobial	antimicrobial	ADJ
ajlm-741	226	5	agents	agent	NOUN
ajlm-741	226	6	and	and	CCONJ
ajlm-741	226	7	chemotherapy	chemotherapy	NOUN
ajlm-741	226	8	(	(	PUNCT
ajlm-741	226	9	icaac	icaac	PROPN
ajlm-741	226	10	)	)	PUNCT
ajlm-741	226	11	;	;	PUNCT
ajlm-741	226	12	sep	sep	PROPN
ajlm-741	226	13	9–12	9–12	PROPN
ajlm-741	226	14	;	;	PUNCT
ajlm-741	226	15	san	san	PROPN
ajlm-741	226	16	francisco	francisco	PROPN
ajlm-741	226	17	,	,	PUNCT
ajlm-741	226	18	ca	ca	NOUN
ajlm-741	226	19	;	;	PUNCT
ajlm-741	226	20	2012	2012	NUM
ajlm-741	226	21	.	.	PUNCT
ajlm-741	227	1	rhomberg	rhomberg	PROPN
ajlm-741	227	2	pr	pr	PROPN
ajlm-741	227	3	,	,	PUNCT
ajlm-741	227	4	flamm	flamm	PROPN
ajlm-741	227	5	rk	rk	PROPN
ajlm-741	227	6	,	,	PUNCT
ajlm-741	227	7	jones	jones	PROPN
ajlm-741	227	8	rn	rn	PROPN
ajlm-741	227	9	,	,	PUNCT
ajlm-741	227	10	sader	sader	PROPN
ajlm-741	227	11	hs	hs	PROPN
ajlm-741	227	12	,	,	PUNCT
ajlm-741	227	13	editors	editor	NOUN
ajlm-741	227	14	.	.	PUNCT
ajlm-741	228	1	ceftaroline	ceftaroline	NOUN
ajlm-741	228	2	and	and	CCONJ
ajlm-741	228	3	comparator	comparator	NOUN
ajlm-741	228	4	agent	agent	NOUN
ajlm-741	228	5	activity	activity	NOUN
ajlm-741	228	6	against	against	ADP
ajlm-741	228	7	contemporary	contemporary	ADJ
ajlm-741	228	8	(	(	PUNCT
ajlm-741	228	9	2010	2010	NUM
ajlm-741	228	10	)	)	PUNCT
ajlm-741	228	11	staphylococcus	staphylococcus	NOUN
ajlm-741	228	12	aureus	aureus	NOUN
ajlm-741	228	13	isolates	isolate	NOUN
ajlm-741	228	14	from	from	ADP
ajlm-741	228	15	asia	asia	PROPN
ajlm-741	228	16	-	-	PUNCT
ajlm-741	228	17	pacific	pacific	PROPN
ajlm-741	228	18	region	region	NOUN
ajlm-741	228	19	and	and	CCONJ
ajlm-741	228	20	south	south	PROPN
ajlm-741	228	21	africa	africa	PROPN
ajlm-741	228	22	hospitals	hospital	NOUN
ajlm-741	228	23	.	.	PUNCT
ajlm-741	229	1	interscience	interscience	NOUN
ajlm-741	229	2	conference	conference	NOUN
ajlm-741	229	3	on	on	ADP
ajlm-741	229	4	antimicrobial	antimicrobial	ADJ
ajlm-741	229	5	agents	agent	NOUN
ajlm-741	229	6	and	and	CCONJ
ajlm-741	229	7	chemotherapy	chemotherapy	NOUN
ajlm-741	229	8	(	(	PUNCT
ajlm-741	229	9	icaac	icaac	PROPN
ajlm-741	229	10	)	)	PUNCT
ajlm-741	229	11	;	;	PUNCT
ajlm-741	229	12	sep	sep	PROPN
ajlm-741	229	13	9–12	9–12	PROPN
ajlm-741	229	14	;	;	PUNCT
ajlm-741	229	15	san	san	PROPN
ajlm-741	229	16	fransisco	fransisco	PROPN
ajlm-741	229	17	,	,	PUNCT
ajlm-741	229	18	ca	ca	PROPN
ajlm-741	229	19	;	;	PUNCT
ajlm-741	229	20	2012	2012	NUM
ajlm-741	229	21	.	.	PUNCT
ajlm-741	230	1	sader	sader	PROPN
ajlm-741	230	2	hs	hs	PROPN
ajlm-741	230	3	,	,	PUNCT
ajlm-741	230	4	farrel	farrel	NOUN
ajlm-741	230	5	dj	dj	PROPN
ajlm-741	230	6	,	,	PUNCT
ajlm-741	230	7	flamm	flamm	PROPN
ajlm-741	230	8	rk	rk	PROPN
ajlm-741	230	9	,	,	PUNCT
ajlm-741	230	10	jones	jones	PROPN
ajlm-741	230	11	rn	rn	PROPN
ajlm-741	230	12	,	,	PUNCT
ajlm-741	230	13	editors	editor	NOUN
ajlm-741	230	14	.	.	PUNCT
ajlm-741	231	1	antimicrobial	antimicrobial	ADJ
ajlm-741	231	2	activity	activity	NOUN
ajlm-741	231	3	of	of	ADP
ajlm-741	231	4	ceftaroline	ceftaroline	NOUN
ajlm-741	231	5	and	and	CCONJ
ajlm-741	231	6	comparator	comparator	NOUN
ajlm-741	231	7	agents	agent	NOUN
ajlm-741	231	8	against	against	ADP
ajlm-741	231	9	contemporary	contemporary	ADJ
ajlm-741	231	10	(	(	PUNCT
ajlm-741	231	11	2010	2010	NUM
ajlm-741	231	12	)	)	PUNCT
ajlm-741	231	13	staphylococcus	staphylococcus	NOUN
ajlm-741	231	14	aureus	aureus	NOUN
ajlm-741	231	15	isolates	isolate	NOUN
ajlm-741	231	16	from	from	ADP
ajlm-741	231	17	europe	europe	PROPN
ajlm-741	231	18	and	and	CCONJ
ajlm-741	231	19	south	south	PROPN
ajlm-741	231	20	africa	africa	PROPN
ajlm-741	231	21	.	.	PUNCT
ajlm-741	232	1	interscience	interscience	NOUN
ajlm-741	232	2	conference	conference	NOUN
ajlm-741	232	3	on	on	ADP
ajlm-741	232	4	antimicrobial	antimicrobial	ADJ
ajlm-741	232	5	agents	agent	NOUN
ajlm-741	232	6	and	and	CCONJ
ajlm-741	232	7	chemotherapy	chemotherapy	NOUN
ajlm-741	232	8	(	(	PUNCT
ajlm-741	232	9	icaac	icaac	PROPN
ajlm-741	232	10	)	)	PUNCT
ajlm-741	232	11	;	;	PUNCT
ajlm-741	232	12	sep	sep	PROPN
ajlm-741	232	13	9–12	9–12	PROPN
ajlm-741	232	14	;	;	PUNCT
ajlm-741	232	15	san	san	PROPN
ajlm-741	232	16	francisco	francisco	PROPN
ajlm-741	232	17	,	,	PUNCT
ajlm-741	232	18	ca	ca	NOUN
ajlm-741	232	19	;	;	PUNCT
ajlm-741	232	20	2012	2012	NUM
ajlm-741	232	21	.	.	PUNCT
ajlm-741	233	1	sader	sader	PROPN
ajlm-741	233	2	hs	hs	PROPN
ajlm-741	233	3	,	,	PUNCT
ajlm-741	233	4	flamm	flamm	PROPN
ajlm-741	233	5	rk	rk	PROPN
ajlm-741	233	6	,	,	PUNCT
ajlm-741	233	7	jones	jones	PROPN
ajlm-741	233	8	rn	rn	PROPN
ajlm-741	233	9	.	.	PROPN
ajlm-741	233	10	antimicrobial	antimicrobial	ADJ
ajlm-741	233	11	activity	activity	NOUN
ajlm-741	233	12	of	of	ADP
ajlm-741	233	13	ceftaroline	ceftaroline	NOUN
ajlm-741	233	14	and	and	CCONJ
ajlm-741	233	15	comparator	comparator	NOUN
ajlm-741	233	16	agents	agent	NOUN
ajlm-741	233	17	tested	test	VERB
ajlm-741	233	18	against	against	ADP
ajlm-741	233	19	bacterial	bacterial	ADJ
ajlm-741	233	20	isolates	isolate	NOUN
ajlm-741	233	21	causing	cause	VERB
ajlm-741	233	22	skin	skin	NOUN
ajlm-741	233	23	and	and	CCONJ
ajlm-741	233	24	soft	soft	ADJ
ajlm-741	233	25	tissue	tissue	NOUN
ajlm-741	233	26	infections	infection	NOUN
ajlm-741	233	27	and	and	CCONJ
ajlm-741	233	28	community	community	NOUN
ajlm-741	233	29	-	-	PUNCT
ajlm-741	233	30	acquired	acquire	VERB
ajlm-741	233	31	respiratory	respiratory	ADJ
ajlm-741	233	32	tract	tract	NOUN
ajlm-741	233	33	infections	infection	NOUN
ajlm-741	233	34	isolated	isolate	VERB
ajlm-741	233	35	from	from	ADP
ajlm-741	233	36	the	the	DET
ajlm-741	233	37	asia	asia	PROPN
ajlm-741	233	38	-	-	PUNCT
ajlm-741	233	39	pacific	pacific	PROPN
ajlm-741	233	40	region	region	NOUN
ajlm-741	233	41	and	and	CCONJ
ajlm-741	233	42	south	south	PROPN
ajlm-741	233	43	africa	africa	PROPN
ajlm-741	233	44	(	(	PUNCT
ajlm-741	233	45	2010	2010	NUM
ajlm-741	233	46	)	)	PUNCT
ajlm-741	233	47	.	.	PUNCT
ajlm-741	234	1	diagn	diagn	PROPN
ajlm-741	234	2	microbiol	microbiol	PROPN
ajlm-741	234	3	infect	infect	VERB
ajlm-741	234	4	dis	dis	PROPN
ajlm-741	234	5	.	.	PUNCT
ajlm-741	235	1	2013;76(1):61–68	2013;76(1):61–68	NUM
ajlm-741	235	2	.	.	PUNCT
ajlm-741	235	3	https://doi.org/10.1016/j.diagmicrobio.2013.01.005	https://doi.org/10.1016/j.diagmicrobio.2013.01.005	PROPN
ajlm-741	235	4	dramowski	dramowski	PROPN
ajlm-741	235	5	a	a	X
ajlm-741	235	6	,	,	PUNCT
ajlm-741	235	7	cotton	cotton	NOUN
ajlm-741	235	8	mf	mf	NOUN
ajlm-741	235	9	,	,	PUNCT
ajlm-741	235	10	whitelaw	whitelaw	PROPN
ajlm-741	235	11	a.	a.	NOUN
ajlm-741	235	12	surveillance	surveillance	NOUN
ajlm-741	235	13	of	of	ADP
ajlm-741	235	14	healthcare	healthcare	NOUN
ajlm-741	235	15	-	-	PUNCT
ajlm-741	235	16	associated	associate	VERB
ajlm-741	235	17	infection	infection	NOUN
ajlm-741	235	18	in	in	ADP
ajlm-741	235	19	hospitalised	hospitalise	VERB
ajlm-741	235	20	south	south	ADJ
ajlm-741	235	21	afrcian	afrcian	ADJ
ajlm-741	235	22	children	child	NOUN
ajlm-741	235	23	:	:	PUNCT
ajlm-741	235	24	which	which	DET
ajlm-741	235	25	method	method	NOUN
ajlm-741	235	26	performs	perform	VERB
ajlm-741	235	27	best	well	ADV
ajlm-741	235	28	?	?	PUNCT
ajlm-741	236	1	samj	samj	NOUN
ajlm-741	236	2	.	.	PUNCT
ajlm-741	237	1	2017;107(156–163	2017;107(156–163	NUM
ajlm-741	237	2	)	)	PUNCT
ajlm-741	237	3	.	.	PUNCT
ajlm-741	238	1	perovic	perovic	ADJ
ajlm-741	238	2	o	o	NOUN
ajlm-741	238	3	,	,	PUNCT
ajlm-741	238	4	chetty	chetty	VERB
ajlm-741	238	5	v	v	NOUN
ajlm-741	238	6	,	,	PUNCT
ajlm-741	238	7	iyloo	iyloo	PROPN
ajlm-741	238	8	s.	s.	PROPN
ajlm-741	238	9	antimicrobial	antimicrobial	PROPN
ajlm-741	238	10	resistance	resistance	NOUN
ajlm-741	238	11	surveillance	surveillance	NOUN
ajlm-741	238	12	from	from	ADP
ajlm-741	238	13	sentinal	sentinal	ADJ
ajlm-741	238	14	public	public	ADJ
ajlm-741	238	15	hospitals	hospital	NOUN
ajlm-741	238	16	,	,	PUNCT
ajlm-741	238	17	south	south	PROPN
ajlm-741	238	18	africa	africa	PROPN
ajlm-741	238	19	,	,	PUNCT
ajlm-741	238	20	2014	2014	NUM
ajlm-741	238	21	.	.	PUNCT
ajlm-741	239	1	communicable	communicable	NOUN
ajlm-741	239	2	diseases	disease	NOUN
ajlm-741	239	3	surveillance	surveillance	NOUN
ajlm-741	239	4	bulletin	bulletin	NOUN
ajlm-741	239	5	.	.	PUNCT
ajlm-741	240	1	pretoria	pretoria	PROPN
ajlm-741	240	2	:	:	PUNCT
ajlm-741	240	3	nicd	nicd	NOUN
ajlm-741	240	4	;	;	PUNCT
ajlm-741	240	5	2014	2014	NUM
ajlm-741	240	6	.	.	PUNCT
ajlm-741	241	1	fortuin	fortuin	ADJ
ajlm-741	241	2	-	-	PUNCT
ajlm-741	241	3	de	de	X
ajlm-741	241	4	smidt	smidt	PROPN
ajlm-741	241	5	mc	mc	PROPN
ajlm-741	241	6	,	,	PUNCT
ajlm-741	241	7	singh	singh	ADJ
ajlm-741	241	8	-	-	PUNCT
ajlm-741	241	9	moodley	moodley	NOUN
ajlm-741	241	10	a	a	NOUN
ajlm-741	241	11	,	,	PUNCT
ajlm-741	241	12	badat	badat	PROPN
ajlm-741	241	13	r	r	NOUN
ajlm-741	241	14	,	,	PUNCT
ajlm-741	241	15	et	et	PROPN
ajlm-741	241	16	al	al	PROPN
ajlm-741	241	17	.	.	PROPN
ajlm-741	241	18	staphylococcus	staphylococcus	PROPN
ajlm-741	241	19	aureus	aureus	PROPN
ajlm-741	241	20	bacteraemia	bacteraemia	PROPN
ajlm-741	241	21	in	in	ADP
ajlm-741	241	22	gauteng	gauteng	PROPN
ajlm-741	241	23	academic	academic	ADJ
ajlm-741	241	24	hospitals	hospital	NOUN
ajlm-741	241	25	,	,	PUNCT
ajlm-741	241	26	south	south	PROPN
ajlm-741	241	27	africa	africa	PROPN
ajlm-741	241	28	.	.	PUNCT
ajlm-741	242	1	int	int	PROPN
ajlm-741	242	2	j	j	PROPN
ajlm-741	242	3	infect	infect	VERB
ajlm-741	242	4	dis	dis	PROPN
ajlm-741	242	5	.	.	PUNCT
ajlm-741	243	1	2015;30:41–48	2015;30:41–48	NUM
ajlm-741	243	2	.	.	PUNCT
ajlm-741	244	1	https://doi.org/10.1016/j.ijid.2014.10.011	https://doi.org/10.1016/j.ijid.2014.10.011	PROPN
ajlm-741	244	2	jansen	jansen	PROPN
ajlm-741	244	3	van	van	PROPN
ajlm-741	244	4	rensburg	rensburg	PROPN
ajlm-741	244	5	mj	mj	PROPN
ajlm-741	244	6	,	,	PUNCT
ajlm-741	244	7	madikane	madikane	PROPN
ajlm-741	244	8	ve	ve	PROPN
ajlm-741	244	9	,	,	PUNCT
ajlm-741	244	10	whitelaw	whitelaw	PROPN
ajlm-741	244	11	a	a	PRON
ajlm-741	244	12	,	,	PUNCT
ajlm-741	244	13	chachage	chachage	NOUN
ajlm-741	244	14	m	m	NOUN
ajlm-741	244	15	,	,	PUNCT
ajlm-741	244	16	haffejee	haffejee	NOUN
ajlm-741	244	17	s	s	PROPN
ajlm-741	244	18	,	,	PUNCT
ajlm-741	244	19	elisha	elisha	PROPN
ajlm-741	244	20	bg	bg	PROPN
ajlm-741	244	21	.	.	PUNCT
ajlm-741	245	1	the	the	DET
ajlm-741	245	2	dominant	dominant	ADJ
ajlm-741	245	3	methicillin	methicillin	NOUN
ajlm-741	245	4	-	-	PUNCT
ajlm-741	245	5	resistant	resistant	ADJ
ajlm-741	245	6	staphylococcus	staphylococcus	NOUN
ajlm-741	245	7	aureus	aureus	NOUN
ajlm-741	245	8	clone	clone	NOUN
ajlm-741	245	9	from	from	ADP
ajlm-741	245	10	hospitals	hospital	NOUN
ajlm-741	245	11	in	in	ADP
ajlm-741	245	12	cape	cape	NOUN
ajlm-741	245	13	town	town	NOUN
ajlm-741	245	14	has	have	VERB
ajlm-741	245	15	an	an	DET
ajlm-741	245	16	unusual	unusual	ADJ
ajlm-741	245	17	genotype	genotype	NOUN
ajlm-741	245	18	:	:	PUNCT
ajlm-741	245	19	st612	st612	PROPN
ajlm-741	245	20	.	.	PUNCT
ajlm-741	246	1	clin	clin	PROPN
ajlm-741	246	2	microbiol	microbiol	PROPN
ajlm-741	246	3	and	and	CCONJ
ajlm-741	246	4	infect	infect	VERB
ajlm-741	246	5	dis	dis	PROPN
ajlm-741	246	6	.	.	PUNCT
ajlm-741	246	7	2011;17:785–792	2011;17:785–792	NUM
ajlm-741	246	8	.	.	PUNCT
ajlm-741	247	1	https://doi.org/10.1111/j.1469-0691.2010.03373.x	https://doi.org/10.1111/j.1469-0691.2010.03373.x	PROPN
ajlm-741	247	2	moodley	moodley	PROPN
ajlm-741	247	3	a	a	PRON
ajlm-741	247	4	,	,	PUNCT
ajlm-741	247	5	oosthuysen	oosthuysen	NOUN
ajlm-741	247	6	wf	wf	PROPN
ajlm-741	247	7	,	,	PUNCT
ajlm-741	247	8	duse	duse	PROPN
ajlm-741	247	9	ag	ag	PROPN
ajlm-741	247	10	,	,	PUNCT
ajlm-741	247	11	marais	marais	PROPN
ajlm-741	247	12	e.	e.	PROPN
ajlm-741	247	13	molecular	molecular	ADJ
ajlm-741	247	14	characterization	characterization	NOUN
ajlm-741	247	15	of	of	ADP
ajlm-741	247	16	clinical	clinical	ADJ
ajlm-741	247	17	methicillin	methicillin	NOUN
ajlm-741	247	18	-	-	PUNCT
ajlm-741	247	19	resistant	resistant	ADJ
ajlm-741	247	20	staphylococcus	staphylococcus	NOUN
ajlm-741	247	21	aureus	aureus	NOUN
ajlm-741	247	22	isolates	isolate	NOUN
ajlm-741	247	23	in	in	ADP
ajlm-741	247	24	south	south	PROPN
ajlm-741	247	25	africa	africa	PROPN
ajlm-741	247	26	.	.	PUNCT
ajlm-741	248	1	j	j	PROPN
ajlm-741	248	2	clin	clin	PROPN
ajlm-741	248	3	microbiol	microbiol	PROPN
ajlm-741	248	4	.	.	PUNCT
ajlm-741	249	1	2010;48(12):4608–4611	2010;48(12):4608–4611	X
ajlm-741	249	2	.	.	PUNCT
ajlm-741	250	1	https://doi.org/10.1128/jcm.01704-10	https://doi.org/10.1128/jcm.01704-10	INTJ
ajlm-741	250	2	orth	orth	PROPN
ajlm-741	250	3	h	h	NOUN
ajlm-741	250	4	,	,	PUNCT
ajlm-741	250	5	dreyer	dreyer	PROPN
ajlm-741	250	6	zs	zs	PROPN
ajlm-741	250	7	,	,	PUNCT
ajlm-741	250	8	makgotlho	makgotlho	PROPN
ajlm-741	250	9	e	e	PROPN
ajlm-741	250	10	,	,	PUNCT
ajlm-741	250	11	oosthuysen	oosthuysen	PROPN
ajlm-741	250	12	wf	wf	PROPN
ajlm-741	250	13	,	,	PUNCT
ajlm-741	250	14	sinha	sinha	PROPN
ajlm-741	250	15	a	a	PROPN
ajlm-741	250	16	,	,	PUNCT
ajlm-741	250	17	wasserman	wasserman	PROPN
ajlm-741	250	18	e.	e.	PROPN
ajlm-741	250	19	characterisation	characterisation	PROPN
ajlm-741	250	20	of	of	ADP
ajlm-741	250	21	staphylococcus	staphylococcus	NOUN
ajlm-741	250	22	aureus	aureus	PROPN
ajlm-741	250	23	bacteraemia	bacteraemia	NOUN
ajlm-741	250	24	at	at	ADP
ajlm-741	250	25	tygerberg	tygerberg	PROPN
ajlm-741	250	26	hospital	hospital	NOUN
ajlm-741	250	27	.	.	PUNCT
ajlm-741	251	1	south	south	PROPN
ajlm-741	251	2	afr	afr	PROPN
ajlm-741	251	3	j	j	PROPN
ajlm-741	251	4	epidemiol	epidemiol	PROPN
ajlm-741	251	5	infect	infect	PROPN
ajlm-741	251	6	.	.	PUNCT
ajlm-741	252	1	2013;28(1):22–27	2013;28(1):22–27	NUM
ajlm-741	252	2	.	.	PUNCT
ajlm-741	252	3	https://doi.org/10.1080/10158782.2013.11441515	https://doi.org/10.1080/10158782.2013.11441515	NOUN